TWI833040B - Quantum dot, curable composition comprising the same, cured layer using the composition, and color filter including the cured layer - Google Patents

Quantum dot, curable composition comprising the same, cured layer using the composition, and color filter including the cured layer Download PDF

Info

Publication number
TWI833040B
TWI833040B TW109132893A TW109132893A TWI833040B TW I833040 B TWI833040 B TW I833040B TW 109132893 A TW109132893 A TW 109132893A TW 109132893 A TW109132893 A TW 109132893A TW I833040 B TWI833040 B TW I833040B
Authority
TW
Taiwan
Prior art keywords
chemical formula
group
substituted
unsubstituted
vinyl
Prior art date
Application number
TW109132893A
Other languages
Chinese (zh)
Other versions
TW202116720A (en
Inventor
姜龍熙
金鐘基
林知泫
金東俊
金美善
朴民志
李範珍
李仁宰
崔美貞
Original Assignee
南韓商三星Sdi股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 南韓商三星Sdi股份有限公司 filed Critical 南韓商三星Sdi股份有限公司
Publication of TW202116720A publication Critical patent/TW202116720A/en
Application granted granted Critical
Publication of TWI833040B publication Critical patent/TWI833040B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/02Use of particular materials as binders, particle coatings or suspension media therefor
    • C09K11/025Use of particular materials as binders, particle coatings or suspension media therefor non-luminescent particle coatings or suspension media
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y20/00Nanooptics, e.g. quantum optics or photonic crystals
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00Manufacture or treatment of nanostructures
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/44Polymerisation in the presence of compounding ingredients, e.g. plasticisers, dyestuffs, fillers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/10Esters
    • C08F20/26Esters containing oxygen in addition to the carboxy oxygen
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F22/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides or nitriles thereof
    • C08F22/10Esters
    • C08F22/1006Esters of polyhydric alcohols or polyhydric phenols, e.g. ethylene glycol dimethacrylate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/09Carboxylic acids; Metal salts thereof; Anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/36Sulfur-, selenium-, or tellurium-containing compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K9/00Use of pretreated ingredients
    • C08K9/04Ingredients treated with organic substances
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/62Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing gallium, indium or thallium
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/66Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing germanium, tin or lead
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/70Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing phosphorus
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/88Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing selenium, tellurium or unspecified chalcogen elements
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/89Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing mercury
    • C09K11/892Chalcogenides
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B5/00Optical elements other than lenses
    • G02B5/20Filters
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/027Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
    • G03F7/032Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds with binders
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1007Non-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1011Condensed systems

Abstract

Provided are a quantum dot surface-modified with a compound represented by Chemical Formula 1, a curable composition including the quantum dot, a cured layer, and a color filter.

Description

量子點、包括其的可固化組成物、使用所述組成物的固化層以及包括所述固化層的彩色濾光片Quantum dots, curable compositions including the same, cured layers using the compositions, and color filters including the cured layers

[相關申請案的交叉參考][Cross-reference to related applications]

本申請案主張於2019年10月14日在韓國智慧財產局提出申請的韓國專利申請案第10-2019-0127123號的優先權及權利,所述韓國專利申請案的全部內容併入本案供參考。 This application claims the priority and rights of Korean Patent Application No. 10-2019-0127123, which was filed with the Korean Intellectual Property Office on October 14, 2019. The entire content of the Korean patent application is incorporated into this case for reference. .

本揭露是有關於一種量子點、一種包括其的可固化組成物、一種使用所述組成物的固化層以及一種包括所述固化層的彩色濾光片。 The present disclosure relates to a quantum dot, a curable composition including the same, a cured layer using the composition, and a color filter including the cured layer.

在一般量子點的情況下,由於具有疏水性的表面特性,其中分散量子點的溶劑是有限的。因此,難以將其引入極性體系,例如黏合劑或可固化單體。 In the case of general quantum dots, the solvents in which quantum dots are dispersed are limited due to their hydrophobic surface properties. Therefore, it is difficult to introduce them into polar systems such as adhesives or curable monomers.

例如,即使在積極研究量子點油墨組成物的情況下,極性在初始步驟中相對低,且其可分散在用於具有高疏水性的可固化組成物的溶劑中。因此,由於以組成物的總量計,難以包含20重量%或大於20重量%的量子點,因此無法將油墨的光效率提高至超過某一水準。儘管另外添加及分散量子點來提高光效率,但黏度會超過能夠噴墨的範圍(12厘泊),且因此可能無法滿足可處理性。For example, even where quantum dot ink compositions are actively studied, the polarity is relatively low in the initial step, and it may be dispersed in a solvent for a curable composition with high hydrophobicity. Therefore, since it is difficult to contain 20% by weight or more of quantum dots based on the total amount of the composition, the optical efficiency of the ink cannot be increased beyond a certain level. Although quantum dots are additionally added and dispersed to improve light efficiency, the viscosity will exceed the range capable of inkjet (12 centipoise), and therefore handleability may not be satisfied.

為獲得能夠噴墨的黏度範圍,一種藉由溶解以組成物的總量計50重量%或大於50重量%的溶劑來降低油墨固體含量的方法,其在黏度方面亦提供稍微令人滿意的結果。然而,就黏度而言,其可被認為是令人滿意的結果,但由於溶劑揮發而導致的噴嘴乾燥、噴嘴堵塞及噴射後隨著時間流逝單層減少可能變得更差,且難以控制固化後的厚度偏差。因此,難以將其應用於實際製程。To obtain a viscosity range capable of jetting, a method of reducing the solids content of the ink by dissolving 50% or more of the solvent based on the total weight of the composition also provides somewhat satisfactory results in terms of viscosity . However, in terms of viscosity, it can be considered a satisfactory result, but may become worse due to drying of the nozzle due to solvent evaporation, clogging of the nozzle and reduction of the monolayer over time after spraying, and difficulty in controlling the curing thickness deviation after. Therefore, it is difficult to apply it to actual manufacturing processes.

因此,不包含溶劑的無溶劑量子點油墨是應用於實際製程的最期望形式。將量子點本身應用於溶劑型組成物的當前技術現在受到一定程度的限制。Therefore, solvent-free quantum dot inks that do not contain solvents are the most desirable form for practical process applications. Current technologies for applying quantum dots themselves to solvent-based compositions are now somewhat limited.

如迄今所報導的,在待應用於實際製程的最期望的溶劑型組成物的情況下,以溶劑型組成物的總量計,未被表面改質(例如配位體取代)的量子點具有20重量%至25重量%的含量。因此,由於黏度限制,難以提高光效率及吸收率。同時,已經嘗試在其他改進途徑中降低量子點含量且增加光擴散劑(散射體)的含量,但此亦未能解決沈澱問題及低光效率問題。As reported so far, in the case of the most desirable solvent-based compositions to be applied in practical processes, quantum dots that are not surface modified (e.g., ligand substituted) have, based on the total amount of the solvent-based composition, Content of 20% to 25% by weight. Therefore, it is difficult to improve the optical efficiency and absorbance due to viscosity limitations. At the same time, attempts have been made to reduce the quantum dot content and increase the light diffusing agent (scatterer) content in other improvement approaches, but this has also failed to solve the precipitation problem and low light efficiency.

一實施例是提供一種量子點,所述量子點用具有優異鈍化效果的化合物進行表面改質,且因此具有提高的光效率。One embodiment provides a quantum dot that is surface-modified with a compound having an excellent passivation effect and therefore has improved light efficiency.

另一實施例是提供一種含量子點的可固化組成物。Another embodiment provides a curable composition containing quantum dots.

另一實施例是提供一種使用所述可固化組成物生產的固化層。Another embodiment provides a cured layer produced using the curable composition.

另一實施例是提供一種包括所述固化層的彩色濾光片。Another embodiment provides a color filter including the solidified layer.

一實施例提供一種用由化學式1表示的化合物進行表面改質的量子點。One embodiment provides a quantum dot surface-modified with a compound represented by Chemical Formula 1.

[化學式1] [Chemical formula 1]

在化學式1中, R1 是羧基、*-P(=O)(OH)2 或硫醇基,且 R2 是「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C1至C20烷基」、「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C1至C20烷氧基」、「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C6至C20芳基」或者「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C6至C20芳氧基」,或「由化學式1A表示」, [化學式1A] 其中,在化學式1A中, R3 是「經取代或未經取代的乙烯基」、「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C1至C20烷基」或者「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C2至C20烯基」,且 L1 是「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20伸烷基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C3至C20伸環烷基」或「由化學式1B-1-1至化學式1B-7-2中的一者表示」, [化學式1B-1-1] [化學式1B-1-2] [化學式1B-2-1] [化學式1B-2-2] [化學式1B-3-1] In Chemical Formula 1, R 1 is a carboxyl group, *-P(=O)(OH) 2 or a thiol group, and R 2 is "unsubstituted or substituted by vinyl, allyl, epoxy, (methyl ) acrylate group, C1 to C10 alkyl group or C6 to C12 aryl group substituted C1 to C20 alkyl group", "unsubstituted or vinyl, allyl, epoxy group, (meth)acrylate group, C1 to C20 alkoxy substituted by C1 to C10 alkyl or C6 to C12 aryl", "unsubstituted or substituted by vinyl, allyl, epoxy, (meth)acrylate group, C1 to C10 alkyl "C6 to C20 aryl group substituted by C6 to C12 aryl group" or "unsubstituted or substituted by vinyl group, allyl group, epoxy group, (meth)acrylate group, C1 to C10 alkyl group or C6 to C12 Aryl-substituted C6 to C20 aryloxy group", or "represented by Chemical Formula 1A", [Chemical Formula 1A] Wherein, in Chemical Formula 1A, R 3 is "substituted or unsubstituted vinyl group", "unsubstituted or vinyl group, allyl group, epoxy group, (meth)acrylate group, C1 to C10 Alkyl or C6 to C12 aryl substituted C1 to C20 alkyl" or "unsubstituted or vinyl, allyl, epoxy, (meth)acrylate group, C1 to C10 alkyl or C6 to C12 aryl-substituted C2 to C20 alkenyl", and L 1 is "C1 to C20 alkylene unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group" or "C3 to C20 cycloalkyl group that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group" or "from Chemical Formula 1B-1-1 to Chemical Formula 1B-7-2 "One of the expressions", [Chemical Formula 1B-1-1] [Chemical formula 1B-1-2] [Chemical formula 1B-2-1] [Chemical formula 1B-2-2] [Chemical formula 1B-3-1]

[化學式1B-3-2]

Figure 109132893-A0305-02-0008-1
[Chemical formula 1B-3-2]
Figure 109132893-A0305-02-0008-1

Figure 109132893-A0305-02-0008-2
Figure 109132893-A0305-02-0008-2

Figure 109132893-A0305-02-0008-3
Figure 109132893-A0305-02-0008-3

Figure 109132893-A0305-02-0008-4
Figure 109132893-A0305-02-0008-4

[化學式1B-5-2] [化學式1B-6-1] [化學式1B-6-2] [化學式1B-7-1] [化學式1B-7-2] 其中,在化學式1B-1-1至化學式1B-7-2中, Ra 及Rb 獨立地是氫原子或羧基, Rc 是O、S、NH、C1至C20伸烷基、C1至C20烷基胺基或C2至C20烯丙基胺基, L2 是單鍵、*-C(=O)O-*或*-S-*,且 L3 由化學式1C-1或化學式1C-2表示, [化學式1C-1] [化學式1C-2] 其中,在化學式1C-1及化學式1C-2中, L4 是單鍵或者經取代或未經取代的C1至C20伸烷基, L5 是經取代或未經取代的C1至C20伸烷基, m是1至20的整數,且 n是1或2的整數。[Chemical formula 1B-5-2] [Chemical formula 1B-6-1] [Chemical formula 1B-6-2] [Chemical formula 1B-7-1] [Chemical formula 1B-7-2] Wherein, in Chemical Formula 1B-1-1 to Chemical Formula 1B-7-2, R a and R b are independently a hydrogen atom or a carboxyl group, and R c is O, S, NH, C1 to C20 alkylene group, C1 to C20 Alkylamino group or C2 to C20 allylamine group, L 2 is a single bond, *-C(=O)O-* or *-S-*, and L 3 is composed of Chemical Formula 1C-1 or Chemical Formula 1C-2 represents, [Chemical Formula 1C-1] [Chemical formula 1C-2] Wherein, in Chemical Formula 1C-1 and Chemical Formula 1C-2, L 4 is a single bond or a substituted or unsubstituted C1 to C20 alkylene group, and L 5 is a substituted or unsubstituted C1 to C20 alkylene group. , m is an integer from 1 to 20, and n is an integer from 1 or 2.

所述由化學式1表示的化合物可由化學式2表示。The compound represented by Chemical Formula 1 may be represented by Chemical Formula 2.

[化學式2] [Chemical formula 2]

在化學式2中, R2 可為「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C1至C20烷基」、「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C1至C20烷氧基」、「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C6至C20芳基」或者「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C6至C20芳氧基」,或「可由化學式1A表示」, [化學式1A] 其中,在化學式1A中, R3 可為「經取代或未經取代的乙烯基」、「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C1至C20烷基」或者「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C2至C20烯基」,且 L1 可為「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20伸烷基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C3至C20伸環烷基」或「可由化學式1B-1-1、化學式1B-2-1、化學式1B-3-1、化學式1B-4-1、化學式1B-5-1、化學式1B-6-1及化學式1B-7-1中的一者表示」, [化學式1B-1-1] [化學式1B-2-1] [化學式1B-3-1] [化學式1B-4-1] [化學式1B-5-1] [化學式1B-6-1] [化學式1B-7-1] 其中,在化學式1B-1-1至化學式1B-7-1中, Ra 及Rb 可獨立地為氫原子或羧基, Rc 可為O、S、NH、C1至C20伸烷基、C1至C20烷基胺基或C2至C20烯丙基胺基, L2 可為單鍵、*-C(=O)O-*或*-S-*,且 L3 可由化學式1C-1或化學式1C-2表示, [化學式1C-1] [化學式1C-2] 其中,在化學式1C-1及化學式1C-2中, L4 可為單鍵或者經取代或未經取代的C1至C20伸烷基, L5 可為經取代或未經取代的C1至C20伸烷基,且 m可為1至20的整數。In Chemical Formula 2, R 2 may be "C1 to C20 that is unsubstituted or substituted by vinyl, allyl, epoxy, (meth)acrylate, C1 to C10 alkyl, or C6 to C12 aryl. "Alkyl", "C1 to C20 alkoxy that is unsubstituted or substituted by vinyl, allyl, epoxy, (meth)acrylate, C1 to C10 alkyl or C6 to C12 aryl", "C6 to C20 aryl group that is unsubstituted or substituted by vinyl, allyl, epoxy, (meth)acrylate, C1 to C10 alkyl or C6 to C12 aryl" or "unsubstituted or [ Chemical formula 1A] Wherein, in Chemical Formula 1A, R 3 may be "substituted or unsubstituted vinyl", "unsubstituted or vinyl, allyl, epoxy, (meth)acrylate group, C1 to C10 alkyl or C6 to C12 aryl substituted C1 to C20 alkyl" or "unsubstituted or vinyl, allyl, epoxy, (meth)acrylate, C1 to C10 alkyl or C6 to C12 aryl-substituted C2 to C20 alkenyl group", and L 1 can be "C1 to C20 alkylene group that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group ” or “C3 to C20 cycloalkyl group that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group” or “can be represented by Chemical Formula 1B-1-1, Chemical Formula 1B-2 -1. Expressed by one of Chemical Formula 1B-3-1, Chemical Formula 1B-4-1, Chemical Formula 1B-5-1, Chemical Formula 1B-6-1 and Chemical Formula 1B-7-1", [Chemical Formula 1B-1- 1] [Chemical formula 1B-2-1] [Chemical formula 1B-3-1] [Chemical formula 1B-4-1] [Chemical formula 1B-5-1] [Chemical formula 1B-6-1] [Chemical formula 1B-7-1] Among them, in Chemical Formula 1B-1-1 to Chemical Formula 1B-7-1, R a and R b can be independently a hydrogen atom or a carboxyl group, and R c can be O, S, NH, C1 to C20 alkylene group, C1 to C20 alkylamino group or C2 to C20 allylamine group, L 2 can be a single bond, *-C(=O)O-* or *-S-*, and L 3 can be composed of chemical formula 1C-1 or chemical formula 1C-2 represents, [Chemical Formula 1C-1] [Chemical formula 1C-2] Among them, in Chemical Formula 1C-1 and Chemical Formula 1C-2, L 4 may be a single bond or a substituted or unsubstituted C1 to C20 alkylene group, and L 5 may be a substituted or unsubstituted C1 to C20 alkylene group. Alkyl, and m can be an integer from 1 to 20.

在化學式2中,R2 可為「未被取代或被C1至C10烷基或C6至C12芳基取代的C1至C20烷基」、「未被取代或被C1至C10烷基或C6至C12芳基取代的C1至C20烷氧基」、「未被取代或被C1至C10烷基或C6至C12芳基取代的C6至C20芳基」或者「未被取代或被C1至C10烷基或C6至C12芳基取代的C6至C20芳氧基」, L1 可為「未經取代的C1至C20伸烷基」或「未經取代的C3至C20伸環烷基」, L2 可為單鍵、*-C(=O)O-*或*-S-*,且 L3 可由化學式1C-1或化學式1C-2表示, [化學式1C-1] [化學式1C-2] 其中,在化學式1C-1及化學式1C-2中, L4 可為單鍵或者經取代或未經取代的C1至C20伸烷基, L5 可為經取代或未經取代的C1至C20伸烷基,且 m可為1至20的整數。In Chemical Formula 2, R 2 may be "a C1 to C20 alkyl group that is unsubstituted or substituted by a C1 to C10 alkyl group or a C6 to C12 aryl group", "a C1 to C20 alkyl group that is unsubstituted or substituted by a C1 to C10 alkyl group or a C6 to C12 aryl group" Aryl-substituted C1 to C20 alkoxy", "unsubstituted or C6 to C20 aryl substituted by C1 to C10 alkyl or C6 to C12 aryl" or "unsubstituted or C1 to C10 alkyl or C6 to C12 aryl-substituted C6 to C20 aryloxy group", L 1 can be "unsubstituted C1 to C20 alkylene group" or "unsubstituted C3 to C20 cycloalkylene group", L 2 can be Single bond, *-C(=O)O-* or *-S-*, and L 3 can be represented by Chemical Formula 1C-1 or Chemical Formula 1C-2, [Chemical Formula 1C-1] [Chemical formula 1C-2] Among them, in Chemical Formula 1C-1 and Chemical Formula 1C-2, L 4 may be a single bond or a substituted or unsubstituted C1 to C20 alkylene group, and L 5 may be a substituted or unsubstituted C1 to C20 alkylene group. Alkyl, and m can be an integer from 1 to 20.

所述由化學式1表示的化合物可由化學式2-1至化學式2-8中的一者表示。The compound represented by Chemical Formula 1 may be represented by one of Chemical Formula 2-1 to Chemical Formula 2-8.

[化學式2-1] [Chemical formula 2-1]

[化學式2-2] [Chemical formula 2-2]

[化學式2-3] [Chemical formula 2-3]

[化學式2-4] [Chemical formula 2-4]

[化學式2-5] [Chemical formula 2-5]

[化學式2-6] [Chemical formula 2-6]

[化學式2-7] [Chemical formula 2-7]

[化學式2-8] [Chemical formula 2-8]

在化學式1中,R1 可為羧基或硫醇基,且 R2 可為「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷基」、「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷氧基」、「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C6至C20芳基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C6至C20芳氧基」,或可「由化學式1A表示」, [化學式1A] 其中,在化學式1A中, R3 可為「經取代或未經取代的乙烯基」、「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C2至C20烯基」,且 L1 可為「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20伸烷基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C3至C20伸環烷基」或可「由化學式1B-1-1至化學式1B-7-2中的一者表示 , [化學式1B-1-1] [化學式1B-1-2] [化學式1B-2-1] [化學式1B-2-2] [化學式1B-3-1] [化學式1B-3-2] [化學式1B-4-1] [化學式1B-4-2] [化學式1B-5-1] [化學式1B-5-2] [化學式1B-6-1] [化學式1B-6-2] [化學式1B-7-1] [化學式1B-7-2] 其中,在化學式1B-1-1至化學式1B-7-2中, Ra 及Rb 可獨立地為氫原子或羧基, Rc 可為O、S、NH、C1至C20伸烷基、C1至C20烷基胺基或C2至C20烯丙基胺基, L2 可為單鍵、*-C(=O)O-*或*-S-*,且 L3 可由化學式1C-1或化學式1C-2表示, [化學式1C-1] [化學式1C-2] 其中,在化學式1C-1及化學式1C-2中, L4 可為單鍵或者經取代或未經取代的C1至C20伸烷基, L5 可為經取代或未經取代的C1至C20伸烷基, m可為1至20的整數,且 n可為1或2的整數。In Chemical Formula 1, R 1 may be a carboxyl group or a thiol group, and R 2 may be a C1 to C20 alkane that is unsubstituted or substituted by a vinyl group, an allyl group, an epoxy group or a (meth)acrylate group. group", "C1 to C20 alkoxy group that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group", "unsubstituted or substituted by vinyl, allyl, C6 to C20 aryl substituted by epoxy or (meth)acrylate" or "C6 to C20 aryl unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate. Oxygen group", or may be "represented by Chemical Formula 1A", [Chemical Formula 1A] Wherein, in Chemical Formula 1A, R 3 may be "substituted or unsubstituted vinyl", "C1 unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group to C20 alkyl" or "C2 to C20 alkenyl that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate", and L 1 may be "unsubstituted or substituted by C1 to C20 alkylene substituted by vinyl, allyl, epoxy or (meth)acrylate" or "unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylic acid "Ester group-substituted C3 to C20 cycloalkyl group" may be "represented by one of Chemical Formula 1B-1-1 to Chemical Formula 1B-7-2 " , [Chemical Formula 1B-1-1] [Chemical formula 1B-1-2] [Chemical formula 1B-2-1] [Chemical formula 1B-2-2] [Chemical formula 1B-3-1] [Chemical formula 1B-3-2] [Chemical formula 1B-4-1] [Chemical formula 1B-4-2] [Chemical formula 1B-5-1] [Chemical formula 1B-5-2] [Chemical formula 1B-6-1] [Chemical formula 1B-6-2] [Chemical formula 1B-7-1] [Chemical formula 1B-7-2] Among them, in Chemical Formula 1B-1-1 to Chemical Formula 1B-7-2, R a and R b can be independently a hydrogen atom or a carboxyl group, and R c can be O, S, NH, C1 to C20 alkylene group, C1 to C20 alkylamino group or C2 to C20 allylamine group, L 2 can be a single bond, *-C(=O)O-* or *-S-*, and L 3 can be composed of chemical formula 1C-1 or chemical formula 1C-2 represents, [Chemical Formula 1C-1] [Chemical formula 1C-2] Among them, in Chemical Formula 1C-1 and Chemical Formula 1C-2, L 4 may be a single bond or a substituted or unsubstituted C1 to C20 alkylene group, and L 5 may be a substituted or unsubstituted C1 to C20 alkylene group. Alkyl group, m may be an integer from 1 to 20, and n may be an integer of 1 or 2.

所述由化學式1表示的化合物可由化學式3表示。The compound represented by Chemical Formula 1 may be represented by Chemical Formula 3.

[化學式3] [Chemical formula 3]

在化學式3中, R4 可為「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷基」、「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷氧基」、「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C6至C20芳基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C6至C20芳氧基」,或「可由化學式1A表示」, [化學式1A] 其中,在化學式1A中, R3 可為「經取代或未經取代的乙烯基」、「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C2至C20烯基」, R5 可為羧基或硫醇基, L6 及L7 可獨立地為經取代或未經取代的C1至C20伸烷基, L8 可為單鍵、*-S-*、*-C(=O)-*或*-OC(=O)-*, L9 可為單鍵或者經取代或未經取代的C1至C20伸烷基,且 m可為1至20的整數。In Chemical Formula 3, R 4 may be "a C1 to C20 alkyl group that is unsubstituted or substituted by a vinyl group, an allyl group, an epoxy group or a (meth)acrylate group", "an unsubstituted or substituted by a vinyl group" , Allyl, epoxy or (meth)acrylate group substituted C1 to C20 alkoxy group", "Unsubstituted or vinyl, allyl, epoxy or (meth)acrylate group Substituted C6 to C20 aryloxy group" or "C6 to C20 aryloxy group that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group", or "can be represented by Chemical Formula 1A" , [Chemical Formula 1A] Wherein, in Chemical Formula 1A, R 3 may be "substituted or unsubstituted vinyl", "C1 unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group to C20 alkyl" or "C2 to C20 alkenyl that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group", R 5 can be a carboxyl or thiol group, L 6 and L 7 can be independently substituted or unsubstituted C1 to C20 alkylene group, and L 8 can be a single bond, *-S-*, *-C(=O)-* or *-OC(= O)-*, L 9 may be a single bond or a substituted or unsubstituted C1 to C20 alkylene group, and m may be an integer from 1 to 20.

所述由化學式1表示的化合物可由化學式4表示。The compound represented by Chemical Formula 1 may be represented by Chemical Formula 4.

[化學式4] [Chemical formula 4]

在化學式4中, R4 可為「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷基」、「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷氧基」、「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C6至C20芳基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C6至C20芳氧基」,或可「由化學式1A表示」, [化學式1A] 其中,在化學式1A中, R3 可為「經取代或未經取代的乙烯基」、「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C2至C20烯基」, L6 及L7 可獨立地為經取代或未經取代的C1至C20伸烷基, L8 可為單鍵、*-S-*、*-C(=O)-*或*-OC(=O)-*, L9 可為單鍵或者經取代或未經取代的C1至C20伸烷基,且 L10 可為由化學式1B-1-1、化學式1B-2-1、化學式1B-3-1、化學式1B-4-1、化學式1B-5-1、化學式1B-6-1及化學式1B-7-1中的一者表示, [化學式1B-1-1] [化學式1B-2-1] [化學式1B-3-1] [化學式1B-4-1] [化學式1B-5-1] [化學式1B-6-1] [化學式1B-7-1] 其中,在化學式1B-1-1至化學式1B-7-1中, Ra 及Rb 可獨立地為氫原子或羧基, Rc 可為O、S、NH、C1至C20伸烷基、C1至C20烷基胺基或C2至C20烯丙基胺基,且 m可為1至20的整數。In Chemical Formula 4, R 4 may be "a C1 to C20 alkyl group that is unsubstituted or substituted by a vinyl group, an allyl group, an epoxy group or a (meth)acrylate group", "an unsubstituted or substituted by a vinyl group" , Allyl, epoxy or (meth)acrylate group substituted C1 to C20 alkoxy group", "Unsubstituted or vinyl, allyl, epoxy or (meth)acrylate group Substituted C6 to C20 aryloxy group" or "C6 to C20 aryloxy group that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group", or may be "represented by Chemical Formula 1A ", [Chemical Formula 1A] Wherein, in Chemical Formula 1A, R 3 may be "substituted or unsubstituted vinyl", "C1 unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group to C20 alkyl" or "C2 to C20 alkenyl that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group", L 6 and L 7 may independently be substituted Or unsubstituted C1 to C20 alkylene group, L 8 can be a single bond, *-S-*, *-C(=O)-* or *-OC(=O)-*, L 9 can be a single bond The bond is either a substituted or unsubstituted C1 to C20 alkylene group, and L 10 may be composed of Chemical Formula 1B-1-1, Chemical Formula 1B-2-1, Chemical Formula 1B-3-1, Chemical Formula 1B-4-1, One of Chemical Formula 1B-5-1, Chemical Formula 1B-6-1 and Chemical Formula 1B-7-1 represents, [Chemical Formula 1B-1-1] [Chemical formula 1B-2-1] [Chemical formula 1B-3-1] [Chemical formula 1B-4-1] [Chemical formula 1B-5-1] [Chemical formula 1B-6-1] [Chemical formula 1B-7-1] Among them, in Chemical Formula 1B-1-1 to Chemical Formula 1B-7-1, R a and R b can be independently a hydrogen atom or a carboxyl group, and R c can be O, S, NH, C1 to C20 alkylene group, C1 to C20 alkylamino group or C2 to C20 allylamine group, and m may be an integer from 1 to 20.

所述由化學式1表示的化合物可由化學式3-1至化學式3-6中的一者表示。The compound represented by Chemical Formula 1 may be represented by one of Chemical Formula 3-1 to Chemical Formula 3-6.

[化學式3-1] [Chemical formula 3-1]

[化學式3-2] [Chemical formula 3-2]

[化學式3-3] [Chemical formula 3-3]

[化學式3-4] [Chemical formula 3-4]

[化學式3-5] [Chemical formula 3-5]

[化學式3-6] [Chemical formula 3-6]

所述由化學式1表示的化合物可由化學式4-1表示。The compound represented by Chemical Formula 1 may be represented by Chemical Formula 4-1.

[化學式4-1] [Chemical formula 4-1]

所述量子點在500奈米至680奈米下可具有最大螢光發射波長。The quantum dots may have a maximum fluorescence emission wavelength at 500 nanometers to 680 nanometers.

另一實施例提供一種包含量子點及在末端處具有碳-碳雙鍵的可聚合單體的無溶劑可固化組成物。Another embodiment provides a solvent-free curable composition including quantum dots and a polymerizable monomer having a carbon-carbon double bond at the terminus.

所述無溶劑可固化組成物中的所述可聚合單體可具有220克/莫耳至1,000克/莫耳的分子量。The polymerizable monomer in the solvent-free curable composition may have a molecular weight of 220 g/mol to 1,000 g/mol.

所述無溶劑可固化組成物中的所述可聚合單體可由化學式5表示。The polymerizable monomer in the solvent-free curable composition may be represented by Chemical Formula 5.

[化學式5] [Chemical formula 5]

在化學式5中, R101 及R102 可獨立地為氫原子或者經取代或未經取代的C1至C10烷基, L101 及L103 可獨立地為經取代或未經取代的C1至C10伸烷基,且 L102 可為經取代或未經取代的C1至C10伸烷基或醚基(*-O-*)。In Chemical Formula 5, R 101 and R 102 may be independently a hydrogen atom or a substituted or unsubstituted C1 to C10 alkyl group, and L 101 and L 103 may be independently a substituted or unsubstituted C1 to C10 alkyl group. Alkyl group, and L 102 may be substituted or unsubstituted C1 to C10 alkyl or ether group (*-O-*).

所述無溶劑可固化組成物可包含1重量%至60重量%的量子點及40重量%至99重量%的可聚合單體。The solvent-free curable composition may include 1% to 60% by weight of quantum dots and 40% to 99% by weight of polymerizable monomers.

所述無溶劑可固化組成物可更包含聚合起始劑、光擴散劑或其組合。The solvent-free curable composition may further include a polymerization initiator, a light diffusing agent, or a combination thereof.

另一實施例提供一種包含量子點、黏合劑樹脂及溶劑的溶劑型可固化組成物。Another embodiment provides a solvent-based curable composition including quantum dots, a binder resin and a solvent.

所述溶劑型可固化組成物可包含1重量%至40重量%的量子點;1重量%至30重量%的黏合劑樹脂;以及餘量的溶劑。The solvent-based curable composition may include 1 to 40% by weight of quantum dots; 1 to 30% by weight of a binder resin; and the balance of solvent.

所述溶劑型可固化組成物可更包含可聚合單體、聚合起始劑、光擴散劑或其組合。The solvent-based curable composition may further include a polymerizable monomer, a polymerization initiator, a light diffusing agent, or a combination thereof.

另一實施例提供一種使用所述可固化組成物生產的固化層。Another embodiment provides a cured layer produced using the curable composition.

另一實施例提供一種包括固化層的彩色濾光片。Another embodiment provides a color filter including a cured layer.

以下詳細說明中包含本發明的其他實施例。Other embodiments of the invention are included in the following detailed description.

一實施例提供一種用特定配位體進行表面改質的量子點,且所述特定配位體對量子點具有非常好的鈍化效果,並且相較於傳統量子點而言,經表面改質的量子點可容易地應用於溶劑型可固化組成物及無溶劑可固化組成物二者來改善可處理性,且可極大地提高使用所述組成物生產的固化層的光效率。此外,根據實施例的包含量子點的可固化組成物具有改善的儲存穩定性及耐熱性。One embodiment provides a quantum dot surface-modified with a specific ligand, and the specific ligand has a very good passivation effect on the quantum dots, and compared with traditional quantum dots, the surface-modified Quantum dots can be readily applied to both solvent-based and solvent-free curable compositions to improve handleability, and can greatly increase the optical efficiency of cured layers produced using the compositions. In addition, the curable composition including quantum dots according to embodiments has improved storage stability and heat resistance.

在下文中詳細闡述本發明的實施例。然而,該些實施例為示範性的,本發明不限於此,且本發明由申請專利範圍的範圍界定。Embodiments of the invention are explained in detail below. However, these embodiments are exemplary and the present invention is not limited thereto, and the present invention is defined by the scope of the patent application.

如本文所使用,當不另外提供定義時,「烷基」是指C1至C20烷基,「烯基」是指C2至C20烯基,「環烯基」是指C3至C20環烯基,「雜環烯基」是指C3至C20雜環烯基,「芳基」是指C6至C20芳基,「芳基烷基」是指C6至C20芳基烷基,「伸烷基」是指C1至C20伸烷基,「伸芳基」是指C6至C20伸芳基,「烷基伸芳基」是指C6至C20烷基伸芳基,「伸雜芳基」是指C3至C20伸雜芳基,且「伸烷氧基」是指C1至C20伸烷氧基。As used herein, when no definition is otherwise provided, "alkyl" refers to C1 to C20 alkyl, "alkenyl" refers to C2 to C20 alkenyl, "cycloalkenyl" refers to C3 to C20 cycloalkenyl, "Heterocycloalkenyl" refers to C3 to C20 heterocyclic alkenyl, "aryl" refers to C6 to C20 aryl, "arylalkyl" refers to C6 to C20 arylalkyl, and "alkylene" is Refers to C1 to C20 alkylene group, "arylene group" refers to C6 to C20 aryl group, "alkyl aryl group" refers to C6 to C20 alkyl aryl group, "heteroaryl group" refers to C3 to C20 aryl group Heteroaryl, and "alkoxy" refers to C1 to C20 alkoxy.

如本文所使用,當不另外提供具體定義時,「經取代」是指至少一個氫原子經選自以下的取代基代替:鹵素原子(F、Cl、Br或I)、羥基、C1至C20烷氧基、硝基、氰基、胺基、亞胺基、疊氮基、脒基、肼基、腙基、羰基、胺甲醯基、硫醇基、酯基、醚基、羧基或其鹽、磺酸基或其鹽、磷酸或其鹽、C1至C20烷基、C2至C20烯基、C2至C20炔基、C6至C20芳基、C3至C20環烷基、C3至C20環烯基、C3至C20環炔基、C2至C20雜環烷基、C2至C20雜環烯基、C2至C20雜環炔基、C3至C20雜芳基或其組合。As used herein, when no specific definition is otherwise provided, "substituted" means that at least one hydrogen atom is replaced by a substituent selected from: halogen atom (F, Cl, Br or I), hydroxyl group, C1 to C20 alkane Oxygen group, nitro group, cyano group, amine group, imine group, azido group, amidine group, hydrazine group, hydrazone group, carbonyl group, aminomethane group, thiol group, ester group, ether group, carboxyl group or its salt , sulfonic acid group or its salt, phosphoric acid or its salt, C1 to C20 alkyl group, C2 to C20 alkenyl group, C2 to C20 alkynyl group, C6 to C20 aryl group, C3 to C20 cycloalkyl group, C3 to C20 cycloalkenyl group , C3 to C20 cycloalkynyl, C2 to C20 heterocycloalkyl, C2 to C20 heterocycloalkenyl, C2 to C20 heterocycloalkynyl, C3 to C20 heteroaryl or combinations thereof.

如本文所使用,當不另外提供具體定義時,「雜」是指在化學式中包含N、O、S及P中的至少一個雜原子。As used herein, when no specific definition is otherwise provided, "hetero" refers to the inclusion of at least one heteroatom of N, O, S, and P in the chemical formula.

如本文所使用,當不另外提供具體定義時,「(甲基)丙烯酸酯」是指「丙烯酸酯」及「甲基丙烯酸酯」兩者,且「(甲基)丙烯酸」是指「丙烯酸」及「甲基丙烯酸」。As used herein, when no specific definition is otherwise provided, "(meth)acrylate" refers to both "acrylate" and "methacrylate" and "(meth)acrylic" refers to "acrylic" and "methacrylic acid".

如本文所使用,當不另外提供具體定義時,用語「組合」是指混合或共聚合。As used herein, when no specific definition is otherwise provided, the term "combination" refers to mixing or copolymerization.

如本文所使用,當不另外提供定義時,當在化學式中化學鍵並未繪製在應給出處時,氫原子鍵結在所述位置處。As used herein, when a definition is not otherwise provided, when a chemical bond is not drawn where it should be given in a chemical formula, a hydrogen atom is bonded at that position.

如本文所使用,卡多系樹脂是指在樹脂的骨架中包含選自化學式6-1至化學式6-11中的至少一個官能基的樹脂。As used herein, Cardo-based resin refers to a resin containing at least one functional group selected from Chemical Formula 6-1 to Chemical Formula 6-11 in the skeleton of the resin.

此外,在本說明書中,當不另外提供定義時,「*」是指與相同或不同原子或化學式連接的點。Furthermore, in this specification, when no definition is otherwise provided, "*" refers to a point connected to the same or different atoms or chemical formulas.

由於疏水表面特性,一般量子點有限地分散在少數溶劑中,因此在將量子點引入例如黏合劑樹脂、可固化單體等極性體系中時存在許多困難。Due to the hydrophobic surface properties, general quantum dots are limitedly dispersed in a few solvents, so there are many difficulties when introducing quantum dots into polar systems such as binder resins, curable monomers, etc.

例如,甚至已經積極研究的含量子點的可固化組成物在初始步驟中仍具有相對低的極性,且藉由將量子點僅分散在具有高疏水性的可固化組成物中來製備。因此以總組成物計,難以包含20重量%或大於20重量%的高含量的量子點,且因此,可固化組成物的光效率無法提高預定水準或更高,且為提高光效率,即使量子點被過度添加及分散,組成物的黏度(12厘泊)亦會超過能夠噴墨的黏度範圍,且因此可能不滿足可處理性。For example, even quantum dot-containing curable compositions that have been actively studied still have relatively low polarity in the initial steps and are prepared by dispersing quantum dots only in curable compositions with high hydrophobicity. Therefore, it is difficult to include a high content of quantum dots of 20% by weight or more based on the total composition, and therefore, the light efficiency of the curable composition cannot be improved to a predetermined level or higher, and in order to improve the light efficiency, even if the quantum dots are If the dots are excessively added and dispersed, the viscosity of the composition (12 centipoise) will also exceed the viscosity range that can be inkjet, and therefore the handleability may not be met.

此外,為達成能夠進行噴墨的黏度範圍,已使用一種方法,所述方法相對於總可固化組成物以大於或等於50重量%的含量包含溶劑以減少可固化組成物的固體含量,此可帶來優異的黏度,但具有由於溶劑的揮發而導致的噴嘴乾燥、噴嘴堵塞、噴墨後隨著時間的推移單一膜減少以及固化後嚴重的厚度變化的缺點,且因此難以應用於實際製程。Additionally, to achieve a viscosity range within which inkjet can be performed, a method has been used that includes a solvent in an amount greater than or equal to 50% by weight relative to the total curable composition to reduce the solids content of the curable composition, which can It brings excellent viscosity, but has the disadvantages of nozzle drying, nozzle clogging due to solvent evaporation, single film reduction over time after inkjet, and severe thickness changes after curing, and is therefore difficult to apply in actual processes.

因此,慮及不包含溶劑的無溶劑組成物是適用於實際製程的發展方向,含量子點的可固化組成物在應用當前量子點本身方面具有限制。Therefore, considering that solvent-free compositions that do not contain solvents are the development direction suitable for practical processes, curable compositions containing quantum dots have limitations in the application of current quantum dots themselves.

迄今為止所報導的,由於以可固化組成物計以20重量%至25重量%的少量包含未被表面改質(例如配位體取代)的量子點,因此由於黏度的限制,難以提高光效率及吸收率。此外,另一改進途徑是減少量子點的含量並增加例如TiO2 等光擴散劑的含量的方法,所述方法亦不能改善沈澱問題或低光效率。As reported so far, since quantum dots that have not been surface modified (e.g., ligand substituted) are included in a small amount of 20% to 25% by weight based on the curable composition, it is difficult to improve the optical efficiency due to viscosity limitations. and absorption rate. In addition, another way to improve is to reduce the content of quantum dots and increase the content of light diffusing agents such as TiO2 , which cannot improve the precipitation problem or low light efficiency.

包含量子點的傳統溶劑型可固化組成物可能由於如上所述的噴墨過程中噴嘴中的溶劑乾燥而導致噴嘴堵塞,由於噴墨畫素中的油墨蒸發而不能保持目標畫素厚度,且因此不能確保噴墨可處理性。Traditional solvent-based curable compositions containing quantum dots may cause nozzle clogging due to drying of the solvent in the nozzle during the inkjet process as described above, failure to maintain target pixel thickness due to evaporation of ink in the inkjet pixel, and therefore Inkjet processability is not guaranteed.

此外,為在畫素中形成薄膜之後藉由後烘烤(或另外熱固化)形成具有預定厚度的層,應藉由在遠高於畫素高度的位置噴墨大量油墨來形成釘紮點(氣泡不塌陷的最大高度),此實際上是不可能的,且此外,可處理溶劑應具有接近40達因/公分的表面張力,此很少可能發生。Furthermore, in order to form a layer with a predetermined thickness by post-baking (or otherwise thermal curing) after forming a thin film in the pixel, pinning points should be formed by jetting a large amount of ink at a position well above the height of the pixel ( The maximum height at which the bubbles do not collapse), which is practically impossible, and furthermore, the processable solvent should have a surface tension close to 40 dynes/cm, which is rarely possible.

大多數用於對量子點進行表面改質的配位體通常具有硫醇基,但是如上所述,用含硫醇基的配位體進行表面改質的量子點具有低的可分散性及較差的噴墨製程,且最重要的是,慮及市場中對光學特性的需求,已經達到極限。Most ligands used for surface modification of quantum dots usually have thiol groups, but as mentioned above, quantum dots surface modified with thiol group-containing ligands have low dispersibility and poor The inkjet process, and most importantly, considering the demand for optical properties in the market, has reached its limits.

因此,本發明人已長期研究並發明出使用不包括硫醇基或包括碳-碳雙鍵或環氧基的官能基對量子點進行表面改質,即使其具有硫醇基,由此仍會防止量子點的光學特性劣化,且同時極大地提高含量子點的可固化組成物的儲存穩定性及耐熱性。Therefore, the inventors have long studied and invented the surface modification of quantum dots using functional groups that do not include thiol groups or include carbon-carbon double bonds or epoxy groups. Even if they have thiol groups, they will still be Prevent the deterioration of the optical properties of quantum dots, and at the same time greatly improve the storage stability and heat resistance of curable compositions containing quantum dots.

舉例而言,所述配位體可由化學式1表示。For example, the ligand may be represented by Chemical Formula 1.

[化學式1] [Chemical formula 1]

在化學式1中, R1 是羧基、*-P(=O)(OH)2 或硫醇基,且 R2 是「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C1至C20烷基」、「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C1至C20烷氧基」、「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C6至C20芳基」或者「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C6至C20芳氧基」,或「由化學式1A表示」, [化學式1A] 其中,在化學式1A中, R3 是「經取代或未經取代的乙烯基」、「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C1至C20烷基」或者「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C2至C20烯基」,且 L1 是「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20伸烷基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C3至C20伸環烷基」或「可由化學式1B-1-1至化學式1B-7-2中的一者表示」, [化學式1B-1-1] [化學式1B-1-2] [化學式1B-2-1] [化學式1B-2-2] [化學式1B-3-1] [化學式1B-3-2] [化學式1B-4-1] [化學式1B-4-2] [化學式1B-5-1] [化學式1B-5-2] [化學式1B-6-1] [化學式1B-6-2] [化學式1B-7-1] [化學式1B-7-2] 其中,在化學式1B-1-1至化學式1B-7-2中, Ra 及Rb 獨立地是氫原子或羧基, Rc 是O、S、NH、C1至C20伸烷基、C1至C20烷基胺基或C2至C20烯丙基胺基, L2 是單鍵、*-C(=O)O-*或*-S-*,且 L3 由化學式1C-1或化學式1C-2表示, [化學式1C-1] [化學式1C-2] 其中,在化學式1C-1及化學式1C-2中, L4 是單鍵或者經取代或未經取代的C1至C20伸烷基, L5 是經取代或未經取代的C1至C20伸烷基, m是1至20的整數,且 n是1或2的整數。In Chemical Formula 1, R 1 is a carboxyl group, *-P(=O)(OH) 2 or a thiol group, and R 2 is "unsubstituted or substituted by vinyl, allyl, epoxy, (methyl ) acrylate group, C1 to C10 alkyl group or C6 to C12 aryl group substituted C1 to C20 alkyl group", "unsubstituted or vinyl, allyl, epoxy group, (meth)acrylate group, C1 to C20 alkoxy substituted by C1 to C10 alkyl or C6 to C12 aryl", "unsubstituted or substituted by vinyl, allyl, epoxy, (meth)acrylate group, C1 to C10 alkyl "C6 to C20 aryl group substituted by C6 to C12 aryl group" or "unsubstituted or substituted by vinyl group, allyl group, epoxy group, (meth)acrylate group, C1 to C10 alkyl group or C6 to C12 Aryl-substituted C6 to C20 aryloxy group", or "represented by Chemical Formula 1A", [Chemical Formula 1A] Wherein, in Chemical Formula 1A, R 3 is "substituted or unsubstituted vinyl group", "unsubstituted or vinyl group, allyl group, epoxy group, (meth)acrylate group, C1 to C10 Alkyl or C6 to C12 aryl substituted C1 to C20 alkyl" or "unsubstituted or vinyl, allyl, epoxy, (meth)acrylate group, C1 to C10 alkyl or C6 to C12 aryl-substituted C2 to C20 alkenyl", and L 1 is "C1 to C20 alkylene unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group" or "C3 to C20 cycloalkyl group that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group" or "can be from Chemical Formula 1B-1-1 to Chemical Formula 1B-7-2 "One of the expressions", [Chemical Formula 1B-1-1] [Chemical formula 1B-1-2] [Chemical formula 1B-2-1] [Chemical formula 1B-2-2] [Chemical formula 1B-3-1] [Chemical formula 1B-3-2] [Chemical formula 1B-4-1] [Chemical formula 1B-4-2] [Chemical formula 1B-5-1] [Chemical formula 1B-5-2] [Chemical formula 1B-6-1] [Chemical formula 1B-6-2] [Chemical formula 1B-7-1] [Chemical formula 1B-7-2] Wherein, in Chemical Formula 1B-1-1 to Chemical Formula 1B-7-2, R a and R b are independently a hydrogen atom or a carboxyl group, and R c is O, S, NH, C1 to C20 alkylene group, C1 to C20 Alkylamino group or C2 to C20 allylamine group, L 2 is a single bond, *-C(=O)O-* or *-S-*, and L 3 is composed of Chemical Formula 1C-1 or Chemical Formula 1C-2 represents, [Chemical Formula 1C-1] [Chemical formula 1C-2] Wherein, in Chemical Formula 1C-1 and Chemical Formula 1C-2, L 4 is a single bond or a substituted or unsubstituted C1 to C20 alkylene group, and L 5 is a substituted or unsubstituted C1 to C20 alkylene group. , m is an integer from 1 to 20, and n is an integer from 1 or 2.

在L2 中,*-C(=O)O-*可具有與*-O(C=O)-*不同的連接順序,且*-C(=O)O-*的羰基可連接至L1 連接基,並且醚基可連接至L3 連接基。In L 2 , *-C(=O)O-* may have a different attachment order than *-O(C=O)-*, and the carbonyl group of *-C(=O)O-* may be attached to L 1 linker, and the ether group can be attached to the L 3 linker.

例如,所述由化學式1表示的化合物可由化學式2表示。For example, the compound represented by Chemical Formula 1 may be represented by Chemical Formula 2.

[化學式2] [Chemical formula 2]

在化學式2中, R2 可為「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C1至C20烷基」、「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C1至C20烷氧基」、「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C6至C20芳基」或者「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C6至C20芳氧基」,或「可由化學式1A表示」, [化學式1A] 其中,在化學式1A中, R3 可為「經取代或未經取代的乙烯基」、「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C1至C20烷基」或者「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C2至C20烯基」,且 L1 可為「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20伸烷基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C3至C20伸環烷基」或「可由化學式1B-1-1、化學式1B-2-1、化學式1B-3-1、化學式1B-4-1、化學式1B-5-1、化學式1B-6-1及化學式1B-7-1中的一者表示」, [化學式1B-1-1] [化學式1B-2-1] [化學式1B-3-1] [化學式1B-4-1] [化學式1B-5-1] [化學式1B-6-1] [化學式1B-7-1] 其中,在化學式1B-1-1至化學式1B-7-1中, Ra 及Rb 可獨立地為氫原子或羧基, Rc 可為O、S、NH、C1至C20伸烷基、C1至C20烷基胺基或C2至C20烯丙基胺基, L2 可為單鍵、*-C(=O)O-*或*-S-*,且 L3 可由化學式1C-1或化學式1C-2表示, [化學式1C-1] [化學式1C-2] 其中,在化學式1C-1及化學式1C-2中, L4 可為單鍵或者經取代或未經取代的C1至C20伸烷基, L5 可為經取代或未經取代的C1至C20伸烷基,且 m可為1至20的整數。In Chemical Formula 2, R 2 may be "C1 to C20 that is unsubstituted or substituted by vinyl, allyl, epoxy, (meth)acrylate, C1 to C10 alkyl, or C6 to C12 aryl. "Alkyl", "C1 to C20 alkoxy that is unsubstituted or substituted by vinyl, allyl, epoxy, (meth)acrylate, C1 to C10 alkyl or C6 to C12 aryl", "C6 to C20 aryl group that is unsubstituted or substituted by vinyl, allyl, epoxy, (meth)acrylate, C1 to C10 alkyl or C6 to C12 aryl" or "unsubstituted or [ Chemical formula 1A] Wherein, in Chemical Formula 1A, R 3 may be "substituted or unsubstituted vinyl", "unsubstituted or vinyl, allyl, epoxy, (meth)acrylate group, C1 to C10 alkyl or C6 to C12 aryl substituted C1 to C20 alkyl" or "unsubstituted or vinyl, allyl, epoxy, (meth)acrylate, C1 to C10 alkyl or C6 to C12 aryl-substituted C2 to C20 alkenyl group", and L 1 can be "C1 to C20 alkylene group that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group ” or “C3 to C20 cycloalkyl group that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group” or “can be represented by Chemical Formula 1B-1-1, Chemical Formula 1B-2 -1. Expressed by one of Chemical Formula 1B-3-1, Chemical Formula 1B-4-1, Chemical Formula 1B-5-1, Chemical Formula 1B-6-1 and Chemical Formula 1B-7-1", [Chemical Formula 1B-1- 1] [Chemical formula 1B-2-1] [Chemical formula 1B-3-1] [Chemical formula 1B-4-1] [Chemical formula 1B-5-1] [Chemical formula 1B-6-1] [Chemical formula 1B-7-1] Among them, in Chemical Formula 1B-1-1 to Chemical Formula 1B-7-1, R a and R b can be independently a hydrogen atom or a carboxyl group, and R c can be O, S, NH, C1 to C20 alkylene group, C1 to C20 alkylamino group or C2 to C20 allylamine group, L 2 can be a single bond, *-C(=O)O-* or *-S-*, and L 3 can be composed of chemical formula 1C-1 or chemical formula 1C-2 represents, [Chemical Formula 1C-1] [Chemical formula 1C-2] Among them, in Chemical Formula 1C-1 and Chemical Formula 1C-2, L 4 may be a single bond or a substituted or unsubstituted C1 to C20 alkylene group, and L 5 may be a substituted or unsubstituted C1 to C20 alkylene group. Alkyl, and m can be an integer from 1 to 20.

由化學式1表示的化合物,具體而言由化學式2表示的化合物是具有與通常用作量子點的傳統表面改質材料的硫醇系化合物完全不同的結構的配位體,且當用此種配位體對量子點進行表面改質時,經表面改質的量子點可極大提高使用含量子點的組成物生產的固化層的光效率,並且進一步提高組成物的儲存穩定性及耐熱性。The compound represented by Chemical Formula 1, specifically the compound represented by Chemical Formula 2, is a ligand having a completely different structure from a thiol-based compound generally used as a conventional surface modification material for quantum dots, and when using such a When the surface of quantum dots is modified by a bit body, the surface-modified quantum dots can greatly improve the light efficiency of the cured layer produced using a composition containing quantum dots, and further improve the storage stability and heat resistance of the composition.

在化學式2中,R2 可為「未被取代或被C1至C10烷基或C6至C12芳基取代的C1至C20烷基」、「未被取代或被C1至C10烷基或C6至C12芳基取代的C1至C20烷氧基」、「未被取代或被C1至C10烷基或C6至C12芳基取代的C6至C20芳基」或者「未被取代或被C1至C10烷基或C6至C12芳基取代的C6至C20芳氧基」,L1 可為「未經取代的C1至C20伸烷基」或「未經取代的C3至C20伸環烷基」,L2 可為單鍵、*-C(=O)O-*或*-S-*,且L3 可由化學式1C-1或化學式1C-2表示,In Chemical Formula 2, R 2 may be "a C1 to C20 alkyl group that is unsubstituted or substituted by a C1 to C10 alkyl group or a C6 to C12 aryl group", "a C1 to C20 alkyl group that is unsubstituted or substituted by a C1 to C10 alkyl group or a C6 to C12 aryl group" Aryl-substituted C1 to C20 alkoxy", "unsubstituted or C6 to C20 aryl substituted by C1 to C10 alkyl or C6 to C12 aryl" or "unsubstituted or C1 to C10 alkyl or C6 to C12 aryl-substituted C6 to C20 aryloxy group", L 1 can be "unsubstituted C1 to C20 alkylene group" or "unsubstituted C3 to C20 cycloalkylene group", L 2 can be Single bond, *-C(=O)O-* or *-S-*, and L 3 can be represented by Chemical Formula 1C-1 or Chemical Formula 1C-2,

[化學式1C-1] [Chemical formula 1C-1]

[化學式1C-2] [Chemical formula 1C-2]

其中,在化學式1C-1及化學式1C-2中, L4 可為單鍵或者經取代或未經取代的C1至C20伸烷基,L5 可為經取代或未經取代的C1至C20伸烷基,且m可為1至20的整數。Among them, in Chemical Formula 1C-1 and Chemical Formula 1C-2, L 4 can be a single bond or a substituted or unsubstituted C1 to C20 alkylene group, and L 5 can be a substituted or unsubstituted C1 to C20 alkylene group. Alkyl, and m can be an integer from 1 to 20.

另一方面,所述由化學式1表示的化合物可為不由化學式2表示的化合物,其中(在化學式1中)R1 可為羧基或硫醇基,R2 可為「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷基」、「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷氧基」、「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C6至C20芳基」、「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C6至C20芳氧基」,或「可由化學式1A表示」, [化學式1A] 其中,在化學式1A中, R3 可為「經取代或未經取代的乙烯基」、「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C2至C20烯基」,且 L1 可為「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20伸烷基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C3至C20伸環烷基」或「可由化學式1B-1-1至化學式1B-7-2中的一者表示 , [化學式1B-1-1] [化學式1B-1-2] [化學式1B-2-1] [化學式1B-2-2] [化學式1B-3-1] [化學式1B-3-2] [化學式1B-4-1] [化學式1B-4-2] [化學式1B-5-1] [化學式1B-5-2] [化學式1B-6-1] [化學式1B-6-2] [化學式1B-7-1] [化學式1B-7-2] 其中,在化學式1B-1-1至化學式1B-7-2中, Ra 及Rb 可獨立地為氫原子或羧基, Rc 可為O、S、NH、C1至C20伸烷基、C1至C20烷基胺基或C2至C20烯丙基胺基, L2 可為單鍵、*-C(=O)O-*或*-S-*,且 L3 可由化學式1C-1或化學式1C-2表示, [化學式1C-1] [化學式1C-2] 其中,在化學式1C-1及化學式1C-2中, L4 可為單鍵或者經取代或未經取代的C1至C20伸烷基, L5 可為經取代或未經取代的C1至C20伸烷基, m可為1至20的整數,且 n可為1或2的整數。On the other hand, the compound represented by Chemical Formula 1 may be a compound not represented by Chemical Formula 2, wherein (in Chemical Formula 1) R 1 may be a carboxyl group or a thiol group, and R 2 may be unsubstituted or vinyl. , C1 to C20 alkyl group substituted by allyl, epoxy or (meth)acrylate group", "unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group "C1 to C20 alkoxy group", "C6 to C20 aryl group that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group", "unsubstituted or substituted by vinyl group" , allyl, epoxy or (meth)acrylate group substituted C6 to C20 aryloxy group", or "can be represented by Chemical Formula 1A", [Chemical Formula 1A] Wherein, in Chemical Formula 1A, R 3 may be "substituted or unsubstituted vinyl", "C1 unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group to C20 alkyl" or "C2 to C20 alkenyl that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate", and L 1 may be "unsubstituted or substituted by C1 to C20 alkylene substituted by vinyl, allyl, epoxy or (meth)acrylate" or "unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylic acid "Ester group-substituted C3 to C20 cycloalkyl group" or "can be represented by one of Chemical Formula 1B-1-1 to Chemical Formula 1B-7-2 " , [Chemical Formula 1B-1-1] [Chemical formula 1B-1-2] [Chemical formula 1B-2-1] [Chemical formula 1B-2-2] [Chemical formula 1B-3-1] [Chemical formula 1B-3-2] [Chemical formula 1B-4-1] [Chemical formula 1B-4-2] [Chemical formula 1B-5-1] [Chemical formula 1B-5-2] [Chemical formula 1B-6-1] [Chemical formula 1B-6-2] [Chemical formula 1B-7-1] [Chemical formula 1B-7-2] Among them, in Chemical Formula 1B-1-1 to Chemical Formula 1B-7-2, R a and R b can be independently a hydrogen atom or a carboxyl group, and R c can be O, S, NH, C1 to C20 alkylene group, C1 to C20 alkylamino group or C2 to C20 allylamine group, L 2 can be a single bond, *-C(=O)O-* or *-S-*, and L 3 can be composed of chemical formula 1C-1 or chemical formula 1C-2 represents, [Chemical Formula 1C-1] [Chemical formula 1C-2] Among them, in Chemical Formula 1C-1 and Chemical Formula 1C-2, L 4 may be a single bond or a substituted or unsubstituted C1 to C20 alkylene group, and L 5 may be a substituted or unsubstituted C1 to C20 alkylene group. Alkyl group, m may be an integer from 1 to 20, and n may be an integer of 1 or 2.

例如,所述由化學式1表示的化合物可由化學式3或化學式4表示。For example, the compound represented by Chemical Formula 1 may be represented by Chemical Formula 3 or Chemical Formula 4.

[化學式3] [Chemical formula 3]

[化學式4] [Chemical formula 4]

在化學式3中, R4 可為「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷基」、「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷氧基」、「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C6至C20芳基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C6至C20芳氧基」,或「可由化學式1A表示」, [化學式1A] 其中,在化學式1A中, R3 可為「經取代或未經取代的乙烯基」、「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C2至C20烯基」, R5 可為羧基或硫醇基, L6 及L7 可獨立地為經取代或未經取代的C1至C20伸烷基, L8 可為單鍵、*-S-*、*-C(=O)-*或*-OC(=O)-*, L9 可為單鍵或者經取代或未經取代的C1至C20伸烷基,且 m可為1至20的整數,以及 [化學式4] 其中,在化學式4中, R4 可為「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷基」、「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷氧基」、「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C6至C20芳基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C6至C20芳氧基」,或「可由化學式1A表示」, [化學式1A] 其中,在化學式1A中, R3 可為「經取代或未經取代的乙烯基」、「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C2至C20烯基」, L6 及L7 可獨立地為經取代或未經取代的C1至C20伸烷基, L8 可為單鍵、*-S-*、*-C(=O)-*或*-OC(=O)-*, L9 可為單鍵或者經取代或未經取代的C1至C20伸烷基,且 L10 可為由化學式1B-1-1、化學式1B-2-1、化學式1B-3-1、化學式1B-4-1、化學式1B-5-1、化學式1B-6-1及化學式1B-7-1中的一者表示, [化學式1B-1-1] [化學式1B-2-1] [化學式1B-3-1] [化學式1B-4-1] [化學式1B-5-1] [化學式1B-6-1] [化學式1B-7-1] 其中,在化學式1B-1-1至化學式1B-7-1中, Ra 及Rb 可獨立地為氫原子或羧基, Rc 可為O、S、NH、C1至C20伸烷基、C1至C20烷基胺基或C2至C20烯丙基胺基,且 m可為1至20的整數。In Chemical Formula 3, R 4 may be "a C1 to C20 alkyl group that is unsubstituted or substituted by a vinyl group, an allyl group, an epoxy group or a (meth)acrylate group", "an unsubstituted or substituted by a vinyl group" , Allyl, epoxy or (meth)acrylate group substituted C1 to C20 alkoxy group", "Unsubstituted or vinyl, allyl, epoxy or (meth)acrylate group Substituted C6 to C20 aryloxy group" or "C6 to C20 aryloxy group that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group", or "can be represented by Chemical Formula 1A" , [Chemical Formula 1A] Wherein, in Chemical Formula 1A, R 3 may be "substituted or unsubstituted vinyl", "C1 unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group to C20 alkyl" or "C2 to C20 alkenyl that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group", R 5 can be a carboxyl or thiol group, L 6 and L 7 can be independently substituted or unsubstituted C1 to C20 alkylene group, and L 8 can be a single bond, *-S-*, *-C(=O)-* or *-OC(= O)-*, L 9 may be a single bond or a substituted or unsubstituted C1 to C20 alkylene group, and m may be an integer from 1 to 20, and [Chemical Formula 4] Among them, in Chemical Formula 4, R 4 may be "C1 to C20 alkyl group that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group", "unsubstituted or substituted by C1 to C20 alkoxy substituted by vinyl, allyl, epoxy or (meth)acrylate", "unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylic acid "C6 to C20 aryloxy group substituted by ester group" or "C6 to C20 aryloxy group that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group", or "can be represented by Chemical Formula 1A represents", [Chemical Formula 1A] Wherein, in Chemical Formula 1A, R 3 may be "substituted or unsubstituted vinyl", "C1 unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group to C20 alkyl" or "C2 to C20 alkenyl that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group", L 6 and L 7 may independently be substituted Or unsubstituted C1 to C20 alkylene group, L 8 can be a single bond, *-S-*, *-C(=O)-* or *-OC(=O)-*, L 9 can be a single bond The bond is either a substituted or unsubstituted C1 to C20 alkylene group, and L 10 may be composed of Chemical Formula 1B-1-1, Chemical Formula 1B-2-1, Chemical Formula 1B-3-1, Chemical Formula 1B-4-1, One of Chemical Formula 1B-5-1, Chemical Formula 1B-6-1 and Chemical Formula 1B-7-1 represents, [Chemical Formula 1B-1-1] [Chemical formula 1B-2-1] [Chemical formula 1B-3-1] [Chemical formula 1B-4-1] [Chemical formula 1B-5-1] [Chemical formula 1B-6-1] [Chemical formula 1B-7-1] Among them, in Chemical Formula 1B-1-1 to Chemical Formula 1B-7-1, R a and R b can be independently a hydrogen atom or a carboxyl group, and R c can be O, S, NH, C1 to C20 alkylene group, C1 to C20 alkylamino group or C2 to C20 allylamine group, and m may be an integer from 1 to 20.

由化學式1表示的化合物可具有小於或等於1000克/莫耳、例如200克/莫耳至1000克/莫耳的重量平均分子量。當由化學式1表示的化合物的重量平均分子量在上述範圍內時,包含用所述化合物進行表面改質的量子點的可固化組成物的黏度可保持低,此對於噴墨可能是有利的。The compound represented by Chemical Formula 1 may have a weight average molecular weight of less than or equal to 1000 g/mol, such as 200 g/mol to 1000 g/mol. When the weight average molecular weight of the compound represented by Chemical Formula 1 is within the above range, the viscosity of the curable composition including quantum dots surface-modified with the compound can be kept low, which may be advantageous for inkjet.

例如,化學式1可由化學式2-1至化學式2-8、化學式3-1至化學式3-6及化學式4-1中的一者表示,但不必受限於此。For example, Chemical Formula 1 may be represented by one of Chemical Formula 2-1 to Chemical Formula 2-8, Chemical Formula 3-1 to Chemical Formula 3-6, and Chemical Formula 4-1, but is not necessarily limited thereto.

[化學式2-1] [Chemical formula 2-1]

[化學式2-2] [Chemical formula 2-2]

[化學式2-3] [Chemical formula 2-3]

[化學式2-4] [Chemical formula 2-4]

[化學式2-5] [Chemical formula 2-5]

[化學式2-6] [Chemical formula 2-6]

[化學式2-7] [Chemical formula 2-7]

[化學式2-8] [Chemical formula 2-8]

[化學式3-1] [Chemical formula 3-1]

[化學式3-2] [Chemical formula 3-2]

[化學式3-3] [Chemical formula 3-3]

[化學式3-4] [Chemical formula 3-4]

[化學式3-5] [Chemical formula 3-5]

[化學式3-6] [Chemical formula 3-6]

[化學式4-1] [Chemical formula 4-1]

例如,量子點在500奈米至680奈米下可具有最大螢光發射波長。For example, quantum dots can have a maximum fluorescence emission wavelength at 500 nanometers to 680 nanometers.

根據另一實施例的可固化組成物包含用由化學式1表示的化合物進行表面改質的量子點。A curable composition according to another embodiment includes quantum dots surface-modified with the compound represented by Chemical Formula 1.

至此,包含量子點的可固化組成物(油墨)已經朝向與量子點具有良好相容性的專門化單體發展,且此外,已經商業化。To this point, curable compositions (inks) containing quantum dots have been developed toward specialized monomers having good compatibility with quantum dots and, in addition, have been commercialized.

另一方面,由於一般及廣泛使用的可聚合單體、-烯系單體(包括乙烯系單體、丙烯酸酯系單體、甲基丙烯酸酯系單體等,其包括單官能單體或多官能單體)與量子點具有低的相容性,並且在量子點的分散性方面受到限制,因此有效地將其應用於含量子點的可固化組成物的各種開發實質上是困難的。最重要的是,-烯系單體沒有顯示出高濃度量子點可分散性,且因此難以應用於含量子點的可固化組成物。On the other hand, due to the general and widely used polymerizable monomers and vinyl monomers (including vinyl monomers, acrylate monomers, methacrylate monomers, etc., including monofunctional monomers or polyethylene monomers), Functional monomers) have low compatibility with quantum dots and are limited in the dispersibility of quantum dots, so effectively applying them to various developments of curable compositions containing quantum dots is essentially difficult. Most importantly, -olefinic monomers do not exhibit high concentration quantum dot dispersibility and are therefore difficult to apply to curable compositions containing quantum dots.

由於該些缺點,含量子點的可固化組成物已經被開發成具有包含相當量(大於或等於50重量%)的溶劑的組成物,但當溶劑含量增加時,噴墨可處理性可能劣化。因此,為滿足噴墨可處理性,對無溶劑可固化組成物的需求不斷增加。Due to these disadvantages, curable compositions containing quantum dots have been developed with compositions containing a considerable amount (greater than or equal to 50% by weight) of solvent, but when the solvent content is increased, inkjet processability may deteriorate. Therefore, there is an increasing demand for solvent-free curable compositions to satisfy inkjet processability.

本發明提供一種需求不斷增加的無溶劑可固化組成物,且藉由使用包括在末端處具有碳-碳雙鍵的化合物的可聚合單體以及用由化學式1表示的化合物進行表面改質的量子點,即使在無溶劑體系中亦可提高量子點對可固化組成物的親和力,以達成量子點的高濃度可分散性及甚至鈍化效果,同時不損害量子點的自然光學特性。The present invention provides a solvent-free curable composition, which is increasingly in demand, and performs surface modification by using a polymerizable monomer including a compound having a carbon-carbon double bond at the terminal and a compound represented by Chemical Formula 1. dots, even in solvent-free systems, the affinity of quantum dots to curable compositions can be improved to achieve high-concentration dispersibility and even passivation effects of quantum dots without damaging the natural optical properties of quantum dots.

以下,詳細闡述構成無溶劑可固化組成物的每一組分。 量子點Each component constituting the solvent-free curable composition is explained in detail below. quantum dots

包含在無溶劑可固化組成物中的量子點包括用由化學式1表示的化合物進行表面改質的量子點。The quantum dots contained in the solvent-free curable composition include quantum dots surface-modified with the compound represented by Chemical Formula 1.

例如,量子點在360奈米至780奈米、例如400奈米至780奈米的波長區中吸收光,且在500奈米至700奈米、例如500奈米至580奈米的波長區中發射螢光或在600奈米至680奈米的波長區中發射螢光。亦即,量子點在500奈米至680奈米下可具有最大螢光發射波長(λem )。For example, quantum dots absorb light in the wavelength region of 360 nanometers to 780 nanometers, such as 400 nanometers to 780 nanometers, and in the wavelength region of 500 nanometers to 700 nanometers, such as 500 nanometers to 580 nanometers. Emit fluorescence or emit fluorescence in the wavelength region of 600 nanometers to 680 nanometers. That is, the quantum dots may have a maximum fluorescence emission wavelength (λ em ) at 500 nm to 680 nm.

量子點可獨立地具有20奈米至100奈米、例如20奈米至50奈米的半高寬(full width at half maximum,FWHM)。當量子點具有所述範圍的半高寬(FWHM)時,當用作彩色濾光片中的顏色材料時,由於高顏色純度而使顏色再現性增加。Quantum dots may independently have a full width at half maximum (FWHM) of 20 nm to 100 nm, such as 20 nm to 50 nm. When the quantum dots have a full width at half maximum (FWHM) in the stated range, when used as color materials in color filters, color reproducibility is increased due to high color purity.

量子點可獨立地為有機材料、或無機材料或者有機材料與無機材料的混成(混合物)。Quantum dots can be independently organic materials, inorganic materials, or a mixture (mixture) of organic materials and inorganic materials.

量子點可獨立地由核及圍繞核的殼構成,且核及殼可獨立地具有由II-IV族、III-V族等構成的核、核/殼、核/第一殼/第二殼、合金、合金/殼等的結構,但不限於此。Quantum dots can independently be composed of a core and a shell surrounding the core, and the core and the shell can independently have a core, core/shell, core/first shell/second shell composed of II-IV groups, III-V groups, etc. , alloy, alloy/shell, etc. structure, but not limited to this.

舉例而言,所述核可至少包含選自CdS、CdSe、CdTe、ZnS、ZnSe、ZnTe、HgS、HgSe、HgTe、GaN、GaP、GaAs、InP、InAs及其合金的至少一種材料,但不必受限於此。環繞所述核的所述殼可至少包含選自CdSe、ZnSe、ZnS、ZnTe、CdTe、PbS、TiO、SrSe、HgSe及其合金中的至少一種材料,但不必受僅限於此。For example, the core may include at least one material selected from CdS, CdSe, CdTe, ZnS, ZnSe, ZnTe, HgS, HgSe, HgTe, GaN, GaP, GaAs, InP, InAs and alloys thereof, but need not be affected by Limited to this. The shell surrounding the core may include at least one material selected from CdSe, ZnSe, ZnS, ZnTe, CdTe, PbS, TiO, SrSe, HgSe and alloys thereof, but is not necessarily limited thereto.

在實施例中,由於近來全世界對環境的關注已大大增加,且有毒材料的管制已加強,因此使用量子效率(量子產率)稍低但對環境友好的非鎘系發光材料(InP/ZnS、InP/ZnSe/ZnS等)來替代具有鎘系核的發光材料,但不必受限於此。In the embodiment, since global environmental concerns have greatly increased recently and regulations on toxic materials have been tightened, a non-cadmium-based luminescent material (InP/ZnS) that is slightly lower in quantum efficiency (quantum yield) but is environmentally friendly is used , InP/ZnSe/ZnS, etc.) to replace the luminescent material with a cadmium core, but it is not necessarily limited to this.

在核/殼結構的量子點的情況下,包括殼的整體大小(平均粒徑)可為1奈米至15奈米、例如5奈米至15奈米。In the case of core/shell structured quantum dots, the overall size (average particle diameter) including the shell may be 1 nm to 15 nm, such as 5 nm to 15 nm.

舉例而言,量子點可獨立地包括紅色量子點、綠色量子點或其組合。紅色量子點可獨立地具有10奈米至15奈米的平均粒徑。綠色量子點可獨立地具有5奈米至8奈米的平均粒徑。For example, quantum dots may independently include red quantum dots, green quantum dots, or combinations thereof. Red quantum dots can independently have an average particle size of 10 to 15 nanometers. Green quantum dots can independently have an average particle size of 5 to 8 nanometers.

另一方面,為達成量子點的分散穩定性,根據實施例的無溶劑可固化組成物可更包含分散劑。分散劑有助於例如量子點等光轉換材料在無溶劑可固化組成物中的均勻分散性,且可包含非離子分散劑、陰離子分散劑或陽離子分散劑。具體而言,分散劑可為聚烷二醇或其酯、聚氧化烯烴、多元醇酯環氧烷加成產物、醇環氧烷加成產物、磺酸酯、磺酸鹽、羧酸酯、羧酸鹽、烷基醯胺環氧烷加成產物、烷基胺等,且其可單獨使用或者以二或更多者的混合物形式使用。以光轉換材料(例如量子點)的固體含量計,可使用0.1重量%至100重量%、例如10重量%至20重量%的量的分散劑。On the other hand, in order to achieve dispersion stability of quantum dots, the solvent-free curable composition according to embodiments may further include a dispersant. The dispersant contributes to the uniform dispersion of the light conversion material, such as quantum dots, in the solvent-free curable composition, and may include a nonionic, anionic, or cationic dispersant. Specifically, the dispersant can be polyalkylene glycol or its ester, polyoxyalkylene, polyol ester alkylene oxide addition product, alcohol alkylene oxide addition product, sulfonate ester, sulfonate salt, carboxylate ester, carboxylates, alkylamide alkylene oxide addition products, alkylamines, etc., and they may be used alone or in a mixture of two or more. The dispersant may be used in an amount of 0.1% to 100% by weight, such as 10% to 20% by weight, based on the solids content of the light conversion material (eg quantum dots).

以無溶劑可固化組成物的總量計,可包含1重量%至60重量%、例如3重量%至50重量%的量的用化學式1或化學式2進行表面改質的量子點。當包含處於所述範圍內的表面改質的量子點時,可提高光轉換率,且圖案特性及顯影特性不受干擾,使得其可具有優異的可處理性。 在末端處具有碳-碳雙鍵的可聚合單體Quantum dots surface-modified with Chemical Formula 1 or Chemical Formula 2 may be included in an amount of 1 to 60% by weight, for example, 3 to 50% by weight based on the total amount of the solvent-free curable composition. When surface-modified quantum dots within the above range are included, the light conversion rate can be improved, and the pattern characteristics and development characteristics are not disturbed, so that it can have excellent handleability. Polymerizable monomers with carbon-carbon double bonds at the termini

以無溶劑可固化組成物的總量計,應包含40重量%至99重量%、例如50重量%至97重量%的量的在末端處具有碳-碳雙鍵的單體。當包含處於所述範圍內的在末端處具有碳-碳雙鍵的單體時,可製備具有能夠噴墨的黏度的無溶劑可固化組成物,且製備的無溶劑可固化組成物中的量子點可具有改善的分散性,由此改善光學特性。The monomer having a carbon-carbon double bond at the terminal should be included in an amount of 40 to 99% by weight, such as 50 to 97% by weight, based on the total amount of the solvent-free curable composition. When a monomer having a carbon-carbon double bond at the terminal is included within the range, a solvent-free curable composition having a viscosity capable of inkjet can be prepared, and the quantum of the solvent-free curable composition prepared The dots may have improved dispersion, thereby improving optical properties.

例如,在末端處具有碳-碳雙鍵的單體可具有220克/莫耳至1,000克/莫耳的分子量。當在末端處具有碳-碳雙鍵的單體具有處於所述範圍內的分子量時,可有利地進行噴墨,此乃因其不會增加組成物的黏度且不妨礙量子點的光學特性。For example, a monomer with a carbon-carbon double bond at the terminus may have a molecular weight of 220 g/mol to 1,000 g/mol. When the monomer having a carbon-carbon double bond at the terminus has a molecular weight within the stated range, inkjet can be advantageously performed because it does not increase the viscosity of the composition and does not hinder the optical properties of the quantum dots.

例如,在末端處具有碳-碳雙鍵的單體可由化學式5表示,但不必受限於此。For example, a monomer having a carbon-carbon double bond at the terminal may be represented by Chemical Formula 5, but is not necessarily limited thereto.

[化學式5] [Chemical formula 5]

在化學式5中, R101 及R102 可獨立地為氫原子或者經取代或未經取代的C1至C10烷基, L101 及L103 可獨立地為經取代或未經取代的C1至C10伸烷基,且 L102 可為經取代或未經取代的C1至C10伸烷基或醚基(*-O-*)。In Chemical Formula 5, R 101 and R 102 may independently be a hydrogen atom or a substituted or unsubstituted C1 to C10 alkyl group, and L 101 and L 103 may independently be a substituted or unsubstituted C1 to C10 alkyl group. Alkyl group, and L 102 may be substituted or unsubstituted C1 to C10 alkyl or ether group (*-O-*).

例如,在末端處具有碳-碳雙鍵的單體可由化學式5-1或5-2表示,但不必受限於此。For example, a monomer having a carbon-carbon double bond at the terminal may be represented by Chemical Formula 5-1 or 5-2, but is not necessarily limited thereto.

[化學式5-1] [Chemical formula 5-1]

[化學式5-2] [Chemical formula 5-2]

例如,除了上述化學式5-1或化學式5-2的化合物之外,在末端處具有碳-碳雙鍵的單體可更包括乙二醇二丙烯酸酯、三乙乙二醇二丙烯酸酯、1,4-丁二醇二丙烯酸酯、1,6-己二醇二丙烯酸酯、新戊二醇二丙烯酸酯、季戊四醇二丙烯酸酯、季戊四醇三丙烯酸酯、二季戊四醇二丙烯酸酯、二季戊四醇三丙烯酸酯、二季戊四醇五丙烯酸酯、季戊四醇六丙烯酸酯、雙酚A二丙烯酸酯、三羥甲基丙烷三丙烯酸酯、酚醛環氧丙烯酸酯、乙二醇二甲基丙烯酸酯、三乙二醇二甲基丙烯酸酯、丙二醇二甲基丙烯酸酯、1,4-丁二醇二甲基丙烯酸酯、1,6-己二醇二甲基丙烯酸酯或其組合。For example, in addition to the compound of the above-mentioned Chemical Formula 5-1 or Chemical Formula 5-2, the monomer having a carbon-carbon double bond at the terminal may further include ethylene glycol diacrylate, triethylene glycol diacrylate, 1 , 4-butanediol diacrylate, 1,6-hexanediol diacrylate, neopentyl glycol diacrylate, pentaerythritol diacrylate, pentaerythritol triacrylate, dipentaerythritol diacrylate, dipentaerythritol triacrylate , dipentaerythritol pentaacrylate, pentaerythritol hexaacrylate, bisphenol A diacrylate, trimethylolpropane triacrylate, phenolic epoxy acrylate, ethylene glycol dimethacrylate, triethylene glycol dimethyl Acrylate, propylene glycol dimethacrylate, 1,4-butanediol dimethacrylate, 1,6-hexanediol dimethacrylate or combinations thereof.

此外,與在末端處具有碳-碳雙鍵的單體一起,可更包含傳統熱固性或光可固化組成物的常用單體。例如,單體更包括氧雜環丁烷系化合物,例如雙[1-乙基(3-氧雜環丁基)]甲醚等。 聚合起始劑In addition, common monomers of conventional thermosetting or photocurable compositions may be further included together with monomers having carbon-carbon double bonds at the terminals. For example, the monomer further includes oxetane-based compounds, such as bis[1-ethyl(3-oxetanyl)]methyl ether and the like. polymerization initiator

根據實施例的無溶劑可固化組成物可更包含聚合起始劑,例如光聚合起始劑、熱聚合起始劑或其組合。The solvent-free curable composition according to embodiments may further include a polymerization initiator, such as a photopolymerization initiator, a thermal polymerization initiator, or a combination thereof.

光聚合起始劑是常用於感光性樹脂組成物的起始劑,例如苯乙酮系化合物、二苯甲酮系化合物、噻噸酮系化合物、安息香系化合物、三嗪系化合物、肟系化合物、胺基酮系化合物等,但不必受限於此。Photopolymerization initiators are commonly used initiators for photosensitive resin compositions, such as acetophenone compounds, benzophenone compounds, thioxanthone compounds, benzoin compounds, triazine compounds, and oxime compounds. , aminoketone compounds, etc., but are not necessarily limited thereto.

苯乙酮系化合物的實例可為2,2'-二乙氧基苯乙酮、2,2'-二丁氧基苯乙酮、2-羥基-2-甲基苯丙酮、對第三丁基三氯苯乙酮、對第三丁基二氯苯乙酮、4-氯苯乙酮、2,2'-二氯-4-苯氧基苯乙酮、2-甲基-1-(4-(甲硫基)苯基)-2-嗎啉基丙-1-酮、2-苯甲基-2-二甲基胺基-1-(4-嗎啉基苯基)-丁-1-酮等。Examples of the acetophenone-based compound may be 2,2'-diethoxyacetophenone, 2,2'-dibutoxyacetophenone, 2-hydroxy-2-methylpropiophenone, p-tertiary butyl Trichloroacetophenone, p-tert-butyldichloroacetophenone, 4-chloroacetophenone, 2,2'-dichloro-4-phenoxyacetophenone, 2-methyl-1-( 4-(Methylthio)phenyl)-2-morpholinylpropan-1-one, 2-phenylmethyl-2-dimethylamino-1-(4-morpholinylphenyl)-butan- 1-Keto etc.

二苯甲酮系化合物的實例可為二苯甲酮、苯甲酸苯甲醯基酯、苯甲酸苯甲醯基甲酯、4-苯基二苯甲酮、羥基二苯甲酮、丙烯酸化二苯甲酮、4,4'-雙(二甲基胺基)二苯甲酮、4,4'-雙(二乙基胺基)二苯甲酮、4,4'-二甲基胺基二苯甲酮、4,4'-二氯二苯甲酮、3,3'-二甲基-2-甲氧基二苯甲酮等。Examples of the benzophenone-based compound may be benzophenone, benzoyl benzoate, benzoyl methyl benzoate, 4-phenylbenzophenone, hydroxybenzophenone, diacrylate Benzophenone, 4,4'-bis(dimethylamino)benzophenone, 4,4'-bis(diethylamino)benzophenone, 4,4'-dimethylamino Benzophenone, 4,4'-dichlorobenzophenone, 3,3'-dimethyl-2-methoxybenzophenone, etc.

噻噸酮系化合物的實例可為噻噸酮、2-甲基噻噸酮、異丙基噻噸酮、2,4-二乙基噻噸酮、2,4-二異丙基噻噸酮、2-氯噻噸酮等。Examples of the thioxanthone-based compound may be thioxanthone, 2-methylthioxanthone, isopropylthioxanthone, 2,4-diethylthioxanthone, and 2,4-diisopropylthioxanthone , 2-chlorothioxanthone, etc.

安息香系化合物的實例可為安息香、安息香甲醚、安息香乙醚、安息香異丙醚、安息香異丁醚、苯甲基二甲基縮酮等。Examples of benzoin-based compounds include benzoin, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, benzoin isobutyl ether, benzoin dimethyl ketal, and the like.

三嗪系化合物的實例可為2,4,6-三氯-s-三嗪、2-苯基-4,6-雙(三氯甲基)-s-三嗪、2-(3',4'-二甲氧基苯乙烯基)-4,6-雙(三氯甲基)-s-三嗪、2-(4'-甲氧基萘基)-4,6-雙(三氯甲基)-s-三嗪、2-(對甲氧基苯基)-4,6-雙(三氯甲基)-s-三嗪、2-(對甲苯基)-4,6-雙(三氯甲基)-s-三嗪、2-聯苯基-4,6-雙(三氯甲基)-s-三嗪、雙(三氯甲基)-6-苯乙烯基-s-三嗪、2-(萘酚1-基)-4,6-雙(三氯甲基)-s-三嗪、2-(4-甲氧基萘酚1-基)-4,6-雙(三氯甲基)-s-三嗪、2-4-雙(三氯甲基)-6-胡椒基-s-三嗪、2-4-雙(三氯甲基)-6-(4-甲氧基苯乙烯基)-s-三嗪等。Examples of the triazine-based compound may be 2,4,6-trichloro-s-triazine, 2-phenyl-4,6-bis(trichloromethyl)-s-triazine, 2-(3', 4'-dimethoxystyryl)-4,6-bis(trichloromethyl)-s-triazine, 2-(4'-methoxynaphthyl)-4,6-bis(trichloro Methyl)-s-triazine, 2-(p-methoxyphenyl)-4,6-bis(trichloromethyl)-s-triazine, 2-(p-tolyl)-4,6-bis (Trichloromethyl)-s-triazine, 2-biphenyl-4,6-bis(trichloromethyl)-s-triazine, bis(trichloromethyl)-6-styryl-s -Triazine, 2-(naphthol 1-yl)-4,6-bis(trichloromethyl)-s-triazine, 2-(4-methoxynaphthol 1-yl)-4,6- Bis(trichloromethyl)-s-triazine, 2-4-bis(trichloromethyl)-6-piperonyl-s-triazine, 2-4-bis(trichloromethyl)-6-( 4-methoxystyryl)-s-triazine, etc.

肟系化合物的實例可為O-醯基肟系化合物、2-(O-苯甲醯基肟)-1-[4-(苯硫基)苯基]-1,2-辛二酮、1-(O-乙醯基肟)-1-[9-乙基-6-(2-甲基苯甲醯基)-9H-咔唑-3-基]乙酮、O-乙氧基羰基-α-氧基胺基-1-苯基丙-1-酮等。O-醯基肟系化合物的具體實例可為1,2-辛二酮、2-二甲基胺基-2-(4-甲基苯甲基)-1-(4-嗎啉-4-基-苯基)-丁-1-酮、1-(4-苯硫基苯基)-丁烷-1,2-二酮-2-肟-O-苯甲酸酯、1-(4-苯硫基苯基)-辛烷-1,2-二酮-2-肟-O-苯甲酸酯、1-(4-苯硫基苯基)-辛-1-酮肟-O-乙酸酯、1-(4-苯硫基苯基)-丁-1-酮肟- O-乙酸酯等。Examples of the oxime-based compound may be an O-acyl oxime-based compound, 2-(O-benzoyl oxime)-1-[4-(phenylthio)phenyl]-1,2-octanedione, 1 -(O-acetyl oxime)-1-[9-ethyl-6-(2-methylbenzoyl)-9H-carbazol-3-yl]ethanone, O-ethoxycarbonyl- α-Oxylamino-1-phenylpropan-1-one, etc. Specific examples of the O-acyl oxime-based compound include 1,2-octanedione, 2-dimethylamino-2-(4-methylbenzyl)-1-(4-morpholine-4- base-phenyl)-butan-1-one, 1-(4-phenylthiophenyl)-butane-1,2-dione-2-oxime-O-benzoate, 1-(4- Phenylthiophenyl)-octane-1,2-dione-2-oxime-O-benzoate, 1-(4-phenylthiophenyl)-octane-1-one oxime-O-ethyl Acid ester, 1-(4-phenylthiophenyl)-butan-1-one oxime-O-acetate, etc.

胺基酮系化合物的實例可為2-苯甲基-2-二甲基胺基-1-(4-嗎啉基苯基)-丁酮-1等。Examples of the aminoketone compound include 2-benzyl-2-dimethylamino-1-(4-morpholinylphenyl)-butanone-1 and the like.

光聚合起始劑除所述化合物之外可更包含咔唑系化合物、二酮系化合物、硼酸鋶系化合物、重氮系化合物、咪唑系化合物、聯咪唑系化合物等。In addition to the above-mentioned compounds, the photopolymerization initiator may further include carbazole-based compounds, diketone-based compounds, sulfonium borate-based compounds, diazo-based compounds, imidazole-based compounds, biimidazole-based compounds, and the like.

光聚合起始劑可與能夠藉由吸收光引起化學反應且變得激發並隨後傳輸其能量的光增感劑一起使用。The photopolymerization initiator may be used with a photosensitizer capable of causing a chemical reaction by absorbing light and becoming excited and subsequently transmitting its energy.

光增感劑的實例可為四乙二醇雙-3-巰基丙酸酯、季戊四醇四-3-巰基丙酸酯、二季戊四醇四-3-巰基丙酸酯等。Examples of the photosensitizer may be tetraethylene glycol bis-3-mercaptopropionate, pentaerythritol tetrakis-3-mercaptopropionate, dipentaerythritol tetrakis-3-mercaptopropionate, and the like.

熱聚合起始劑的實例可為過氧化物,具體而言過氧化苯甲醯、過氧化二苯甲醯、過氧化月桂基、過氧化二月桂基、過氧化二-第二丁基、過氧化環己烷、過氧化甲乙酮、氫過氧化物(例如第三丁基氫過氧化物、枯烯氫過氧化物)、過氧化二碳酸二環己基酯、2,2-偶氮-雙(異丁腈)、過苯甲酸第三丁酯等,例如2,2'-偶氮雙-2-甲基丙腈,但不必受限於此,且可使用此項技術中眾所習知的任何一種。Examples of thermal polymerization initiators may be peroxides, specifically benzoyl peroxide, dibenzoyl peroxide, lauryl peroxide, dilauryl peroxide, di-butyl peroxide, peroxide Cyclohexane oxide, methyl ethyl ketone peroxide, hydroperoxides (such as tert-butyl hydroperoxide, cumene hydroperoxide), dicyclohexyl peroxydicarbonate, 2,2-azobis( isobutyronitrile), tert-butyl perbenzoate, etc., such as 2,2'-azobis-2-methylpropionitrile, but it is not necessarily limited thereto, and those commonly known in the art can be used. Any kind.

以無溶劑可固化組成物的總量計,可包含0.1重量%至5重量%、例如1重量%至4重量%的量的聚合起始劑。當包含處於所述範圍內的聚合起始劑時,由於曝光或熱固化期間的充分固化,可獲得優異的可靠性,且防止由於非反應起始劑導致的透射率劣化,由此防止量子點的光學特性劣化。 光擴散劑(或光擴散劑分散體)The polymerization initiator may be included in an amount of 0.1% to 5% by weight, such as 1% to 4% by weight, based on the total amount of the solvent-free curable composition. When the polymerization initiator is included within the range, excellent reliability can be obtained due to sufficient curing during exposure or thermal curing, and transmittance deterioration due to the non-reactive initiator is prevented, thereby preventing quantum dots optical properties deteriorate. Light diffusing agent (or light diffusing agent dispersion)

根據實施例的無溶劑可固化組成物可更包含光擴散劑。The solvent-free curable composition according to embodiments may further include a light diffusing agent.

舉例而言,光擴散劑可包括硫酸鋇(BaSO4 )、碳酸鈣(CaCO3 )、二氧化鈦(TiO2 )、氧化鋯(ZrO2 )或其組合。For example, the light diffusing agent may include barium sulfate (BaSO 4 ), calcium carbonate (CaCO 3 ), titanium dioxide (TiO 2 ), zirconium oxide (ZrO 2 ), or combinations thereof.

光擴散劑可反射前述量子點中未被吸收的光,且容許量子點再次吸收反射光。亦即,光擴散劑可增加被量子點吸收的光量,且提高可固化組成物的光轉換效率。The light diffusing agent can reflect the unabsorbed light in the quantum dots and allow the quantum dots to absorb the reflected light again. That is, the light diffusing agent can increase the amount of light absorbed by the quantum dots and improve the light conversion efficiency of the curable composition.

光擴散劑可具有150奈米至250奈米、且具體而言180奈米至230奈米的平均粒徑(D50 )。當光擴散劑的平均粒徑處於所述範圍內時,其可具有更佳的光擴散效果並提高光轉換效率。The light diffusing agent may have an average particle diameter (D 50 ) of 150 nm to 250 nm, and specifically 180 nm to 230 nm. When the average particle size of the light diffusing agent is within the above range, it can have better light diffusing effect and improve light conversion efficiency.

以無溶劑可固化組成物的總量計,可包含1重量%至20重量%、例如5重量%至10重量%的量的光擴散劑。當以無溶劑可固化組成物的總量計,包含小於1重量%的量的光擴散劑時,由於光擴散劑的使用,難以期望光轉換效率提高效果,而當包含大於20重量%的光擴散劑時,存在量子點可能沈澱的可能性。 其他添加劑The light diffusing agent may be included in an amount of 1 to 20% by weight, such as 5 to 10% by weight, based on the total amount of the solvent-free curable composition. When the light diffusing agent is included in an amount of less than 1% by weight based on the total amount of the solvent-free curable composition, it is difficult to expect a light conversion efficiency improvement effect due to the use of the light diffusing agent, whereas when the light diffusing agent is included in an amount of more than 20% by weight When using a diffusing agent, there is a possibility that the quantum dots may precipitate. Other additives

為達成量子點的穩定性及分散改善,根據實施例的無溶劑可固化組成物可更包含聚合抑制劑。In order to achieve improved stability and dispersion of quantum dots, the solvent-free curable composition according to embodiments may further include a polymerization inhibitor.

聚合抑制劑可包括氫醌系化合物、兒茶酚系化合物或其組合,但不必受限於此。當根據實施例的無溶劑可固化組成物更包含氫醌系化合物、兒茶酚系化合物或其組合時,可防止在塗佈無溶劑可固化組成物後曝光期間的室溫交聯。The polymerization inhibitor may include a hydroquinone-based compound, a catechol-based compound, or a combination thereof, but is not necessarily limited thereto. When the solvent-free curable composition according to the embodiment further includes a hydroquinone-based compound, a catechol-based compound, or a combination thereof, room temperature cross-linking during exposure after coating of the solvent-free curable composition can be prevented.

例如,氫醌系化合物、兒茶酚系化合物或其組合可為氫醌、甲基氫醌、甲氧基氫醌、第三丁基氫醌、2,5-二-第三丁基氫醌、2,5-雙( 1,1-二甲基丁基)氫醌、2,5-雙(1,1,3,3-四甲基丁基)氫醌、兒茶酚、第三丁基兒茶酚、4-甲氧基兒茶酚、五倍子酚、2,6-二-第三丁基-4-甲基苯酚、2-萘酚、三(N-羥基-N-亞硝基苯基胺基-O,O')鋁或其組合,但不必受限於此。For example, the hydroquinone-based compound, the catechol-based compound or a combination thereof may be hydroquinone, methylhydroquinone, methoxyhydroquinone, tert-butylhydroquinone, 2,5-di-tert-butylhydroquinone , 2,5-bis(1,1-dimethylbutyl)hydroquinone, 2,5-bis(1,1,3,3-tetramethylbutyl)hydroquinone, catechol, tert-butyl Catechol, 4-methoxycatechol, gallicol, 2,6-di-tert-butyl-4-methylphenol, 2-naphthol, tris(N-hydroxy-N-nitroso Phenylamino-O,O')aluminum or combinations thereof, but need not be limited thereto.

氫醌系化合物、兒茶酚系化合物或其組合可以分散體的形式使用。以無溶劑可固化組成物的總量計,可包含0.001重量%至3重量%、例如0.1重量%至2重量%的量的分散體形式的聚合抑制劑。當包含處於所述範圍內的聚合抑制劑時,可解決在室溫下的時間流逝,且同時可防止靈敏度劣化及表面分層現象。 The hydroquinone-based compound, the catechol-based compound, or a combination thereof can be used in the form of a dispersion. The polymerization inhibitor in the form of a dispersion may be included in an amount of 0.001% to 3% by weight, such as 0.1% to 2% by weight, based on the total amount of the solvent-free curable composition. When the polymerization inhibitor is included within the above range, the lapse of time at room temperature can be solved, and at the same time, sensitivity deterioration and surface delamination phenomena can be prevented.

此外,根據實施例的無溶劑可固化組成物可更包含丙二酸;3-胺基-1,2-丙二醇;矽烷系偶合劑;調平劑;氟系界面活性劑;或其組合,以改善耐熱性及可靠性。 In addition, the solvent-free curable composition according to the embodiment may further include malonic acid; 3-amino-1,2-propanediol; silane coupling agent; leveling agent; fluorine-based surfactant; or a combination thereof, to Improve heat resistance and reliability.

舉例而言,根據實施例的無溶劑可固化組成物可更包含具有例如乙烯基、羧基、甲基丙烯醯氧基、異氰酸酯基、環氧基等反應性取代基的矽烷系偶合劑以改善與基板的緊密接觸特性。 For example, the solvent-free curable composition according to the embodiment may further include a silane-based coupling agent having reactive substituents such as vinyl, carboxyl, methacryloxy, isocyanate, epoxy, etc. to improve coupling with Close contact characteristics of the substrate.

矽烷系偶合劑的實例可為三甲氧基矽烷基苯甲酸、γ-甲基丙烯酸基氧基丙基三甲氧基矽烷、乙烯基三乙醯氧基矽烷、乙烯基三甲氧基矽烷、γ-異氰酸酯丙基三乙氧基矽烷、γ-縮水甘油氧基丙基三甲氧基矽烷、β-環氧環己基乙基三甲氧基矽烷等,且該些偶合劑可單獨使用或者以二或更多者的混合物形式使用。 Examples of the silane coupling agent include trimethoxysilyl benzoic acid, γ-methacrylooxypropyltrimethoxysilane, vinyltriacetyloxysilane, vinyltrimethoxysilane, and γ-isocyanate. Propyltriethoxysilane, γ-glycidoxypropyltrimethoxysilane, β-epoxycyclohexylethyltrimethoxysilane, etc., and these coupling agents can be used alone or in combination with two or more used in mixture form.

以100重量份的無溶劑可固化組成物計,可使用0.01重量份至10重量份的量的矽烷系偶合劑。當包含處於所述範圍內的矽烷系偶合劑時,緊密接觸性質、儲存能力等得以改善。 The silane-based coupling agent can be used in an amount of 0.01 to 10 parts by weight based on 100 parts by weight of the solvent-free curable composition. When the silane-based coupling agent is included within the above range, close contact properties, storage capacity, etc. are improved.

此外,無溶劑可固化組成物可視需要更包含界面活性劑(例如氟系界面活性劑)以改善塗佈性質並抑制斑點的產生,即改善調平效能。 In addition, the solvent-free curable composition may optionally further contain a surfactant (such as a fluorine-based surfactant) to improve coating properties and suppress the occurrence of spots, that is, to improve leveling performance.

氟系界面活性劑可具有4,000克/莫耳至10,000克/莫耳、且具體而言6,000克/莫耳至10,000克/莫耳的低重量平均分子量。此外,氟系界面活性劑可具有18毫牛/米至23毫牛/米的表面張力(在0.1%的聚乙二醇單甲醚乙酸酯(polyethylene glycol monomethylether acetate,PGMEA)溶液中測得)。當氟系界面活性劑具有處於所述範圍內的重量平均分子量及表面張力時,調平效能可進一步改善,且當施加狹縫塗佈作為高速塗佈時,可提供優異的特性,此乃因可藉由在高速塗佈期間防止斑點產生並抑制蒸氣產生而較少地產生膜缺陷。The fluorine-based surfactant may have a low weight average molecular weight of 4,000 to 10,000 g/mol, and specifically 6,000 to 10,000 g/mol. In addition, the fluorine-based surfactant can have a surface tension of 18 mN/m to 23 mN/m (measured in a 0.1% polyethylene glycol monomethylether acetate (PGMEA) solution) ). When the fluorine-based surfactant has a weight average molecular weight and a surface tension within the above range, the leveling efficiency can be further improved, and when slit coating is applied as high-speed coating, excellent characteristics can be provided. This is because Film defects can be produced less frequently by preventing spotting and suppressing vapor generation during high-speed coating.

氟系界面活性劑的實例可為BM-1000® 及BM-1100® (BM化學公司(BM Chemie Inc.));美佳法(MEGAFACE)F 142D® 、F 172® 、F 173® 及F 183® (大日本油墨化工有限公司(Dainippon Ink Kagaku Kogyo Co., Ltd.));弗洛拉德(FULORAD)FC-135® 、弗洛拉德FC-170C® 、弗洛拉德FC-430® 及弗洛拉德FC-431® (住友3M有限公司(Sumitomo 3M Co., Ltd.));沙福隆(SURFLON)S-112® 、沙福隆S-113® 、沙福隆S-131® 、沙福隆S-141® 及沙福隆S-145® (旭硝子玻璃有限公司(ASAHI Glass Co., Ltd.));以及SH-28PA® 、SH-190®、SH-193® 、SZ-6032® 及SF-8428® 等(東麗矽酮有限公司(Toray Silicone Co., Ltd.));大日本油墨化工有限公司(DIC Co., Ltd.)的F-482、F-484、F-478、F-554等。Examples of fluorine-based surfactants can be BM-1000 ® and BM-1100 ® (BM Chemie Inc.); MEGAFACE F 142D ® , F 172 ® , F 173 ® and F 183 ® (Dainippon Ink Kagaku Kogyo Co., Ltd.); FULORAD FC-135 ® , FULORAD FC-170C ® , FULORAD FC-430 ® and Florad FC-431 ® (Sumitomo 3M Co., Ltd.); SURFLON S-112 ® , SURFLON S-113 ® , SURFLON S-131 ® , Saffron S-141 ® and Saffron S-145 ® (ASAHI Glass Co., Ltd.); and SH-28PA ® , SH-190 ® , SH-193 ® , SZ- 6032 ® and SF-8428 ® etc. (Toray Silicone Co., Ltd.); F-482, F-484, F from Dainippon Ink Co., Ltd. (DIC Co., Ltd.) -478, F-554, etc.

此外,除了氟系界面活性劑之外,根據實施例的無溶劑可固化組成物可更包含矽酮系界面活性劑。矽酮系界面活性劑的具體實例可為東芝矽酮有限公司(Toshiba silicone Co., Ltd.)的TSF400、TSF401、TSF410、TSF4440等,但不限於此。In addition, in addition to the fluorine-based surfactant, the solvent-free curable composition according to the embodiment may further include a silicone-based surfactant. Specific examples of silicone surfactants include TSF400, TSF401, TSF410, TSF4440, etc. from Toshiba Silicone Co., Ltd., but are not limited thereto.

以100重量份的無溶劑可固化組成物計,可包含0.01重量份至5重量份、例如0.1重量份至2重量份的量的界面活性劑。當包含處於所述範圍內的界面活性劑時,在噴射的組成物中較少地生成異物。The surfactant may be included in an amount of 0.01 to 5 parts by weight, for example, 0.1 to 2 parts by weight based on 100 parts by weight of the solvent-free curable composition. When the surfactant is included within the above range, foreign matter is less generated in the sprayed composition.

另外,除非性質劣化,否則根據實施例的無溶劑可固化組成物可更包含預定量的其他添加劑,例如抗氧化劑、穩定劑等。In addition, unless the properties are deteriorated, the solvent-free curable composition according to the embodiment may further include a predetermined amount of other additives, such as antioxidants, stabilizers, and the like.

例如,除上述無溶劑可固化組成物之外,可固化組成物可提供包含被化學式1或化學式2表面改質的量子點、黏合劑樹脂及溶劑的溶劑型可固化組成物。本文中,以溶劑型可固化組成物的總量計,可包含1重量%至40重量%的經表面改質的量子點。當以溶劑型可固化組成物的總量計包含所述含量範圍內的經表面改質的量子點時,在可處理性方面可能是有利的。For example, in addition to the above solvent-free curable composition, the curable composition may provide a solvent-based curable composition including quantum dots surface-modified by Chemical Formula 1 or Chemical Formula 2, a binder resin, and a solvent. Herein, based on the total amount of the solvent-based curable composition, 1 to 40% by weight of surface-modified quantum dots may be included. It may be advantageous in terms of handleability when surface-modified quantum dots are included in the stated content range based on the total amount of the solvent-based curable composition.

以下,詳細闡述構成溶劑型可固化組成物的每種組分。 黏合劑樹脂Below, each component constituting the solvent-based curable composition is explained in detail. adhesive resin

黏合劑樹脂可包括丙烯酸系樹脂、卡多系樹脂、環氧樹脂或其組合。The adhesive resin may include acrylic resin, Cardo resin, epoxy resin, or combinations thereof.

丙烯酸系樹脂可為第一烯系不飽和單體及可與其共聚合的第二烯系不飽和單體的共聚物,且可為包含至少一個丙烯酸系重複單元的樹脂。The acrylic resin may be a copolymer of a first ethylenically unsaturated monomer and a second ethylenically unsaturated monomer copolymerizable therewith, and may be a resin containing at least one acrylic repeating unit.

第一烯系不飽和單體可為包含至少一個羧基的烯系不飽和單體,且所述單體的實例可包括丙烯酸、甲基丙烯酸、順丁烯二酸、衣康酸、反丁烯二酸或其組合。The first ethylenically unsaturated monomer may be an ethylenically unsaturated monomer including at least one carboxyl group, and examples of the monomer may include acrylic acid, methacrylic acid, maleic acid, itaconic acid, fumarate Diacids or combinations thereof.

以丙烯酸系黏合劑樹脂的總量計,可以5重量%至50重量%(例如10重量%至40重量%)的量包含第一烯系不飽和單體。The first ethylenically unsaturated monomer may be included in an amount of 5% to 50% by weight (for example, 10% to 40% by weight) based on the total amount of the acrylic adhesive resin.

第二烯系不飽和單體可為芳族乙烯基化合物,例如苯乙烯、α-甲基苯乙烯、乙烯基甲苯、乙烯基苯甲基甲醚等;不飽和羧酸酯化合物,例如(甲基)丙烯酸甲酯、(甲基)丙烯酸乙酯、(甲基)丙烯酸丁酯、(甲基)丙烯酸2-羥基乙酯、(甲基)丙烯酸2-羥基丁酯、(甲基)丙烯酸苯甲酯、(甲基)丙烯酸環己基酯、(甲基)丙烯酸苯基酯等;不飽和胺基烷基羧酸酯化合物,例如(甲基)丙烯酸2-胺基乙酯、(甲基)丙烯酸2-二甲基胺基乙酯等;羧酸乙烯酯化合物,例如乙酸乙烯酯、苯甲酸乙烯酯等;不飽和羧酸縮水甘油基酯化合物,例如(甲基)丙烯酸縮水甘油基酯等;氰化乙烯化合物,例如(甲基)丙烯腈等;不飽和醯胺化合物,例如(甲基)丙烯醯胺等;等等,且所述第二烯系不飽和單體可單獨使用或以二或更多者的混合物形式使用。The second ethylenically unsaturated monomer can be an aromatic vinyl compound, such as styrene, α-methylstyrene, vinyl toluene, vinyl benzyl methyl ether, etc.; an unsaturated carboxylate compound, such as (methane Methyl acrylate, ethyl (meth)acrylate, butyl (meth)acrylate, 2-hydroxyethyl (meth)acrylate, 2-hydroxybutyl (meth)acrylate, benzene (meth)acrylate Methyl ester, cyclohexyl (meth)acrylate, phenyl (meth)acrylate, etc.; unsaturated aminoalkyl carboxylate compounds, such as 2-aminoethyl (meth)acrylate, (methyl) 2-Dimethylaminoethyl acrylate, etc.; Carboxylic acid vinyl ester compounds, such as vinyl acetate, vinyl benzoate, etc.; Unsaturated carboxylic acid glycidyl ester compounds, such as (meth)glycidyl acrylate, etc. Ethylene cyanide compounds, such as (meth)acrylonitrile, etc.; Unsaturated amide compounds, such as (meth)acrylamide, etc.; etc., and the second ethylenically unsaturated monomer can be used alone or with Use as a mixture of two or more.

丙烯酸系黏合劑樹脂的具體實例可為聚甲基丙烯酸苯甲酯、(甲基)丙烯酸/甲基丙烯酸苯甲酯共聚物、(甲基)丙烯酸/甲基丙烯酸苯甲酯/苯乙烯共聚物、(甲基)丙烯酸/甲基丙烯酸苯甲酯/甲基丙烯酸2-羥基乙酯共聚物、(甲基)丙烯酸/甲基丙烯酸苯甲酯/苯乙烯/甲基丙烯酸2-羥基乙酯共聚物等,但不限於此,且該些可單獨使用或者以二或更多者的混合物形式使用。Specific examples of the acrylic adhesive resin may be polybenzyl methacrylate, (meth)acrylic acid/benzyl methacrylate copolymer, (meth)acrylic acid/benzyl methacrylate/styrene copolymer , (meth)acrylic acid/benzyl methacrylate/2-hydroxyethyl methacrylate copolymer, (meth)acrylic acid/benzyl methacrylate/styrene/2-hydroxyethyl methacrylate copolymer etc., but are not limited thereto, and these may be used alone or in a mixture of two or more.

丙烯酸系黏合劑樹脂的重量平均分子量可為5,000克/莫耳至15,000克/莫耳。當丙烯酸系黏合劑樹脂的重量平均分子量在所述範圍內時,與基板的緊密接觸性質以及物理及化學性質得以改善,且黏度為適當的。The weight average molecular weight of the acrylic adhesive resin may be 5,000 g/mol to 15,000 g/mol. When the weight average molecular weight of the acrylic adhesive resin is within the range, close contact properties with the substrate and physical and chemical properties are improved, and the viscosity is appropriate.

卡多系樹脂可包含由化學式6表示的重複單元。The Cardo-based resin may include repeating units represented by Chemical Formula 6.

[化學式6] [Chemical formula 6]

在化學式6中, R31 及R32 可獨立地為氫原子或者經取代或未經取代的(甲基)丙烯醯氧基烷基, R33 及R34 可獨立地為氫原子、鹵素原子或者經取代或未經取代的C1至C20烷基,且 Z1 可為單鍵、O、CO、SO2 、CR35 R36 、SiR37 R38 (其中,R35 至R38 可獨立地為氫原子或者經取代或未經取代的C1至C20烷基)或由化學式6-1至化學式6-11表示的連接基中的一者, [化學式6-1] In Chemical Formula 6, R 31 and R 32 may be independently a hydrogen atom or a substituted or unsubstituted (meth)acryloxyalkyl group, and R 33 and R 34 may be independently a hydrogen atom, a halogen atom or Substituted or unsubstituted C1 to C20 alkyl, and Z 1 can be a single bond, O, CO, SO 2 , CR 35 R 36 , SiR 37 R 38 (wherein, R 35 to R 38 can be independently hydrogen Atom is either a substituted or unsubstituted C1 to C20 alkyl group) or one of the linking groups represented by Chemical Formula 6-1 to Chemical Formula 6-11, [Chemical Formula 6-1]

[化學式6-2]

Figure 109132893-A0305-02-0072-5
[Chemical formula 6-2]
Figure 109132893-A0305-02-0072-5

Figure 109132893-A0305-02-0072-6
Figure 109132893-A0305-02-0072-6

Figure 109132893-A0305-02-0072-7
Figure 109132893-A0305-02-0072-7

Figure 109132893-A0305-02-0072-8
Figure 109132893-A0305-02-0072-8

在化學式6-5中,Re可為氫原子、乙基、C2H4Cl、C2H4OH、CH2CH=CH2或苯基。 In Chemical Formula 6-5, R e may be a hydrogen atom, ethyl group, C 2 H 4 Cl, C 2 H 4 OH, CH 2 CH=CH 2 or phenyl group.

[化學式6-6] [Chemical formula 6-6]

[化學式6-7] [Chemical formula 6-7]

[化學式6-8] [Chemical formula 6-8]

[化學式6-9] [Chemical formula 6-9]

[化學式6-10] [Chemical formula 6-10]

[化學式6-11] Z2 可為酸酐部分,且 t1及t2可獨立地為0至4的整數。[Chemical formula 6-11] Z2 can be an anhydride moiety, and t1 and t2 can independently be an integer from 0 to 4.

卡多系黏合劑樹脂的重量平均分子量可為500克/莫耳至50,000克/莫耳、例如1,000克/莫耳至30,000克/莫耳。當卡多系黏合劑樹脂的重量平均分子量處於所述範圍內時,可形成令人滿意的圖案,而在固化層的生產期間無殘基且在溶劑型可固化組成物的顯影期間不會損失膜厚度。The weight average molecular weight of the Cardo-based adhesive resin may be 500 g/mol to 50,000 g/mol, for example, 1,000 g/mol to 30,000 g/mol. When the weight average molecular weight of the Cardo-based binder resin is within the range, a satisfactory pattern can be formed without residues during production of the cured layer and without loss during development of the solvent-based curable composition. film thickness.

卡多系黏合劑樹脂可在兩個末端中的至少一個末端處包含由化學式7表示的官能基。The Cardo-based adhesive resin may include a functional group represented by Chemical Formula 7 at at least one of both terminals.

[化學式7] [Chemical Formula 7]

在化學式7中, Z3 可由化學式7-1至化學式7-7表示。In Chemical Formula 7, Z 3 may be represented by Chemical Formula 7-1 to Chemical Formula 7-7.

[化學式7-1] [Chemical formula 7-1]

在化學式7-1中,Rf 及Rg 可獨立地為氫原子、經取代或未經取代的C1至C20烷基、酯基或醚基。In Chemical Formula 7-1, R f and R g may independently be a hydrogen atom, a substituted or unsubstituted C1 to C20 alkyl group, an ester group or an ether group.

[化學式7-2] [Chemical formula 7-2]

[化學式7-3] [Chemical formula 7-3]

[化學式7-4] [Chemical formula 7-4]

[化學式7-5] [Chemical formula 7-5]

在化學式7-5中,Rh 可為O、S、NH、經取代或未經取代的C1至C20伸烷基、C1至C20烷基胺基或C2至C20烯基胺基。In Chemical Formula 7-5, R h may be O, S, NH, substituted or unsubstituted C1 to C20 alkylene group, C1 to C20 alkylamino group, or C2 to C20 alkenylamine group.

[化學式7-6] [Chemical formula 7-6]

[化學式7-7] [Chemical formula 7-7]

卡多系樹脂可例如藉由將以下化合物中的至少兩者進行混合來製備:含芴化合物,例如9,9-雙(4-氧雜環丙基甲氧苯基)芴;酸酐化合物,例如苯四甲酸二酐、萘四甲酸二酐、聯苯基四甲酸二酐、二苯甲酮四甲酸二酐、均苯四甲酸二酐、環丁烷四甲酸二酐、苝四甲酸二酐、四氫呋喃四甲酸二酐及四氫鄰苯二甲酸酐;二醇化合物,例如乙二醇、丙二醇及聚乙二醇;醇化合物,例如甲醇、乙醇、丙醇、正丁醇、環己醇及苯甲醇;溶劑系化合物,例如丙二醇甲基乙酸乙酯及N-甲基吡咯啶酮;磷化合物,例如三苯基膦等;以及胺或銨鹽化合物,例如四甲基氯化銨、四乙基溴化銨、苯甲基二乙胺、三乙胺、三丁胺或苯甲基三乙基氯化銨。Cardo-based resin can be prepared, for example, by mixing at least two of the following compounds: a fluorene-containing compound, such as 9,9-bis(4-oxiranylmethoxyphenyl)fluorene; an acid anhydride compound, such as Pyromellitic dianhydride, naphthalenetetracarboxylic dianhydride, biphenyltetracarboxylic dianhydride, benzophenonetetracarboxylic dianhydride, pyromellitic dianhydride, cyclobutanetetracarboxylic dianhydride, perylenetetracarboxylic dianhydride, Tetrahydrofuran tetracarboxylic dianhydride and tetrahydrophthalic anhydride; glycol compounds, such as ethylene glycol, propylene glycol and polyethylene glycol; alcohol compounds, such as methanol, ethanol, propanol, n-butanol, cyclohexanol and benzene Methanol; solvent compounds, such as propylene glycol methyl ethyl acetate and N-methylpyrrolidone; phosphorus compounds, such as triphenylphosphine, etc.; and amine or ammonium salt compounds, such as tetramethylammonium chloride, tetraethyl Ammonium bromide, benzyldiethylamine, triethylamine, tributylamine or benzyltriethylammonium chloride.

當黏合劑樹脂為卡多系樹脂時,包含所述卡多系樹脂的溶劑型可固化組成物、特別是感光性樹脂組成物在光固化期間具有優異的可顯影性及敏感度且因此具有精細圖案的形成能力。When the binder resin is a Cardo-based resin, the solvent-based curable composition including the Cardo-based resin, especially the photosensitive resin composition, has excellent developability and sensitivity during photocuring and therefore has fine Pattern forming ability.

丙烯酸系樹脂的酸值可為80毫克KOH/克至130毫克KOH/克。當丙烯酸系樹脂的酸值處於所述範圍內時,可獲得優異的畫素解析度。The acid value of the acrylic resin may range from 80 mg KOH/g to 130 mg KOH/g. When the acid value of the acrylic resin is within the above range, excellent pixel resolution can be obtained.

環氧樹脂可為可熱聚合單體或寡聚物,且可包括具有碳-碳不飽和鍵及碳-碳環鍵的化合物。The epoxy resin may be a thermally polymerizable monomer or oligomer, and may include compounds having carbon-carbon unsaturated bonds and carbon-carbon ring bonds.

環氧樹脂可更包括雙酚A環氧樹脂、雙酚F環氧樹脂、苯酚酚醛環氧樹脂、環狀脂族環氧樹脂及脂族多縮水甘油醚,但不必受限於此。Epoxy resins may further include bisphenol A epoxy resin, bisphenol F epoxy resin, phenol novolac epoxy resin, cyclic aliphatic epoxy resin and aliphatic polyglycidyl ether, but are not necessarily limited thereto.

作為所述化合物的市售產品,可為雙苯基環氧樹脂,例如尤嘉殼牌環氧有限公司(Yuka Shell Epoxy Co., Ltd.)的YX4000、YX4000H、YL6121H、YL6640或YL6677;甲酚酚醛環氧樹脂,例如日本化藥有限公司(Nippon Kayaku Co. Ltd.)的EOCN-102、EOCN-103S、EOCN-104S、EOCN-1020、EOCN-1025及EOCN-1027以及尤嘉殼牌環氧有限公司的埃皮考特(EPIKOTE)180S75等;雙酚A環氧樹脂,例如尤嘉殼牌環氧有限公司的埃皮考特1001、1002、1003、1004、1007、1009、1010及828;雙酚F環氧樹脂,例如尤嘉殼牌環氧有限公司的埃皮考特807及834;苯酚酚醛環氧樹脂,例如尤嘉殼牌環氧公司的埃皮考特152、154或157H65以及日本化藥有限公司的EPPN 201、202;環狀脂族環氧樹脂,例如汽巴-嘉基A.G公司(CIBA-GEIGY A.G Corp.)的CY175、CY177及CY179、U.C.C.公司的ERL-4234、ERL-4299、ERL-4221及ERL-4206,昭和電工公司(Showa Denko K.K.)的秀迪因(Showdyne)509,汽巴-嘉基A.G公司的愛牢達(Araldite)CY-182、CY-192及CY-184,大日本油墨化工有限公司(Dainippon Ink & Chemicals Inc.)的艾比克隆(EPICLON)200及400,尤嘉殼牌環氧有限公司的埃皮考特(EPIKOTE)871及872以及EP1032H60、塞拉尼斯塗料公司(Celanese Coating Corporation)的ED-5661及ED-5662;脂族多縮水甘油醚,例如尤嘉殼牌環氧有限公司的埃皮考特190P及191P,共榮社油脂化學工業有限公司(Kyoeisha Yushi Kagaku Kogyo Co., Ltd.)的艾普利特(EPOLITE)100MF,日本油脂公司(Nihon Yushi K. K.)的EPIOL TMP等。As the commercially available product of the compound, it can be biphenyl epoxy resin, such as YX4000, YX4000H, YL6121H, YL6640 or YL6677 of Yuka Shell Epoxy Co., Ltd.; cresol novolac Epoxy resins such as EOCN-102, EOCN-103S, EOCN-104S, EOCN-1020, EOCN-1025 and EOCN-1027 from Nippon Kayaku Co. Ltd. and Yoka Shell Epoxy Co., Ltd. EPIKOTE 180S75, etc.; Bisphenol A epoxy resin, such as EPIKOTE 1001, 1002, 1003, 1004, 1007, 1009, 1010 and 828 of Youjia Shell Epoxy Co., Ltd.; Bisphenol F Epoxy resins, such as Eucalyptus Shell Epoxy Co., Ltd.'s Epicot 807 and 834; phenol novolac epoxy resins, such as Eucalyptus Shell Epoxy Co., Ltd.'s Epicoat 152, 154 or 157H65 and Nippon Chemical Co., Ltd. EPPN 201, 202; cyclic aliphatic epoxy resins, such as CY175, CY177 and CY179 of CIBA-GEIGY A.G Corp., ERL-4234, ERL-4299, ERL- 4221 and ERL-4206, Showdyne 509 from Showa Denko K.K., Araldite CY-182, CY-192 and CY-184 from Ciba-Geigy A.G. EPICLON 200 and 400 from Dainippon Ink & Chemicals Inc., EPIKOTE 871 and 872 from Youjia Shell Epoxy Co., Ltd. and EP1032H60, Celanese Paint Company Celanese Coating Corporation's ED-5661 and ED-5662; aliphatic polyglycidyl ethers, such as Epicot 190P and 191P from Yujia Shell Epoxy Co., Ltd., Kyoeisha Yushi Kagaku Oleochemical Industry Co., Ltd. EPOLITE 100MF from Kogyo Co., Ltd., EPIOL TMP from Nihon Yushi K. K., etc.

以溶劑型可固化組成物的總量計,可以1重量%至30重量%的量包含黏合劑樹脂。 溶劑The binder resin may be included in an amount of 1 to 30% by weight based on the total amount of the solvent-based curable composition. Solvent

溶劑可例如包括醇,例如甲醇、乙醇等;二醇醚,例如乙二醇甲醚、乙二醇乙醚、丙二醇甲醚等;溶纖劑乙酸酯,例如甲基溶纖劑乙酸酯、乙基溶纖劑乙酸酯、二乙基溶纖劑乙酸酯等;卡必醇,例如甲基乙基卡必醇、二乙基卡必醇、二乙二醇單甲醚、二乙二醇單乙醚、二乙二醇二甲醚、二乙二醇甲乙醚、二乙二醇二乙醚等;丙二醇烷基醚乙酸酯,例如丙二醇單甲醚乙酸酯、丙二醇丙醚乙酸酯等;酮,例如甲乙酮、環己酮、4-羥基-4-甲基-2-戊酮、甲基-正丙基酮、甲基-正丁基酮、甲基-正戊基酮、2-庚酮等;飽和脂族單羧酸烷基酯,例如乙酸乙酯、乙酸正丁酯、乙酸異丁酯等;乳酸酯,例如乳酸甲酯、乳酸乙酯等;羥基乙酸烷基酯,例如羥基乙酸甲酯、羥基乙酸乙酯、羥基乙酸丁酯等;乙酸烷氧基烷基酯,例如甲氧基乙酸甲酯、甲氧基乙酸乙酯、甲氧基乙酸丁酯、乙氧基乙酸甲酯、乙氧基乙酸乙酯等;3-羥基丙酸烷基酯,例如3-羥基丙酸甲酯、3-羥基丙酸乙酯等;3-烷氧基丙酸烷基酯,例如3-甲氧基丙酸甲酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸乙酯、3-乙氧基丙酸甲酯等;2-羥基丙酸烷基酯,例如2-羥基丙酸甲酯、2-羥基丙酸乙酯、2-羥基丙酸丙酯等;2-烷氧基丙酸烷基酯,例如2-甲氧基丙酸甲酯、2-甲氧基丙酸乙酯、2-乙氧基丙酸乙酯、2-乙氧基丙酸甲酯等;2-羥基-2-甲基丙酸烷基酯,例如2-羥基-2-甲基丙酸甲酯、2-羥基-2-甲基丙酸乙酯等;2-烷氧基-2-甲基丙酸烷基酯,例如2-甲氧基-2-甲基丙酸甲酯、2-乙氧基-2-甲基丙酸乙酯等;酯,例如丙酸2-羥基乙酯、丙酸2-羥基-2-甲基乙酯、乙酸羥基乙酯、丁酸2-羥基-3-甲基甲酯等;或酮酸酯,例如丙酮酸乙酯等,且此外,可為N-甲基甲醯胺、N,N-二甲基甲醯胺、N-甲基甲醯苯胺、N-甲基乙醯胺、N,N-二甲基乙醯胺、N-甲基吡咯啶酮、二甲亞碸、苯甲基乙基醚、二己基醚、乙醯丙酮、異佛爾酮、己酸、辛酸、1-辛醇、1-壬醇、苯甲醇、乙酸苯甲酯、苯甲酸乙酯、乙二酸二乙酯、順丁烯二酸二乙酯、γ-丁內酯、碳酸伸乙酯、碳酸伸丙酯、苯基溶纖劑乙酸酯(phenyl cellosolve acetate)等,但不限於此。Solvents may include, for example, alcohols, such as methanol, ethanol, etc.; glycol ethers, such as ethylene glycol methyl ether, ethylene glycol ethyl ether, propylene glycol methyl ether, etc.; cellosolve acetate, such as methyl cellosolve acetate, Ethyl cellosolve acetate, diethyl cellosolve acetate, etc.; carbitol, such as methyl ethyl carbitol, diethyl carbitol, diethylene glycol monomethyl ether, diethyl carbitol, etc. Glycol monoethyl ether, diethylene glycol dimethyl ether, diethylene glycol methyl ethyl ether, diethylene glycol diethyl ether, etc.; propylene glycol alkyl ether acetate, such as propylene glycol monomethyl ether acetate, propylene glycol propyl ether acetate. Esters, etc.; ketones, such as methyl ethyl ketone, cyclohexanone, 4-hydroxy-4-methyl-2-pentanone, methyl-n-propyl ketone, methyl-n-butyl ketone, methyl-n-amyl ketone, 2-Heptanone, etc.; Saturated aliphatic monocarboxylic acid alkyl esters, such as ethyl acetate, n-butyl acetate, isobutyl acetate, etc.; Lactic acid esters, such as methyl lactate, ethyl lactate, etc.; Alkyl glycolate Esters, such as methyl glycolate, ethyl glycolate, butyl glycolate, etc.; alkoxyalkyl acetates, such as methyl methoxyacetate, ethyl methoxyacetate, butyl methoxyacetate, ethyl acetate, etc. Methyl oxyacetate, ethoxyethyl acetate, etc.; Alkyl 3-hydroxypropionate, such as methyl 3-hydroxypropionate, ethyl 3-hydroxypropionate, etc.; Alkyl 3-alkoxypropionate Esters, such as methyl 3-methoxypropionate, ethyl 3-methoxypropionate, ethyl 3-ethoxypropionate, methyl 3-ethoxypropionate, etc.; 2-hydroxypropionic acid alkyl esters, such as methyl 2-hydroxypropionate, ethyl 2-hydroxypropionate, propyl 2-hydroxypropionate, etc.; alkyl 2-alkoxypropionates, such as methyl 2-methoxypropionate , ethyl 2-methoxypropionate, ethyl 2-ethoxypropionate, methyl 2-ethoxypropionate, etc.; 2-hydroxy-2-methylpropionic acid alkyl ester, such as 2-hydroxy -Methyl 2-methylpropionate, ethyl 2-hydroxy-2-methylpropionate, etc.; alkyl 2-alkoxy-2-methylpropionate, such as 2-methoxy-2-methyl Methyl propionate, ethyl 2-ethoxy-2-methylpropionate, etc.; esters, such as 2-hydroxyethyl propionate, 2-hydroxy-2-methylethyl propionate, hydroxyethyl acetate , 2-hydroxy-3-methylmethyl butyrate, etc.; or ketoacid ester, such as ethyl pyruvate, etc., and in addition, it can be N-methylformamide, N,N-dimethylformamide , N-methylformaniline, N-methylacetamide, N,N-dimethylacetamide, N-methylpyrrolidone, dimethyltrisoxide, benzyl ethyl ether, dihexyl Ether, acetylacetone, isophorone, hexanoic acid, octanoic acid, 1-octanol, 1-nonanol, benzyl alcohol, benzyl acetate, ethyl benzoate, diethyl oxalate, maleic acid Diethyl acid, γ-butyrolactone, ethyl carbonate, propyl carbonate, phenyl cellosolve acetate, etc., but are not limited to these.

例如,溶劑可期望為二醇醚,例如乙二醇單乙醚、乙二醇甲乙醚等;乙二醇烷基醚乙酸酯,例如乙基溶纖劑乙酸酯等;酯,例如丙酸2-羥基乙酯等;卡必醇,例如二乙二醇單甲醚等;丙二醇烷基醚乙酸酯,例如丙二醇單甲醚乙酸酯、丙二醇丙醚乙酸酯等;醇,例如乙醇等或其組合。For example, the solvent may be expected to be a glycol ether, such as ethylene glycol monoethyl ether, ethylene glycol methyl ethyl ether, etc.; a glycol alkyl ether acetate, such as ethyl cellosolve acetate, etc.; an ester, such as propionic acid 2-hydroxyethyl ester, etc.; carbitol, such as diethylene glycol monomethyl ether, etc.; propylene glycol alkyl ether acetate, such as propylene glycol monomethyl ether acetate, propylene glycol propyl ether acetate, etc.; alcohols, such as ethanol etc. or a combination thereof.

例如,溶劑可為極性溶劑,包括丙二醇單甲醚乙酸酯、二丙二醇甲醚乙酸酯、乙醇、乙二醇二甲醚、乙二醇甲乙醚、二乙二醇二甲醚、2-丁氧基乙醇、N-甲基吡咯啶、N-乙基吡咯啶、碳酸伸丙酯、γ-丁內酯或其組合。For example, the solvent may be a polar solvent, including propylene glycol monomethyl ether acetate, dipropylene glycol methyl ether acetate, ethanol, ethylene glycol dimethyl ether, ethylene glycol methyl ethyl ether, diethylene glycol dimethyl ether, 2- Butoxyethanol, N-methylpyrrolidine, N-ethylpyrrolidine, propylene carbonate, γ-butyrolactone or combinations thereof.

以溶劑型可固化組成物的總量計,可包含餘量、例如30重量%至80重量%、例如35重量%至70重量%的溶劑。當溶劑處於所述範圍內時,溶劑型可固化組成物具有適當黏度,且因此可在藉由旋塗及狹縫塗佈而被塗佈於大區域中時具有優異的塗佈性質。Based on the total amount of the solvent-based curable composition, the balance, such as 30 to 80 wt%, such as 35 to 70 wt% of the solvent, may be included. When the solvent is within the range, the solvent-based curable composition has an appropriate viscosity and therefore has excellent coating properties when being coated in a large area by spin coating and slot coating.

例如,除上述組分之外,溶劑型可固化組成物可更包含前述在末端處具有碳-碳雙鍵的可聚合單體、聚合起始劑、光擴散劑及其他添加劑中的一或多者,且其具體組成或量與上述相同。For example, in addition to the above components, the solvent-based curable composition may further include one or more of the aforementioned polymerizable monomers having carbon-carbon double bonds at the terminals, polymerization initiators, light diffusing agents and other additives. , and its specific composition or amount is the same as above.

例如,溶劑型可固化組成物可為感光性樹脂組成物。在此種情況下,溶劑型可固化組成物可包含光聚合起始劑作為聚合起始劑。For example, the solvent-based curable composition may be a photosensitive resin composition. In this case, the solvent-type curable composition may include a photopolymerization initiator as a polymerization initiator.

另一實施例提供一種使用上述無溶劑可固化組成物及溶劑型可固化組成物製造的固化層、一種包括所述固化層的彩色濾光片及一種包括所述彩色濾光片的顯示裝置。Another embodiment provides a cured layer manufactured using the solvent-free curable composition and the solvent-based curable composition, a color filter including the cured layer, and a display device including the color filter.

生產固化層的一種方法可包括:使用噴墨噴射方法將上述無溶劑可固化組成物及溶劑型可固化組成物塗佈在基板上以形成圖案(S1);及對圖案進行固化(S2)。 (S1)形成圖案One method of producing the cured layer may include: coating the above-mentioned solvent-free curable composition and solvent-based curable composition on a substrate using an inkjet jetting method to form a pattern (S1); and curing the pattern (S2). (S1) Form a pattern

可期望以噴墨噴射方法將無溶劑可固化組成物在基板上塗佈成0.5微米至20微米。噴墨噴射方法可藉由每一噴嘴噴射單一顏色且因此重複噴射與所需數目的顏色相等的次數來形成圖案,但圖案可藉由每一噴墨噴嘴同時噴射所需數目的顏色來形成,以減少製程。 (S2)固化It is desirable to apply the solvent-free curable composition to a substrate by an inkjet spraying method to a thickness of 0.5 microns to 20 microns. The inkjet spraying method can form a pattern by each nozzle spraying a single color and thus repeating the spraying a number of times equal to the required number of colors, but the pattern can be formed by each inkjet nozzle spraying the required number of colors simultaneously, to reduce the manufacturing process. (S2) Curing

對所獲得的圖案進行固化以獲得畫素。本文中,固化方法可為熱固化或光固化製程。熱固化製程可在大於或等於100℃下、期望地在100℃至300℃範圍內、且更期望地在160℃至250℃範圍內執行。光固化製程可包括照射光化射線,例如190奈米至450奈米、例如200奈米至500奈米的紫外線。藉由使用例如具有低壓、高壓或超高壓的汞燈、金屬鹵素燈、氬氣雷射等光源來執行照射。根據需要亦可使用X射線、電子束等。The obtained pattern is cured to obtain pixels. Here, the curing method may be a thermal curing or light curing process. The thermal curing process may be performed at greater than or equal to 100°C, desirably in the range of 100°C to 300°C, and more desirably in the range of 160°C to 250°C. The photocuring process may include irradiating actinic rays, such as ultraviolet rays with a wavelength of 190 nanometers to 450 nanometers, such as 200 nanometers to 500 nanometers. Irradiation is performed by using light sources such as mercury lamps, metal halide lamps, argon lasers with low pressure, high pressure or ultra-high pressure. X-rays, electron beams, etc. can also be used as needed.

生產固化層的其他方法可包括使用前述無溶劑可固化組成物及溶劑型可固化組成物藉由如下微影方法來生產固化層。 (1)塗佈及膜形成Other methods of producing the cured layer may include using the aforementioned solvent-free curable composition and solvent-based curable composition to produce the cured layer by the following photolithography method. (1) Coating and film formation

利用旋塗或狹縫塗佈方法、輥塗方法、網版印刷方法、塗料器方法等在經受預定預處理的基板上將前述可固化組成物塗佈成具有所期望的厚度,例如介於2微米至10微米範圍內的厚度。然後,將經塗佈基板在70℃至90℃的溫度下加熱1分鐘至10分鐘,以移除溶劑並形成膜。 (2)曝光The aforementioned curable composition is coated on a substrate subjected to predetermined pretreatment using a spin coating or slit coating method, a roller coating method, a screen printing method, a coater method, etc. to have a desired thickness, for example, between 2 Thicknesses in the micron to 10 micron range. The coated substrate is then heated at a temperature of 70°C to 90°C for 1 minute to 10 minutes to remove the solvent and form a film. (2) Exposure

在安放具有預定形狀的遮罩之後,藉由190奈米至450奈米、例如200奈米至500奈米的例如UV射線等光化射線來照射所得膜以形成期望的圖案。使用例如具有低壓、高壓或超高壓的汞燈、金屬鹵素燈、氬氣雷射等光源來執行照射。根據需要亦可使用X射線、電子束等。After placing a mask with a predetermined shape, the resulting film is irradiated with actinic rays such as UV rays of 190 to 450 nanometers, such as 200 to 500 nanometers, to form a desired pattern. The irradiation is performed using light sources such as mercury lamps, metal halide lamps, argon lasers with low pressure, high pressure or ultra-high pressure. X-rays, electron beams, etc. can also be used as needed.

當使用高壓汞燈時,曝光製程使用例如500毫焦/平方公分或小於500毫焦/平方公分的光劑量(利用365奈米感測器)。然而,所述光劑量可依據可固化組成物的每一組分的種類、其組合比率及乾膜厚度而變化。 (3)顯影When using a high-pressure mercury lamp, the exposure process uses a light dose of, for example, 500 mJ/cm2 or less (using a 365 nm sensor). However, the light dose may vary depending on the type of each component of the curable composition, their combination ratio, and dry film thickness. (3) Development

在曝光製程之後,使用鹼性水溶液藉由溶解並移除除了被曝光部分外的多餘部分而將被曝光膜顯影,以形成影像圖案。換言之,當使用鹼性顯影溶液來顯影時,溶解未曝光區,且形成影像彩色濾光片圖案。 (4)後處理After the exposure process, the exposed film is developed using an alkaline aqueous solution to form an image pattern by dissolving and removing excess parts except the exposed parts. In other words, when developed using an alkaline developing solution, the unexposed areas are dissolved and an image color filter pattern is formed. (4) Post-processing

可再次加熱或藉由光化射線等照射所顯影影像圖案來進行固化,以達成耐熱性、耐光性、緊密接觸性質、抗裂性、耐化學性、高強度、儲存穩定性等方面的優異品質。The developed image pattern can be cured by heating again or by irradiating it with actinic rays, etc. to achieve excellent qualities in terms of heat resistance, light resistance, close contact properties, crack resistance, chemical resistance, high strength, storage stability, etc. .

在下文中,參考實例更詳細地說明本發明。然而,該些實例不應在任何意義上被解釋為限制本發明的範圍。(配位體合成) 合成例 1 In the following, the invention is explained in more detail with reference to examples. However, these examples should not be construed in any sense as limiting the scope of the invention. (Ligand synthesis) Synthesis example 1

將400克聚氧乙烯單甲醚(MPEG-400,漢農化學公司(Hannong Chemicals Inc.))及100克琥珀酸酐放在一起,且然後加熱至100℃並反應了12小時。當反應完成時,將所得物冷卻至室溫(23℃)以獲得500克由化學式2-1表示的最終產物。400 grams of polyoxyethylene monomethyl ether (MPEG-400, Hannong Chemicals Inc.) and 100 grams of succinic anhydride were put together, and then heated to 100°C and reacted for 12 hours. When the reaction was completed, the resultant was cooled to room temperature (23°C) to obtain 500 g of the final product represented by Chemical Formula 2-1.

[化學式2-1] 合成例 2 [Chemical formula 2-1] Synthesis example 2

除了使用270克聚氧乙烯苯基醚(PH-4,漢農化學公司)代替400克聚氧乙烯單甲醚(MPEG-400,漢農化學公司)之外,根據與合成例1相同的方法獲得了370克由化學式2-2表示的最終產物。According to the same method as Synthesis Example 1 except that 270 grams of polyoxyethylene phenyl ether (PH-4, Hannon Chemical Company) was used instead of 400 grams of polyoxyethylene monomethyl ether (MPEG-400, Hannon Chemical Company) 370 g of the final product represented by Chemical Formula 2-2 was obtained.

[化學式2-2] 合成例 3 [Chemical formula 2-2] Synthesis example 3

除了使用114克戊二酸酐代替100克琥珀酸酐之外,根據與合成例2相同的方法獲得了384克由化學式2-3表示的最終產物。384 g of the final product represented by Chemical Formula 2-3 was obtained according to the same method as Synthesis Example 2, except that 114 g of glutaric anhydride was used instead of 100 g of succinic anhydride.

[化學式2-3] 合成例 4 [Chemical formula 2-3] Synthesis example 4

將270克聚氧乙烯苯基醚(PH-4,漢農化學公司)及152克四氫鄰苯二甲酸酐放在一起,且然後加熱至100℃並反應了12小時。當反應完成時,將所得物冷卻至室溫(23℃)以獲得422克由化學式2-4表示的最終產物。270 grams of polyoxyethylene phenyl ether (PH-4, Hannon Chemical Company) and 152 grams of tetrahydrophthalic anhydride were put together, and then heated to 100°C and reacted for 12 hours. When the reaction was completed, the resultant was cooled to room temperature (23°C) to obtain 422 g of the final product represented by Chemical Formula 2-4.

[化學式2-4] 合成例 5 [Chemical formula 2-4] Synthesis example 5

將934克聚氧乙烯苯乙烯化苯基醚(TSP-150,漢農化學公司)、100克琥珀酸酐及500克甲苯放在一起,且然後加熱至100℃並反應了24小時。當反應完成時,移除了甲苯以獲得1000克由化學式2-5表示的最終產物。934 grams of polyoxyethylene styrenated phenyl ether (TSP-150, Hannon Chemical Company), 100 grams of succinic anhydride and 500 grams of toluene were put together, and then heated to 100°C and reacted for 24 hours. When the reaction was completed, toluene was removed to obtain 1000 g of the final product represented by Chemical Formula 2-5.

[化學式2-5] 合成例 6 [Chemical formula 2-5] Synthesis example 6

除了使用520克聚氧乙烯枯基苯基醚(DCP-3016,漢農化學公司)代替934克聚氧乙烯苯乙烯化苯基醚之外,根據與合成例5相同的方法獲得了620克由化學式2-6表示的最終產物。620 g of polyoxyethylene styrenated phenyl ether was obtained according to the same method as Synthesis Example 5, except that 520 g of polyoxyethylene cumyl phenyl ether (DCP-3016, Hannon Chemical Co., Ltd.) was used instead of 934 g of polyoxyethylene styrenated phenyl ether. The final product represented by Chemical Formula 2-6.

[化學式2-6] 合成例 7 [Chemical formula 2-6] Synthesis Example 7

在0℃下,將191克對甲苯磺醯氯及150毫升四氫呋喃(tetrahydrofuran,THF)緩慢注入400克聚氧乙烯單甲醚(MPEG-400,漢農化學公司)、44克NaOH、500毫升四氫呋喃(THF)及100毫升蒸餾水的混合溶液中。注射30分鐘後,將所得混合物在室溫(23℃)下攪拌了12小時。當反應完成時,藉由萃取、中和及濃縮製程對所得物進行了純化,且然後在真空烘箱中進行了充分乾燥。將所得產物放入燒瓶中,並在氮氣氣氛下溶解在乙醇中。隨後,向其中添加了4當量的硫脲,且然後在100℃下攪拌了12小時。向其中另外添加了NaOH稀釋溶液,並進一步攪拌了5小時。當反應完成時,將所得物用蒸餾水及稀鹽酸溶液洗滌了幾次、萃取並中和,且然後在真空烘箱中進行了充分乾燥,以最終獲得由化學式A表示的化合物。At 0°C, slowly inject 191 g of p-toluenesulfonyl chloride and 150 ml of tetrahydrofuran (THF) into 400 g of polyoxyethylene monomethyl ether (MPEG-400, Hannon Chemical Company), 44 g of NaOH, and 500 ml of tetrahydrofuran. (THF) and 100 ml of distilled water. 30 minutes after injection, the resulting mixture was stirred at room temperature (23°C) for 12 hours. When the reaction is complete, the resultant is purified by extraction, neutralization and concentration, and then fully dried in a vacuum oven. The resulting product was placed in a flask and dissolved in ethanol under a nitrogen atmosphere. Subsequently, 4 equivalents of thiourea were added thereto, and then stirred at 100°C for 12 hours. A dilute solution of NaOH was additionally added thereto, and the mixture was further stirred for 5 hours. When the reaction was completed, the resultant was washed several times with distilled water and dilute hydrochloric acid solution, extracted and neutralized, and then sufficiently dried in a vacuum oven to finally obtain the compound represented by Chemical Formula A.

[化學式A] [Chemical formula A]

將444克由化學式A表示的化合物、72克丙烯酸、10克三乙胺及300克THF放在一起,且然後在50℃下反應了12小時,並用過量的二氯甲烷進行了稀釋。隨後,用5% HCl水溶液中和稀釋的所得物以單獨獲得有機層,且在減壓下對有機層進行了濃縮以獲得500克由化學式2-7表示的最終產物。444 g of the compound represented by Chemical Formula A, 72 g of acrylic acid, 10 g of triethylamine and 300 g of THF were put together, and then reacted at 50° C. for 12 hours, and diluted with excess methylene chloride. Subsequently, the diluted result was neutralized with a 5% HCl aqueous solution to obtain an organic layer alone, and the organic layer was concentrated under reduced pressure to obtain 500 g of the final product represented by Chemical Formula 2-7.

[化學式2-7] 合成例 8 [Chemical formula 2-7] Synthesis example 8

除了使用270克聚氧乙烯苯基醚(PH-4,漢農化學公司)代替400克聚氧乙烯單甲醚之外,根據與合成例7相同的方法獲得了340克由化學式2-8表示的最終產物。Except that 270 g of polyoxyethylene phenyl ether (PH-4, Hannon Chemical Co., Ltd.) was used instead of 400 g of polyoxyethylene monomethyl ether, 340 g was obtained according to the same method as Synthesis Example 7, represented by Chemical Formula 2-8 the final product.

[化學式2-8] 合成例 9 [Chemical formula 2-8] Synthesis example 9

將270克聚氧乙烯苯基醚(PH-4,漢農化學公司)及140克烯丙基琥珀酸酐放在一起,且然後加熱至100℃並反應了12小時。當反應完成時,將所得物冷卻至室溫以獲得410克由化學式3-1表示的最終產物。270 grams of polyoxyethylene phenyl ether (PH-4, Hannon Chemical Company) and 140 grams of allyl succinic anhydride were put together, and then heated to 100°C and reacted for 12 hours. When the reaction was completed, the resultant was cooled to room temperature to obtain 410 g of the final product represented by Chemical Formula 3-1.

[化學式3-1] 合成例 10 [Chemical formula 3-1] Synthesis example 10

將130克甲基丙烯酸2-羥乙酯、100克琥珀酸酐及0.1克MEHQ放在一起,且然後加熱至70℃並反應了12小時。當反應完成時,將所得物冷卻至室溫以獲得230克由化學式3-2表示的最終產物。130 g of 2-hydroxyethyl methacrylate, 100 g of succinic anhydride and 0.1 g of MEHQ were put together, and then heated to 70°C and reacted for 12 hours. When the reaction was completed, the resultant was cooled to room temperature to obtain 230 g of the final product represented by Chemical Formula 3-2.

[化學式3-2] 合成例 11 [Chemical formula 3-2] Synthesis Example 11

在0℃下,將191克對甲苯磺醯氯及150毫升THF緩慢注入600克聚氧乙烯單烯丙基醚(APEG-1000,漢農化學公司)、44克NaOH、500毫升THF及100毫升蒸餾水的混合溶液中。注射30分鐘後,將所得混合物冷卻至室溫(23℃)並攪拌了12小時。當反應完成時,藉由萃取、中和及濃縮製程對所得物進行了純化,且然後在真空烘箱中進行了充分乾燥。將所得產物放入燒瓶中,並在氮氣氣氛下溶解在乙醇中。然後,向其中添加了4當量的硫脲,且然後在100℃下攪拌了12小時。向其中另外添加了NaOH稀釋溶液,且然後攪拌了5小時。當反應完成時,將所得物用蒸餾水及稀鹽酸溶液洗滌及萃取,且在真空烘箱中進行了充分乾燥,以獲得580克由化學式3-3表示的最終產物。At 0°C, 191 g of p-toluenesulfonyl chloride and 150 ml of THF were slowly injected into 600 g of polyoxyethylene monoallyl ether (APEG-1000, Hannon Chemical Company), 44 g of NaOH, 500 ml of THF and 100 ml of THF. mixed solution of distilled water. 30 minutes after injection, the resulting mixture was cooled to room temperature (23°C) and stirred for 12 hours. When the reaction is complete, the resultant is purified by extraction, neutralization and concentration, and then fully dried in a vacuum oven. The resulting product was placed in a flask and dissolved in ethanol under a nitrogen atmosphere. Then, 4 equivalents of thiourea were added thereto, and then stirred at 100°C for 12 hours. To this was additionally added a dilute solution of NaOH, and then stirred for 5 hours. When the reaction was completed, the resultant was washed and extracted with distilled water and dilute hydrochloric acid solution, and sufficiently dried in a vacuum oven to obtain 580 g of the final product represented by Chemical Formula 3-3.

[化學式3-3] 合成例 12 [Chemical formula 3-3] Synthesis example 12

將600克聚氧乙烯單烯丙基醚(APEG-1000,漢農化學公司)及100克琥珀酸酐放在一起,且然後加熱至100℃並反應了12小時。當反應完成時,將所得物冷卻至室溫以獲得700克由化學式3-4表示的最終產物。600 grams of polyoxyethylene monoallyl ether (APEG-1000, Hannon Chemical Company) and 100 grams of succinic anhydride were put together, and then heated to 100°C and reacted for 12 hours. When the reaction was completed, the resultant was cooled to room temperature to obtain 700 g of the final product represented by Chemical Formula 3-4.

[化學式3-4] 合成例 13 [Chemical formula 3-4] Synthesis example 13

將500克根據合成例11的由化學式3-3表示的化合物、72克丙烯酸、10克三乙胺及300克THF放在一起,且然後在50℃下反應了12小時,並用過量的二氯甲烷進行了稀釋。隨後,使用5% HCl水溶液進行中和以單獨獲得有機層,且在減壓下對有機層進行了濃縮以獲得500克由化學式3-5表示的最終產物。500 g of the compound represented by Chemical Formula 3-3 according to Synthesis Example 11, 72 g of acrylic acid, 10 g of triethylamine and 300 g of THF were put together, and then reacted at 50° C. for 12 hours, with an excess of dichloride Methane is diluted. Subsequently, neutralization was performed using a 5% HCl aqueous solution to obtain an organic layer alone, and the organic layer was concentrated under reduced pressure to obtain 500 g of the final product represented by Chemical Formula 3-5.

[化學式3-5] 合成例 14 [Chemical formula 3-5] Synthesis Example 14

將600克聚氧乙烯單烯丙基醚(APEG-1000,漢農化學公司)、124克雙環[2.2.2]辛-7-烯-2,3,5,6-四羧酸二酐、500克甲苯及60克三乙胺放在一起,且然後加熱至100℃並反應了24小時。當反應完成時,用5% HCl溶液對所得物進行了中和以移除甲苯,且然後獲得700克由化學式4-1表示的最終產物。Mix 600 grams of polyoxyethylene monoallyl ether (APEG-1000, Hannong Chemical Company), 124 grams of bicyclo[2.2.2]oct-7-ene-2,3,5,6-tetracarboxylic dianhydride, 500 grams of toluene and 60 grams of triethylamine were put together, and then heated to 100°C and reacted for 24 hours. When the reaction was completed, the resultant was neutralized with a 5% HCl solution to remove toluene, and then 700 g of the final product represented by Chemical Formula 4-1 was obtained.

[化學式4-1] 比較合成例 1 [Chemical formula 4-1] Comparative synthesis example 1

分別將10克2-巰基-1-乙醇、13.3克2-2-(2-甲氧基乙氧基)乙氧基乙酸及2.1克對甲苯磺酸一水合物放入2頸圓底燒瓶中,且然後溶解在300毫升環己烷中。在將迪安斯塔克緊固至注射孔後,向其連接冷凝器。使溶液回流8小時後,反應完成。(檢查迪安斯塔克中收集的最終水量)。將反應物輸送至分液漏斗中,進行萃取、中和以移除溶劑,且在真空烘箱中進行了乾燥以獲得由化學式C-1表示的最終產物。Put 10 grams of 2-mercapto-1-ethanol, 13.3 grams of 2-2-(2-methoxyethoxy)ethoxyacetic acid and 2.1 grams of p-toluenesulfonic acid monohydrate into a 2-neck round-bottomed flask. , and then dissolved in 300 ml of cyclohexane. After tightening the Dean Stark to the injection hole, attach the condenser to it. After the solution was refluxed for 8 hours, the reaction was completed. (Check the final amount of water collected in Dean Stark). The reactants were transferred to a separatory funnel, extracted, neutralized to remove the solvent, and dried in a vacuum oven to obtain the final product represented by Chemical Formula C-1.

[化學式C-1] (製備用配位體進行表面改質的量子點的分散體) 製備例 1 [Chemical formula C-1] (Preparation of dispersion of quantum dots surface-modified with ligand) Preparation Example 1

將磁棒放入3頸圓底圓燒瓶中,且對量子點-CHA(乙酸環己酯(cyclohexyl acetate))溶液(固體含量:26重量%至27重量%)進行了秤重並添加至其中。向其中添加了由化學式2-1表示的配位體。The magnetic rod was placed into a 3-neck round-bottomed round flask, and the quantum dot-CHA (cyclohexyl acetate) solution (solid content: 26% to 27% by weight) was weighed and added thereto. . A ligand represented by Chemical Formula 2-1 is added thereto.

將混合物充分混合了1分鐘,且然後在氮氣氣氛下在80℃下進行了攪拌。當反應完成時,將所得物冷卻至室溫,且將量子點反應溶液添加至環己烷中以獲得沈澱物。藉由離心分離將沈澱的量子點粉末與環己烷分離。倒出澄清的溶液並丟棄,且然後將沈澱物在真空烘箱中充分乾燥了一天以獲得經表面改質的量子點。The mixture was mixed thoroughly for 1 minute and then stirred at 80°C under a nitrogen atmosphere. When the reaction was completed, the result was cooled to room temperature, and the quantum dot reaction solution was added to cyclohexane to obtain a precipitate. Separate the precipitated quantum dot powder from cyclohexane by centrifugation. The clear solution was decanted and discarded, and the precipitate was then fully dried in a vacuum oven for one day to obtain surface-modified quantum dots.

將經表面改質的量子點與由化學式5-2表示的單體(1,6-己二醇二丙烯酸酯;美源商業有限公司(Miwon Commercial Co., Ltd.))一起攪拌了12小時,以獲得經表面改質的量子點分散體。The surface-modified quantum dots were stirred together with the monomer represented by Chemical Formula 5-2 (1,6-hexanediol diacrylate; Miwon Commercial Co., Ltd.) for 12 hours. , to obtain surface-modified quantum dot dispersions.

[化學式5-2] 製備例 2 [Chemical formula 5-2] Preparation Example 2

除了使用由化學式2-2表示的配位體代替由化學式2-1表示的配位體之外,根據與製備例1相同的方法獲得了經表面改質的量子點分散體。製備例 3 A surface-modified quantum dot dispersion was obtained according to the same method as Preparation Example 1, except that the ligand represented by Chemical Formula 2-2 was used instead of the ligand represented by Chemical Formula 2-1. Preparation Example 3

除了使用由化學式2-3表示的配位體代替由化學式2-1表示的配位體之外,根據與製備例1相同的方法獲得了經表面改質的量子點分散體。製備例 4 A surface-modified quantum dot dispersion was obtained according to the same method as Preparation Example 1, except that the ligand represented by Chemical Formula 2-3 was used instead of the ligand represented by Chemical Formula 2-1. Preparation Example 4

除了使用由化學式2-4表示的配位體代替由化學式2-1表示的配位體之外,根據與製備例1相同的方法獲得了經表面改質的量子點分散體。製備例 5 A surface-modified quantum dot dispersion was obtained according to the same method as Preparation Example 1, except that the ligand represented by Chemical Formula 2-4 was used instead of the ligand represented by Chemical Formula 2-1. Preparation Example 5

除了使用由化學式2-5表示的配位體代替由化學式2-1表示的配位體之外,根據與製備例1相同的方法獲得了經表面改質的量子點分散體。製備例 6 A surface-modified quantum dot dispersion was obtained according to the same method as Preparation Example 1, except that the ligand represented by Chemical Formula 2-5 was used instead of the ligand represented by Chemical Formula 2-1. Preparation Example 6

除了使用由化學式2-6表示的配位體代替由化學式2-1表示的配位體之外,根據與製備例1相同的方法獲得了經表面改質的量子點分散體。製備例 7 A surface-modified quantum dot dispersion was obtained according to the same method as Preparation Example 1, except that the ligand represented by Chemical Formula 2-6 was used instead of the ligand represented by Chemical Formula 2-1. Preparation Example 7

除了使用由化學式2-7表示的配位體代替由化學式2-1表示的配位體之外,根據與製備例1相同的方法獲得了經表面改質的量子點分散體。製備例 8 A surface-modified quantum dot dispersion was obtained according to the same method as Preparation Example 1, except that the ligand represented by Chemical Formula 2-7 was used instead of the ligand represented by Chemical Formula 2-1. Preparation Example 8

除了使用由化學式2-8表示的配位體代替由化學式2-1表示的配位體之外,根據與製備例1相同的方法獲得了經表面改質的量子點分散體。製備例 9 A surface-modified quantum dot dispersion was obtained according to the same method as Preparation Example 1, except that the ligand represented by Chemical Formula 2-8 was used instead of the ligand represented by Chemical Formula 2-1. Preparation Example 9

除了使用由化學式3-1表示的配位體代替由化學式2-1表示的配位體之外,根據與製備例1相同的方法獲得了經表面改質的量子點分散體。製備例 10 A surface-modified quantum dot dispersion was obtained according to the same method as Preparation Example 1, except that the ligand represented by Chemical Formula 3-1 was used instead of the ligand represented by Chemical Formula 2-1. Preparation Example 10

除了使用由化學式3-2表示的配位體代替由化學式2-1表示的配位體之外,根據與製備例1相同的方法獲得了經表面改質的量子點分散體。製備例 11 A surface-modified quantum dot dispersion was obtained according to the same method as Preparation Example 1, except that the ligand represented by Chemical Formula 3-2 was used instead of the ligand represented by Chemical Formula 2-1. Preparation Example 11

除了使用由化學式3-3表示的配位體代替由化學式2-1表示的配位體之外,根據與製備例1相同的方法獲得了經表面改質的量子點分散體。製備例 12 A surface-modified quantum dot dispersion was obtained according to the same method as Preparation Example 1, except that the ligand represented by Chemical Formula 3-3 was used instead of the ligand represented by Chemical Formula 2-1. Preparation Example 12

除了使用由化學式3-4表示的配位體代替由化學式2-1表示的配位體之外,根據與製備例1相同的方法獲得了經表面改質的量子點分散體。製備例 13 A surface-modified quantum dot dispersion was obtained according to the same method as Preparation Example 1, except that the ligand represented by Chemical Formula 3-4 was used instead of the ligand represented by Chemical Formula 2-1. Preparation Example 13

除了使用由化學式3-5表示的配位體代替由化學式2-1表示的配位體之外,根據與製備例1相同的方法獲得了經表面改質的量子點分散體。製備例 14 A surface-modified quantum dot dispersion was obtained according to the same method as Preparation Example 1, except that the ligand represented by Chemical Formula 3-5 was used instead of the ligand represented by Chemical Formula 2-1. Preparation Example 14

除了使用由化學式4-1表示的配位體代替由化學式2-1表示的配位體之外,根據與製備例1相同的方法獲得了經表面改質的量子點分散體。比較製備例 1 A surface-modified quantum dot dispersion was obtained according to the same method as Preparation Example 1, except that the ligand represented by Chemical Formula 4-1 was used instead of the ligand represented by Chemical Formula 2-1. Comparative Preparation Example 1

除了使用由化學式C-1表示的配位體代替由化學式2-1表示的配位體之外,根據與製備例1相同的方法獲得了經表面改質的量子點分散體。評價 1 :可分散性 A surface-modified quantum dot dispersion was obtained according to the same method as Preparation Example 1, except that the ligand represented by Chemical Formula C-1 was used instead of the ligand represented by Chemical Formula 2-1. Evaluation 1 : Dispersibility

藉由使用微粒大小分析儀將根據製備例1至14及比較製備例1的每一量子點分散體的顆粒大小量測了三次,以獲得平均顆粒大小,且結果顯示在表1及2中。The particle size of each quantum dot dispersion according to Preparation Examples 1 to 14 and Comparative Preparation Example 1 was measured three times by using a particle size analyzer to obtain an average particle size, and the results are shown in Tables 1 and 2.

(表1) 顆粒大小(nm) 製備例1 製備例2 製備例3 製備例4 製備例5 製備例6 製備例7 製備例8 D50 11.4 11.5 11.4 11.3 11.0 10.8 10.9 11.0 (表2) 顆粒大小(nm) 製備例9 製備例10 製備例11 製備例12 製備例13 製備例14 比較製備例1 D50 11.0 11.1 10.7 10.8 11.0 11.8 15.0 (Table 1) Particle size (nm) Preparation Example 1 Preparation Example 2 Preparation Example 3 Preparation Example 4 Preparation Example 5 Preparation Example 6 Preparation Example 7 Preparation Example 8 D50 11.4 11.5 11.4 11.3 11.0 10.8 10.9 11.0 (Table 2) Particle size (nm) Preparation Example 9 Preparation Example 10 Preparation Example 11 Preparation Example 12 Preparation Example 13 Preparation Example 14 Comparative Preparation Example 1 D50 11.0 11.1 10.7 10.8 11.0 11.8 15.0

參考表1及2,根據製備例1至14的量子點分散體中的每一者表現出窄的顆粒分佈,此表明量子點很好地分散在高沸點及高表面張力溶劑中,但根據比較製備例1的量子點分散體表現出寬的顆粒分佈,此表明量子點沒有很好地分散在高沸點及高表面張力溶劑中。 Referring to Tables 1 and 2, each of the quantum dot dispersions according to Preparation Examples 1 to 14 exhibits a narrow particle distribution, which indicates that the quantum dots are well dispersed in high boiling point and high surface tension solvents, but according to comparison The quantum dot dispersion of Preparation Example 1 exhibits a broad particle distribution, which indicates that the quantum dots are not well dispersed in high boiling point and high surface tension solvents.

(製備無溶劑可固化組成物)(Preparation of solvent-free curable composition)

實例1Example 1

對製備例1中獲得的分散體進行了秤重,且然後與由化學式5-2表示的單體混合並稀釋,且向其中添加了聚合抑制劑(甲基氫醌,東京化學工業有限公司(Tokyo Chemical Industry Co.,Ltd.)),且然後攪拌了5分鐘。隨後,向其中注入了光起始劑(TPO-L,玻利尼通公司(polynetron)),且向其中添加了光擴散劑(TiO2(固體含量:50重量%);迪圖技術公司(Ditto Technology))。將總體分散體攪拌了1小時以製備無溶劑可固化組成物。以無溶劑可固化組成物的總量計,包含40重量%的量子點、48重量%的由化學式3-2表示的單體、1重量%的聚合抑制劑、3重量%的光起始劑及8重量%的光擴散劑。 The dispersion obtained in Preparation Example 1 was weighed, and then mixed and diluted with the monomer represented by Chemical Formula 5-2, and a polymerization inhibitor (methylhydroquinone, Tokyo Chemical Industry Co., Ltd. ( Tokyo Chemical Industry Co., Ltd.)), and then stirred for 5 minutes. Subsequently, a photoinitiator (TPO-L, Polynetron) was injected thereto, and a light diffusing agent (TiO 2 (solid content: 50% by weight)) was added thereto; Ditto Technologies ( Ditto Technology)). The overall dispersion was stirred for 1 hour to prepare a solvent-free curable composition. Based on the total amount of the solvent-free curable composition, it contains 40% by weight of quantum dots, 48% by weight of the monomer represented by Chemical Formula 3-2, 1% by weight of polymerization inhibitor, and 3% by weight of photoinitiator. and 8% by weight of light diffusing agent.

實例2Example 2

除了使用在製備例2中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例1相同的方法製備了無溶劑可固化組成物。 A solvent-free curable composition was prepared according to the same method as Example 1, except that the dispersion obtained in Preparation Example 2 was used instead of the dispersion obtained in Preparation Example 1.

實例3Example 3

除了使用在製備例3中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例1相同的方法製備了無溶劑可固化組成物。實例 4 A solvent-free curable composition was prepared according to the same method as Example 1, except that the dispersion obtained in Preparation Example 3 was used instead of the dispersion obtained in Preparation Example 1. Example 4

除了使用在製備例4中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例1相同的方法製備了無溶劑可固化組成物。實例 5 A solvent-free curable composition was prepared according to the same method as Example 1, except that the dispersion obtained in Preparation Example 4 was used instead of the dispersion obtained in Preparation Example 1. Example 5

除了使用在製備例5中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例1相同的方法製備了無溶劑可固化組成物。實例 6 A solvent-free curable composition was prepared according to the same method as Example 1, except that the dispersion obtained in Preparation Example 5 was used instead of the dispersion obtained in Preparation Example 1. Example 6

除了使用在製備例6中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例1相同的方法製備了無溶劑可固化組成物。實例 7 A solvent-free curable composition was prepared according to the same method as Example 1, except that the dispersion obtained in Preparation Example 6 was used instead of the dispersion obtained in Preparation Example 1. Example 7

除了使用在製備例7中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例1相同的方法製備了無溶劑可固化組成物。實例 8 A solvent-free curable composition was prepared according to the same method as Example 1, except that the dispersion obtained in Preparation Example 7 was used instead of the dispersion obtained in Preparation Example 1. Example 8

除了使用在製備例8中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例1相同的方法製備了無溶劑可固化組成物。實例 9 A solvent-free curable composition was prepared according to the same method as Example 1, except that the dispersion obtained in Preparation Example 8 was used instead of the dispersion obtained in Preparation Example 1. Example 9

除了使用在製備例9中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例1相同的方法製備了無溶劑可固化組成物。實例 10 A solvent-free curable composition was prepared according to the same method as Example 1, except that the dispersion obtained in Preparation Example 9 was used instead of the dispersion obtained in Preparation Example 1. Example 10

除了使用在製備例10中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例1相同的方法製備了無溶劑可固化組成物。實例 11 A solvent-free curable composition was prepared according to the same method as Example 1, except that the dispersion obtained in Preparation Example 10 was used instead of the dispersion obtained in Preparation Example 1. Example 11

除了使用在製備例11中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例1相同的方法製備了無溶劑可固化組成物。實例 12 A solvent-free curable composition was prepared according to the same method as Example 1, except that the dispersion obtained in Preparation Example 11 was used instead of the dispersion obtained in Preparation Example 1. Example 12

除了使用在製備例12中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例1相同的方法製備了無溶劑可固化組成物。實例 13 A solvent-free curable composition was prepared according to the same method as Example 1, except that the dispersion obtained in Preparation Example 12 was used instead of the dispersion obtained in Preparation Example 1. Example 13

除了使用在製備例13中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例1相同的方法製備了無溶劑可固化組成物。實例 14 A solvent-free curable composition was prepared according to the same method as Example 1, except that the dispersion obtained in Preparation Example 13 was used instead of the dispersion obtained in Preparation Example 1. Example 14

除了使用在製備例14中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例1相同的方法製備了無溶劑可固化組成物。比較例 1 A solvent-free curable composition was prepared according to the same method as Example 1, except that the dispersion obtained in Preparation Example 14 was used instead of the dispersion obtained in Preparation Example 1. Comparative example 1

除了使用在比較製備例1中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例1相同的方法製備了無溶劑可固化組成物。評價 2 :評價光學特性 A solvent-free curable composition was prepared according to the same method as Example 1, except that the dispersion obtained in Comparative Preparation Example 1 was used instead of the dispersion obtained in Preparation Example 1. Evaluation 2 : Evaluation of optical characteristics

使用旋轉塗佈機(800轉/分鐘,5秒,奧普提科特(Opticoat)MS-A150,三笠有限公司(Mikasa Co., Ltd.))將根據實例1至14及比較例1的每一無溶劑可固化組成物在黃色光致抗蝕劑(YPR)上塗佈至15微米厚,且在氮氣氣氛下用395奈米紫外(ultraviolet,UV)曝光機以5000毫焦進行了曝光(83℃,10秒)。隨後,將每一2公分×2公分的單一膜樣品裝載在積分球設備(QE-2100,大塚電子有限公司(Otsuka Electronics, Co., Ltd.))中,並量測光轉換率。此後,將裝載的單一膜樣品在180℃下在氮氣氛乾燥爐中乾燥了30分鐘,且然後量測了曝光後乾燥前的光保持率,且量測結果示於表3中。Each of Examples 1 to 14 and Comparative Example 1 was coated using a spin coater (800 rpm, 5 seconds, Opticoat MS-A150, Mikasa Co., Ltd.). A solvent-free curable composition was coated on yellow photoresist (YPR) to a thickness of 15 microns and exposed using a 395 nm ultraviolet (UV) exposure machine at 5000 millijoules under a nitrogen atmosphere ( 83℃, 10 seconds). Subsequently, each 2 cm × 2 cm single film sample was loaded into an integrating sphere device (QE-2100, Otsuka Electronics, Co., Ltd.), and the light conversion rate was measured. Thereafter, the loaded single film sample was dried in a nitrogen atmosphere drying oven at 180° C. for 30 minutes, and then the light retention rate after exposure and before drying was measured, and the measurement results are shown in Table 3.

(表3)   光轉換率(%) 光保持率(%) 最大發射波長(nm) 實例1 26.0 88 544 實例2 29.9 99 545 實例3 29.5 99 545 實例4 30.0 95 543 實例5 28.5 89 543 實例6 32.2 97 543 實例7 31.6 93 535 實例8 31.9 92 535 實例9 31.1 96 542 實例10 27.5 95 544 實例11 32.0 90 541 實例12 31.0 90 542 實例13 26.9 94 543 實例14 28.2 94 542 比較例1 22.8 91 543 (table 3) Light conversion rate (%) Light retention rate (%) Maximum emission wavelength (nm) Example 1 26.0 88 544 Example 2 29.9 99 545 Example 3 29.5 99 545 Example 4 30.0 95 543 Example 5 28.5 89 543 Example 6 32.2 97 543 Example 7 31.6 93 535 Example 8 31.9 92 535 Example 9 31.1 96 542 Example 10 27.5 95 544 Example 11 32.0 90 541 Example 12 31.0 90 542 Example 13 26.9 94 543 Example 14 28.2 94 542 Comparative example 1 22.8 91 543

自表3中,可以看出根據實施例的無溶劑可固化組成物表現出改善的光學特性。(製備溶劑型可固化組成物) 實例 15 From Table 3, it can be seen that the solvent-free curable composition according to the Example exhibits improved optical properties. (Preparation of solvent-based curable composition) Example 15

使用對應量的以下組分製備了每一溶劑型可固化組成物(感光性樹脂組成物)。Each solvent-type curable composition (photosensitive resin composition) was prepared using corresponding amounts of the following components.

具體而言,在溶劑中溶解了光聚合起始劑,且在室溫下將所述溶液充分攪拌了2小時。隨後,一起添加了黏合劑樹脂與製備例1的量子點分散體、分散劑(迪高(TEGO)D685,由贏創公司(Evonik Corp.)製成),且將所得混合物在室溫下再次攪拌了2小時。然後,向其中添加了光擴散劑及氟系界面活性劑,且然後在室溫下攪拌了1小時,且將其中的產物過濾了三次以移除雜質並製備感光性樹脂組成物。 1)量子點分散體:製備例1 2)黏合劑樹脂:25重量%的卡多系黏合劑樹脂(TSR-TA01,塔科瑪公司(TAKOMA)) 3)可聚合單體:5.4重量%的季戊四醇六甲基丙烯酸酯(DPHA,日本化藥有限公司) 4)光聚合起始劑:0.7重量%的二苯基(2,4,6-三甲基苯甲醯基)氧化膦(TPO,西格瑪-奧德里奇公司(Sigma-Aldrich Corporation)) 5)溶劑:39重量%的己二酸二甲酯 6)光擴散劑:39重量%的二氧化鈦分散體(TiO2 固體含量:20重量%,平均粒徑:200奈米,迪圖技術公司) 7)其他添加劑:0.9重量%的氟系界面活性劑(F-554,大日本油墨化學有限公司)實例 16 Specifically, the photopolymerization initiator was dissolved in the solvent, and the solution was sufficiently stirred at room temperature for 2 hours. Subsequently, the binder resin was added together with the quantum dot dispersion and dispersant (TEGO D685, manufactured by Evonik Corp.) of Preparation Example 1, and the resulting mixture was heated again at room temperature. Stirred for 2 hours. Then, a light diffusing agent and a fluorine-based surfactant were added thereto, and then stirred at room temperature for 1 hour, and the product therein was filtered three times to remove impurities and prepare a photosensitive resin composition. 1) Quantum dot dispersion: Preparation Example 1 2) Binder resin: 25 wt% Cardo-based binder resin (TSR-TA01, TAKOMA) 3) Polymerizable monomer: 5.4 wt% Pentaerythritol hexamethacrylate (DPHA, Nippon Chemical Co., Ltd.) 4) Photopolymerization initiator: 0.7% by weight of diphenyl (2,4,6-trimethylbenzyl)phosphine oxide (TPO, Sigma-Aldrich Corporation) 5) Solvent: 39 wt% dimethyl adipate 6) Light diffuser: 39 wt% titanium dioxide dispersion (TiO 2 solids content: 20 wt%, Average particle size: 200 nm, Ditu Technology Co., Ltd.) 7) Other additives: 0.9% by weight fluorine-based surfactant (F-554, Dainippon Ink Chemical Co., Ltd.) Example 16

除了使用在製備例2中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例15相同的方法製備了溶劑型可固化組成物。實例 17 A solvent-type curable composition was prepared according to the same method as Example 15, except that the dispersion obtained in Preparation Example 2 was used instead of the dispersion obtained in Preparation Example 1. Example 17

除了使用在製備例3中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例15相同的方法製備了溶劑型可固化組成物。實例 18 A solvent-type curable composition was prepared according to the same method as Example 15, except that the dispersion obtained in Preparation Example 3 was used instead of the dispersion obtained in Preparation Example 1. Example 18

除了使用在製備例4中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例15相同的方法製備了溶劑型可固化組成物。實例 19 A solvent-type curable composition was prepared according to the same method as Example 15, except that the dispersion obtained in Preparation Example 4 was used instead of the dispersion obtained in Preparation Example 1. Example 19

除了使用在製備例5中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例15相同的方法製備了溶劑型可固化組成物。實例 20 A solvent-type curable composition was prepared according to the same method as Example 15, except that the dispersion obtained in Preparation Example 5 was used instead of the dispersion obtained in Preparation Example 1. Example 20

除了使用在製備例6中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例15相同的方法製備了溶劑型可固化組成物。實例 21 A solvent-type curable composition was prepared according to the same method as Example 15, except that the dispersion obtained in Preparation Example 6 was used instead of the dispersion obtained in Preparation Example 1. Example 21

除了使用在製備例7中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例15相同的方法製備了溶劑型可固化組成物。實例 22 A solvent-type curable composition was prepared according to the same method as Example 15, except that the dispersion obtained in Preparation Example 7 was used instead of the dispersion obtained in Preparation Example 1. Example 22

除了使用在製備例8中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例15相同的方法製備了溶劑型可固化組成物。實例 23 A solvent-type curable composition was prepared according to the same method as Example 15, except that the dispersion obtained in Preparation Example 8 was used instead of the dispersion obtained in Preparation Example 1. Example 23

除了使用在製備例9中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例15相同的方法製備了溶劑型可固化組成物。實例 24 A solvent-type curable composition was prepared according to the same method as Example 15, except that the dispersion obtained in Preparation Example 9 was used instead of the dispersion obtained in Preparation Example 1. Example 24

除了使用在製備例10中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例15相同的方法製備了溶劑型可固化組成物。實例 25 A solvent-type curable composition was prepared according to the same method as Example 15, except that the dispersion obtained in Preparation Example 10 was used instead of the dispersion obtained in Preparation Example 1. Example 25

除了使用在製備例11中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例15相同的方法製備了溶劑型可固化組成物。實例 26 A solvent-type curable composition was prepared according to the same method as Example 15, except that the dispersion obtained in Preparation Example 11 was used instead of the dispersion obtained in Preparation Example 1. Example 26

除了使用在製備例12中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例15相同的方法製備了溶劑型可固化組成物。實例 27 A solvent-type curable composition was prepared according to the same method as Example 15, except that the dispersion obtained in Preparation Example 12 was used instead of the dispersion obtained in Preparation Example 1. Example 27

除了使用在製備例13中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例15相同的方法製備了溶劑型可固化組成物。實例 28 A solvent-type curable composition was prepared according to the same method as Example 15, except that the dispersion obtained in Preparation Example 13 was used instead of the dispersion obtained in Preparation Example 1. Example 28

除了使用在製備例14中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例15相同的方法製備了溶劑型可固化組成物。比較例 2 A solvent-type curable composition was prepared according to the same method as Example 15, except that the dispersion obtained in Preparation Example 14 was used instead of the dispersion obtained in Preparation Example 1. Comparative example 2

除了使用在比較製備例1中獲得的分散體代替在製備例1中獲得的分散體之外,根據與實例15相同的方法製備了溶劑型可固化組成物。評價 3 :量子點的光轉換率及光保持率 A solvent-type curable composition was prepared according to the same method as Example 15, except that the dispersion obtained in Comparative Preparation Example 1 was used instead of the dispersion obtained in Preparation Example 1. Evaluation 3 : Light conversion rate and light retention rate of quantum dots

用旋轉塗佈機(150轉/分,奧普提科特MS-A150,三笠有限公司)將根據實例15至28及比較例2的可固化組成物分別在玻璃基板的單一表面上塗佈至6微米厚,且然後在80℃的熱板上乾燥了1分鐘以獲得膜。然後,在用功率為100毫焦/平方公分的紫外線照射後,藉由將後烘烤(post-baking,POB)在180℃的對流清潔烘箱(瓊格(Jongro))中執行30分鐘,用曝光機(ghi寬頻,優志旺有限公司(Ushio Inc.))量測了光轉換率,且結果示於表4及5中。The curable compositions according to Examples 15 to 28 and Comparative Example 2 were respectively coated on a single surface of the glass substrate to 6 micron thick and then dried on a hot plate at 80°C for 1 minute to obtain a film. Then, after irradiation with UV light at a power of 100 mJ/cm2, post-baking (POB) was performed for 30 minutes in a convection cleaning oven (Jongro) at 180°C. The light conversion rate was measured using an exposure machine (ghi broadband, Ushio Inc.), and the results are shown in Tables 4 and 5.

(表4) (單位:%)   實例15 實例16 實例17 實例18 實例19 實例20 實例21 實例22 初始光轉換率 23.5 27.0 26.7 27.0 25.9 29.3 28.4 28.9 執行POB一次後的光轉換率 23.0 26.5 26.2 26.5 25.4 28.9 27.8 28.3 (Table 4) (Unit: %) Example 15 Example 16 Example 17 Example 18 Example 19 Example 20 Example 21 Example 22 Initial light conversion rate 23.5 27.0 26.7 27.0 25.9 29.3 28.4 28.9 Light conversion rate after executing POB once 23.0 26.5 26.2 26.5 25.4 28.9 27.8 28.3

(表5) (單位:%)   實例23 實例24 實例25 實例26 實例27 實例28 比較例2 初始光轉換率 28.0 24.6 29.0 28.2 23.9 25.3 22.0 執行POB一次後的光轉換率 27.4 24.1 28.4 27.6 23.6 24.8 20.0 (Table 5) (Unit: %) Example 23 Example 24 Example 25 Example 26 Example 27 Example 28 Comparative example 2 Initial light conversion rate 28.0 24.6 29.0 28.2 23.9 25.3 22.0 Light conversion rate after executing POB once 27.4 24.1 28.4 27.6 23.6 24.8 20.0

如表4及5所示,藉由使用根據實施例的經表面改質的量子點製備的溶劑型可固化組成物由於濾色製程而表現出光轉換率的小的劣化,且因此表現出高的光保持率。As shown in Tables 4 and 5, the solvent-based curable composition prepared by using the surface-modified quantum dots according to the embodiments showed little deterioration in light conversion efficiency due to the color filter process, and thus showed high Light retention.

儘管本發明已結合目前視為實用的示例性實施例加以闡述,然而應理解本發明不限於所揭露的實施例,而是相反地旨在涵蓋包含在隨附申請專利範圍的精神及範圍內的各種修改及等效佈置。因此,應理解上述實施例為示範性的,而不以任何方式限制本發明。While the present invention has been described in connection with exemplary embodiments which are presently considered practical, it is to be understood that the invention is not limited to the disclosed embodiments, but is instead intended to cover all embodiments within the spirit and scope of the appended claims. Various modifications and equivalent arrangements. Therefore, it should be understood that the above-described embodiments are exemplary and do not limit the invention in any way.

without

without

Claims (20)

一種量子點,用由化學式1表示的化合物進行表面改質:
Figure 109132893-A0305-02-0104-9
其中,在化學式1中,R1是羧基、*-P(=O)(OH)2或硫醇基,且R2是「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C6至C20芳基」、「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C6至C20芳氧基」,或「由化學式1A表示」,
Figure 109132893-A0305-02-0104-10
其中,在化學式1A中,R3是「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C1至C20烷基」或者「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C2至C20烯基」,且 L1是「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20伸烷基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C3至C20伸環烷基」或「由化學式1B-1-1至化學式1B-7-2中的一者表示」,
Figure 109132893-A0305-02-0105-11
Figure 109132893-A0305-02-0105-12
Figure 109132893-A0305-02-0105-13
[化學式1B-2-2]
Figure 109132893-A0305-02-0106-14
Figure 109132893-A0305-02-0106-15
Figure 109132893-A0305-02-0106-16
Figure 109132893-A0305-02-0106-18
Figure 109132893-A0305-02-0107-19
Figure 109132893-A0305-02-0107-20
Figure 109132893-A0305-02-0107-21
[化學式1B-6-1]
Figure 109132893-A0305-02-0108-22
Figure 109132893-A0305-02-0108-23
Figure 109132893-A0305-02-0108-24
[化學式1B-7-2]
Figure 109132893-A0305-02-0109-25
其中,在化學式1B-1-1至化學式1B-7-2中,Ra及Rb獨立地是氫原子或羧基,Rc是O、S、NH、C1至C20伸烷基、C1至C20烷基胺基或C2至C20烯丙基胺基,L2是單鍵、*-C(=O)O-*或*-S-*,且L3由化學式1C-1或化學式1C-2表示,
Figure 109132893-A0305-02-0109-26
Figure 109132893-A0305-02-0109-27
其中,在化學式1C-1及化學式1C-2中,L4是單鍵或者經取代或未經取代的C1至C20伸烷基,L5是經取代或未經取代的C1至C20伸烷基,m是1至20的整數,且n是1或2的整數。
A quantum dot surface-modified with a compound represented by Chemical Formula 1:
Figure 109132893-A0305-02-0104-9
Wherein, in Chemical Formula 1, R 1 is a carboxyl group, *-P(=O)(OH) 2 or a thiol group, and R 2 is "unsubstituted or substituted by vinyl group, allyl group, epoxy group, ( Meth)acrylate group, C1 to C10 alkyl group or C6 to C20 aryl group substituted by C6 to C12 aryl group", "unsubstituted or vinyl, allyl, epoxy group, (meth)acrylate group, C1 to C10 alkyl group or C6 to C20 aryloxy group substituted by C6 to C12 aryl group", or "represented by Chemical Formula 1A",
Figure 109132893-A0305-02-0104-10
Wherein, in Chemical Formula 1A, R 3 is "C1 to C1 to C10 alkyl group which is unsubstituted or substituted by vinyl group, allyl group, epoxy group, (meth)acrylate group, C1 to C10 alkyl group or C6 to C12 aryl group. C20 alkyl" or "C2 to C20 alkenyl unsubstituted or substituted by vinyl, allyl, epoxy, (meth)acrylate, C1 to C10 alkyl or C6 to C12 aryl", And L 1 is "C1 to C20 alkylene group that is not substituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group" or "unsubstituted or substituted by vinyl, allyl , epoxy or (meth)acrylate group-substituted C3 to C20 cycloalkyl group" or "represented by one of Chemical Formula 1B-1-1 to Chemical Formula 1B-7-2",
Figure 109132893-A0305-02-0105-11
Figure 109132893-A0305-02-0105-12
Figure 109132893-A0305-02-0105-13
[Chemical formula 1B-2-2]
Figure 109132893-A0305-02-0106-14
Figure 109132893-A0305-02-0106-15
Figure 109132893-A0305-02-0106-16
Figure 109132893-A0305-02-0106-18
Figure 109132893-A0305-02-0107-19
Figure 109132893-A0305-02-0107-20
Figure 109132893-A0305-02-0107-21
[Chemical formula 1B-6-1]
Figure 109132893-A0305-02-0108-22
Figure 109132893-A0305-02-0108-23
Figure 109132893-A0305-02-0108-24
[Chemical formula 1B-7-2]
Figure 109132893-A0305-02-0109-25
Among them, in Chemical Formula 1B-1-1 to Chemical Formula 1B-7-2, R a and R b are independently hydrogen atoms or carboxyl groups, and R c is O, S, NH, C1 to C20 alkylene group, C1 to C20 Alkylamino or C2 to C20 allylamine, L 2 is a single bond, *-C(=O)O-* or *-S-*, and L 3 consists of Chemical Formula 1C-1 or Chemical Formula 1C-2 express,
Figure 109132893-A0305-02-0109-26
Figure 109132893-A0305-02-0109-27
Wherein, in Chemical Formula 1C-1 and Chemical Formula 1C-2, L 4 is a single bond or a substituted or unsubstituted C1 to C20 alkylene group, and L 5 is a substituted or unsubstituted C1 to C20 alkylene group. , m is an integer from 1 to 20, and n is an integer from 1 or 2.
如請求項1所述的量子點,其中所述由化學式1表示的化合物是由化學式2表示:
Figure 109132893-A0305-02-0110-28
其中,在化學式2中,R2是「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷基」、「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C1至C20烷氧基」、「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C6至C20芳基」或者「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C6至C20芳氧基」,或「由化學式1A表示」,
Figure 109132893-A0305-02-0110-29
其中,在化學式1A中,R3是「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、C1至C10烷基或C6至C12芳基取代的C1至C20烷基」或者「未被取代或被乙烯基、烯丙基、環氧基、(甲基)丙烯酸酯基、 C1至C10烷基或C6至C12芳基取代的C2至C20烯基」,且L1是「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20伸烷基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C3至C20伸環烷基」或「由化學式1B-1-1、化學式1B-2-1、化學式1B-3-1、化學式1B-4-1、化學式1B-5-1、化學式1B-6-1及化學式1B-7-1中的一者表示」,
Figure 109132893-A0305-02-0111-30
Figure 109132893-A0305-02-0111-31
Figure 109132893-A0305-02-0111-32
Figure 109132893-A0305-02-0112-33
Figure 109132893-A0305-02-0112-34
Figure 109132893-A0305-02-0112-35
[化學式1B-7-1]
Figure 109132893-A0305-02-0113-36
其中,在化學式1B-1-1至化學式1B-7-1中,Ra及Rb獨立地是氫原子或羧基,Rc是O、S、NH、C1至C20伸烷基、C1至C20烷基胺基或C2至C20烯丙基胺基,L2是單鍵、*-C(=O)O-*或*-S-*,且L3由化學式1C-1或化學式1C-2表示,
Figure 109132893-A0305-02-0113-37
Figure 109132893-A0305-02-0113-38
其中,在化學式1C-1及化學式1C-2中,L4是單鍵或者經取代或未經取代的C1至C20伸烷基,L5是經取代或未經取代的C1至C20伸烷基,且m是1至20的整數。
The quantum dot as claimed in claim 1, wherein the compound represented by Chemical Formula 1 is represented by Chemical Formula 2:
Figure 109132893-A0305-02-0110-28
Among them, in Chemical Formula 2, R 2 is "a C1 to C20 alkyl group that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group", "unsubstituted or substituted by vinyl group, allyl, epoxy, (meth)acrylate group, C1 to C10 alkyl or C6 to C12 aryl substituted C1 to C20 alkoxy group", "unsubstituted or vinyl, allyl group, epoxy group, (meth)acrylate group, C1 to C10 alkyl group or C6 to C20 aryl group substituted by C6 to C12 aryl group" or "unsubstituted or vinyl, allyl, epoxy group , (meth)acrylate group, C1 to C10 alkyl group or C6 to C20 aryloxy group substituted by C6 to C12 aryl group", or "represented by Chemical Formula 1A",
Figure 109132893-A0305-02-0110-29
Wherein, in Chemical Formula 1A, R 3 is "C1 to C1 to C10 alkyl group which is unsubstituted or substituted by vinyl group, allyl group, epoxy group, (meth)acrylate group, C1 to C10 alkyl group or C6 to C12 aryl group. C20 alkyl" or "C2 to C20 alkenyl unsubstituted or substituted by vinyl, allyl, epoxy, (meth)acrylate, C1 to C10 alkyl or C6 to C12 aryl", And L 1 is "C1 to C20 alkylene group that is not substituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group" or "unsubstituted or substituted by vinyl, allyl , C3 to C20 cycloalkyl group substituted by epoxy group or (meth)acrylate group" or "from Chemical Formula 1B-1-1, Chemical Formula 1B-2-1, Chemical Formula 1B-3-1, Chemical Formula 1B-4 -1. Expressed by one of Chemical Formula 1B-5-1, Chemical Formula 1B-6-1 and Chemical Formula 1B-7-1",
Figure 109132893-A0305-02-0111-30
Figure 109132893-A0305-02-0111-31
Figure 109132893-A0305-02-0111-32
Figure 109132893-A0305-02-0112-33
Figure 109132893-A0305-02-0112-34
Figure 109132893-A0305-02-0112-35
[Chemical formula 1B-7-1]
Figure 109132893-A0305-02-0113-36
Among them, in Chemical Formula 1B-1-1 to Chemical Formula 1B-7-1, R a and R b are independently hydrogen atoms or carboxyl groups, and R c is O, S, NH, C1 to C20 alkylene group, C1 to C20 Alkylamino or C2 to C20 allylamine, L 2 is a single bond, *-C(=O)O-* or *-S-*, and L 3 is composed of Chemical Formula 1C-1 or Chemical Formula 1C-2 express,
Figure 109132893-A0305-02-0113-37
Figure 109132893-A0305-02-0113-38
Wherein, in Chemical Formula 1C-1 and Chemical Formula 1C-2, L 4 is a single bond or a substituted or unsubstituted C1 to C20 alkylene group, and L 5 is a substituted or unsubstituted C1 to C20 alkylene group. , and m is an integer from 1 to 20.
如請求項2所述的量子點,其中 其中,在化學式2中,R2是「未被取代或被C1至C10烷基或C6至C12芳基取代的C1至C20烷氧基」、「未被取代或被C1至C10烷基或C6至C12芳基取代的C6至C20芳基」或者「未被取代或被C1至C10烷基或C6至C12芳基取代的C6至C20芳氧基」,L1是「未經取代的C1至C20伸烷基」或「未經取代的C3至C20伸環烷基」,L2是單鍵、*-C(=O)O-*或*-S-*,且L3由化學式1C-1或化學式1C-2表示,
Figure 109132893-A0305-02-0114-39
Figure 109132893-A0305-02-0114-40
其中,在化學式1C-1及化學式1C-2中,L4是單鍵或者經取代或未經取代的C1至C20伸烷基,L5是經取代或未經取代的C1至C20伸烷基,且m是1至20的整數。
The quantum dot as claimed in claim 2, wherein, in Chemical Formula 2, R 2 is "a C1 to C20 alkoxy group that is unsubstituted or substituted by a C1 to C10 alkyl group or a C6 to C12 aryl group", "unsubstituted "C6 to C20 aryl group substituted or substituted by C1 to C10 alkyl group or C6 to C12 aryl group" or "C6 to C20 aryloxy group unsubstituted or substituted by C1 to C10 alkyl group or C6 to C12 aryl group" , L 1 is "unsubstituted C1 to C20 alkylene group" or "unsubstituted C3 to C20 cycloalkylene group", L 2 is a single bond, *-C(=O)O-* or *- S-*, and L3 is represented by Chemical Formula 1C-1 or Chemical Formula 1C-2,
Figure 109132893-A0305-02-0114-39
Figure 109132893-A0305-02-0114-40
Wherein, in Chemical Formula 1C-1 and Chemical Formula 1C-2, L 4 is a single bond or a substituted or unsubstituted C1 to C20 alkylene group, and L 5 is a substituted or unsubstituted C1 to C20 alkylene group. , and m is an integer from 1 to 20.
如請求項1所述的量子點,其中所述由化學式1表示的化合物是由化學式2-2至化學式2-6及化學式2-8中的一者表示:
Figure 109132893-A0305-02-0115-41
Figure 109132893-A0305-02-0115-42
Figure 109132893-A0305-02-0115-43
Figure 109132893-A0305-02-0115-44
Figure 109132893-A0305-02-0115-45
Figure 109132893-A0305-02-0115-46
The quantum dot of claim 1, wherein the compound represented by Chemical Formula 1 is represented by one of Chemical Formula 2-2 to Chemical Formula 2-6 and Chemical Formula 2-8:
Figure 109132893-A0305-02-0115-41
Figure 109132893-A0305-02-0115-42
Figure 109132893-A0305-02-0115-43
Figure 109132893-A0305-02-0115-44
Figure 109132893-A0305-02-0115-45
Figure 109132893-A0305-02-0115-46
如請求項1所述的量子點,其中在化學式1中,R1是羧基或硫醇基,且R2是「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷基」、「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷氧基」、「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C6至C20芳基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C6至C20芳氧基」,或「由化學式1A表示」,
Figure 109132893-A0305-02-0116-47
其中,在化學式1A中,R3是「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C2至C20烯基」,且L1是「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20伸烷基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C3至C20伸環烷基」或「由化學式1B-1-1至化學式1B-7-2中的一者表示」,[化學式1B-1-1]
Figure 109132893-A0305-02-0117-48
Figure 109132893-A0305-02-0117-49
Figure 109132893-A0305-02-0117-50
Figure 109132893-A0305-02-0117-51
[化學式1B-3-1]
Figure 109132893-A0305-02-0118-52
Figure 109132893-A0305-02-0118-53
Figure 109132893-A0305-02-0118-54
Figure 109132893-A0305-02-0118-55
Figure 109132893-A0305-02-0119-56
Figure 109132893-A0305-02-0119-57
Figure 109132893-A0305-02-0119-58
[化學式1B-6-2]
Figure 109132893-A0305-02-0120-59
Figure 109132893-A0305-02-0120-60
Figure 109132893-A0305-02-0120-61
其中,在化學式1B-1-1至化學式1B-7-2中,Ra及Rb獨立地是氫原子或羧基,Rc是O、S、NH、C1至C20伸烷基、C1至C20烷基胺基或C2至C20烯丙基胺基,L2是單鍵、*-C(=O)O-*或*-S-*,且 L3由化學式1C-1或化學式1C-2表示,
Figure 109132893-A0305-02-0121-62
Figure 109132893-A0305-02-0121-63
其中,在化學式1C-1及化學式1C-2中,L4是單鍵或者經取代或未經取代的C1至C20伸烷基,L5是經取代或未經取代的C1至C20伸烷基,m是1至20的整數,且n是1或2的整數。
The quantum dot as claimed in claim 1, wherein in Chemical Formula 1, R 1 is a carboxyl group or a thiol group, and R 2 is "unsubstituted or vinyl, allyl, epoxy or (methyl)""C1 to C20 alkyl group substituted by acrylate group", "C1 to C20 alkoxy group that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group", "unsubstituted or "C6 to C20 aryl substituted by vinyl, allyl, epoxy or (meth)acrylate" or "unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate""C6 to C20 aryloxy group substituted by acrylate group", or "represented by Chemical Formula 1A",
Figure 109132893-A0305-02-0116-47
Wherein, in Chemical Formula 1A, R 3 is "a C1 to C20 alkyl group that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group" or "unsubstituted or substituted by vinyl C2 to C20 alkenyl substituted by vinyl, allyl, epoxy or (meth)acrylate", and L 1 is "unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate ) acrylate group-substituted C1 to C20 alkylene group" or "C3 to C20 cycloalkylene group that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group" or " Represented by one of Chemical Formula 1B-1-1 to Chemical Formula 1B-7-2", [Chemical Formula 1B-1-1]
Figure 109132893-A0305-02-0117-48
Figure 109132893-A0305-02-0117-49
Figure 109132893-A0305-02-0117-50
Figure 109132893-A0305-02-0117-51
[Chemical formula 1B-3-1]
Figure 109132893-A0305-02-0118-52
Figure 109132893-A0305-02-0118-53
Figure 109132893-A0305-02-0118-54
Figure 109132893-A0305-02-0118-55
Figure 109132893-A0305-02-0119-56
Figure 109132893-A0305-02-0119-57
Figure 109132893-A0305-02-0119-58
[Chemical formula 1B-6-2]
Figure 109132893-A0305-02-0120-59
Figure 109132893-A0305-02-0120-60
Figure 109132893-A0305-02-0120-61
Among them, in Chemical Formula 1B-1-1 to Chemical Formula 1B-7-2, R a and R b are independently hydrogen atoms or carboxyl groups, and R c is O, S, NH, C1 to C20 alkylene group, C1 to C20 Alkylamino or C2 to C20 allylamine, L 2 is a single bond, *-C(=O)O-* or *-S-*, and L 3 is composed of Chemical Formula 1C-1 or Chemical Formula 1C-2 express,
Figure 109132893-A0305-02-0121-62
Figure 109132893-A0305-02-0121-63
Wherein, in Chemical Formula 1C-1 and Chemical Formula 1C-2, L 4 is a single bond or a substituted or unsubstituted C1 to C20 alkylene group, and L 5 is a substituted or unsubstituted C1 to C20 alkylene group. , m is an integer from 1 to 20, and n is an integer from 1 or 2.
如請求項1所述的量子點,其中所述由化學式1表示的化合物是由化學式3表示:
Figure 109132893-A0305-02-0121-64
其中,在化學式3中,R4是由化學式1A表示,[化學式1A]
Figure 109132893-A0305-02-0122-65
其中,在化學式1A中,R3是「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C2至C20烯基」,R5是羧基或硫醇基,L6及L7獨立地是經取代或未經取代的C1至C20伸烷基,L8是單鍵、*-S-*或*-OC(=O)-*,L9是經取代或未經取代的C1至C20伸烷基,且m是1至20的整數。
The quantum dot as claimed in claim 1, wherein the compound represented by Chemical Formula 1 is represented by Chemical Formula 3:
Figure 109132893-A0305-02-0121-64
Wherein, in Chemical Formula 3, R 4 is represented by Chemical Formula 1A, [Chemical Formula 1A]
Figure 109132893-A0305-02-0122-65
Wherein, in Chemical Formula 1A, R 3 is "a C1 to C20 alkyl group that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group" or "unsubstituted or substituted by vinyl "C2 to C20 alkenyl group substituted by alkyl, allyl, epoxy or (meth)acrylate", R 5 is a carboxyl or thiol group, L 6 and L 7 are independently substituted or unsubstituted C1 to C20 alkylene group, L 8 is a single bond, *-S-* or *-OC(=O)-*, L 9 is substituted or unsubstituted C1 to C20 alkylene group, and m is 1 An integer up to 20.
如請求項1所述的量子點,其中所述由化學式1表示的化合物是由化學式4表示:
Figure 109132893-A0305-02-0122-66
其中,在化學式4中,R4是由化學式1A表示,[化學式1A]
Figure 109132893-A0305-02-0123-67
其中,在化學式1A中,R3是「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C1至C20烷基」或者「未被取代或被乙烯基、烯丙基、環氧基或(甲基)丙烯酸酯基取代的C2至C20烯基」,L6及L7獨立地是經取代或未經取代的C1至C20伸烷基,L8是單鍵、*-S-*或*-OC(=O)-*,L9是經取代或未經取代的C1至C20伸烷基,且L10是由化學式1B-1-1、化學式1B-2-1、化學式1B-3-1、化學式1B-4-1、化學式1B-5-1、化學式1B-6-1及化學式1B-7-1中的一者表示,
Figure 109132893-A0305-02-0123-68
[化學式1B-2-1]
Figure 109132893-A0305-02-0124-69
Figure 109132893-A0305-02-0124-70
Figure 109132893-A0305-02-0124-71
[化學式1B-5-1]
Figure 109132893-A0305-02-0125-72
Figure 109132893-A0305-02-0125-73
Figure 109132893-A0305-02-0125-74
其中,在化學式1B-1-1至化學式1B-7-1中,Ra及Rb獨立地是羧基、*-P(=O)(OH)2或硫醇基,Rc是O、S、NH、C1至C20伸烷基、C1至C20烷基胺基或C2至C20烯丙基胺基,且m是1至20的整數。
The quantum dot as claimed in claim 1, wherein the compound represented by Chemical Formula 1 is represented by Chemical Formula 4:
Figure 109132893-A0305-02-0122-66
Wherein, in Chemical Formula 4, R 4 is represented by Chemical Formula 1A, [Chemical Formula 1A]
Figure 109132893-A0305-02-0123-67
Wherein, in Chemical Formula 1A, R 3 is "a C1 to C20 alkyl group that is unsubstituted or substituted by vinyl, allyl, epoxy or (meth)acrylate group" or "unsubstituted or substituted by vinyl "C2 to C20 alkenyl group substituted by alkyl, allyl, epoxy or (meth)acrylate group", L 6 and L 7 are independently substituted or unsubstituted C1 to C20 alkylene group, L 8 is a single bond, *-S-* or *-OC(=O)-*, L 9 is a substituted or unsubstituted C1 to C20 alkylene group, and L 10 is composed of Chemical Formula 1B-1-1, Chemical Formula Represents one of 1B-2-1, Chemical Formula 1B-3-1, Chemical Formula 1B-4-1, Chemical Formula 1B-5-1, Chemical Formula 1B-6-1, and Chemical Formula 1B-7-1,
Figure 109132893-A0305-02-0123-68
[Chemical formula 1B-2-1]
Figure 109132893-A0305-02-0124-69
Figure 109132893-A0305-02-0124-70
Figure 109132893-A0305-02-0124-71
[Chemical formula 1B-5-1]
Figure 109132893-A0305-02-0125-72
Figure 109132893-A0305-02-0125-73
Figure 109132893-A0305-02-0125-74
Among them, in Chemical Formula 1B-1-1 to Chemical Formula 1B-7-1, R a and R b are independently a carboxyl group, *-P(=O)(OH) 2 or a thiol group, and R c is O, S , NH, C1 to C20 alkylene group, C1 to C20 alkylamino group or C2 to C20 allylamine group, and m is an integer from 1 to 20.
如請求項1所述的量子點,其中所述由化學式1表示的化合物是由化學式3-1至化學式3-6中的一者表示:
Figure 109132893-A0305-02-0126-75
Figure 109132893-A0305-02-0126-76
Figure 109132893-A0305-02-0126-77
Figure 109132893-A0305-02-0126-78
Figure 109132893-A0305-02-0126-79
Figure 109132893-A0305-02-0126-80
其中,在化學式3-6中,n是1至20的整數。
The quantum dot of claim 1, wherein the compound represented by Chemical Formula 1 is represented by one of Chemical Formula 3-1 to Chemical Formula 3-6:
Figure 109132893-A0305-02-0126-75
Figure 109132893-A0305-02-0126-76
Figure 109132893-A0305-02-0126-77
Figure 109132893-A0305-02-0126-78
Figure 109132893-A0305-02-0126-79
Figure 109132893-A0305-02-0126-80
Wherein, in Chemical Formula 3-6, n is an integer from 1 to 20.
如請求項1所述的量子點,其中所述由化學式1表示的化合物是由化學式4-1表示:
Figure 109132893-A0305-02-0127-81
其中,在化學式4-1中,n是1至20的整數。
The quantum dot as claimed in claim 1, wherein the compound represented by Chemical Formula 1 is represented by Chemical Formula 4-1:
Figure 109132893-A0305-02-0127-81
Wherein, in Chemical Formula 4-1, n is an integer from 1 to 20.
如請求項1所述的量子點,其中所述量子點在500奈米至680奈米下具有最大螢光發射波長。 The quantum dot of claim 1, wherein the quantum dot has a maximum fluorescence emission wavelength between 500 nanometers and 680 nanometers. 一種無溶劑可固化組成物,包含如請求項1所述的量子點;以及可聚合單體,在末端處具有碳-碳雙鍵。 A solvent-free curable composition includes the quantum dot as described in claim 1; and a polymerizable monomer having a carbon-carbon double bond at the end. 如請求項11所述的無溶劑可固化組成物,其中所述可聚合單體具有220克/莫耳至1,000克/莫耳的分子量。 The solvent-free curable composition of claim 11, wherein the polymerizable monomer has a molecular weight of 220 g/mol to 1,000 g/mol. 如請求項11所述的無溶劑可固化組成物,其中所述可聚合單體由化學式5表示:
Figure 109132893-A0305-02-0127-82
其中,在化學式5中,R101及R102獨立地是氫原子或者經取代或未經取代的C1至C10烷基,L101及L103獨立地是經取代或未經取代的C1至C10伸烷基,且L102是經取代或未經取代的C1至C10伸烷基或醚基(*-O-*)。
The solvent-free curable composition as claimed in claim 11, wherein the polymerizable monomer is represented by Chemical Formula 5:
Figure 109132893-A0305-02-0127-82
Wherein, in Chemical Formula 5, R 101 and R 102 are independently a hydrogen atom or a substituted or unsubstituted C1 to C10 alkyl group, and L 101 and L 103 are independently a substituted or unsubstituted C1 to C10 alkyl group. Alkyl, and L 102 is substituted or unsubstituted C1 to C10 alkyl or ether group (*-O-*).
如請求項11所述的無溶劑可固化組成物,包含:1重量%至60重量%的所述量子點,及40重量%至99重量%的所述可聚合單體。 The solvent-free curable composition according to claim 11, comprising: 1 to 60 wt% of the quantum dots, and 40 to 99 wt% of the polymerizable monomer. 如請求項11所述的無溶劑可固化組成物,更包含聚合起始劑、光擴散劑或其組合。 The solvent-free curable composition as claimed in claim 11 further includes a polymerization initiator, a light diffusing agent or a combination thereof. 一種溶劑型可固化組成物,包含:如請求項1所述的量子點;黏合劑樹脂;及溶劑。 A solvent-based curable composition includes: the quantum dots described in claim 1; a binder resin; and a solvent. 如請求項16所述的溶劑型可固化組成物,包含1重量%至40重量%的所述量子點;1重量%至30重量%的所述黏合劑樹脂;以及餘量的所述溶劑。 The solvent-based curable composition according to claim 16, comprising 1 to 40% by weight of the quantum dots; 1 to 30% by weight of the binder resin; and the balance of the solvent. 如請求項16所述的溶劑型可固化組成物,更包 含可聚合單體、聚合起始劑、光擴散劑或其組合。 The solvent-based curable composition as described in claim 16, further including Contains polymerizable monomers, polymerization initiators, light diffusing agents or combinations thereof. 一種固化層,使用如請求項11所述的無溶劑可固化組成物或如請求項16所述的溶劑型可固化組成物來生產。 A cured layer produced using the solvent-free curable composition as described in claim 11 or the solvent-based curable composition as described in claim 16. 一種彩色濾光片,包括如請求項19所述的固化層。 A color filter including the cured layer described in claim 19.
TW109132893A 2019-10-14 2020-09-23 Quantum dot, curable composition comprising the same, cured layer using the composition, and color filter including the cured layer TWI833040B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2019-0127123 2019-10-14
KR1020190127123A KR102609622B1 (en) 2019-10-14 2019-10-14 Quantum dot, curable composition comprising the same, cured layer using the composition and color filter including the cured layer

Publications (2)

Publication Number Publication Date
TW202116720A TW202116720A (en) 2021-05-01
TWI833040B true TWI833040B (en) 2024-02-21

Family

ID=75538780

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109132893A TWI833040B (en) 2019-10-14 2020-09-23 Quantum dot, curable composition comprising the same, cured layer using the composition, and color filter including the cured layer

Country Status (4)

Country Link
KR (2) KR102609622B1 (en)
CN (1) CN114096640A (en)
TW (1) TWI833040B (en)
WO (1) WO2021075741A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102582006B1 (en) * 2021-02-24 2023-09-22 (주)유니암 Photosensitive resin composition, photocurable pattern formed from the same and image display comprising the pattern

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190004536A (en) * 2017-07-04 2019-01-14 삼성에스디아이 주식회사 Composition, quantum dot optical sheet, back light unit comprising the same and display apparatus
CN110297391A (en) * 2018-03-21 2019-10-01 东友精细化工有限公司 Light converts resin combination, light conversion layer folds substrate and image display device

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014159927A2 (en) * 2013-03-14 2014-10-02 Nanosys, Inc. Method for solventless quantum dot exchange
JP6299546B2 (en) * 2014-09-25 2018-03-28 Jsr株式会社 Curable resin composition, cured film, wavelength conversion film, light emitting element, and method for forming light emitting layer
US10889755B2 (en) * 2016-11-22 2021-01-12 Samsung Electronics Co., Ltd. Photosensitive resin composition, complex, laminated structure and display device, and electronic device including the same
CN108110144B (en) * 2016-11-25 2021-11-26 三星电子株式会社 Light emitting device and display device including quantum dots
JP6957876B2 (en) * 2016-12-28 2021-11-02 大日本印刷株式会社 Light wavelength conversion member, backlight device, and image display device
KR102554285B1 (en) * 2017-02-03 2023-07-10 동우 화인켐 주식회사 Quantum Dot Dispersion, Self Emission Type Photosensitive Resin Composition, Color Filter and Display Device
US10768485B2 (en) * 2017-07-05 2020-09-08 Nanoco Technologies Ltd. Quantum dot architectures for color filter applications
KR102270495B1 (en) * 2018-02-27 2021-06-29 삼성에스디아이 주식회사 Curable composition including quantum dot, manufacturing method of the quantum dot and color filter
JP7011055B2 (en) * 2017-10-27 2022-01-26 サムスン エスディアイ カンパニー,リミテッド Quantum dot-containing composition, quantum dot manufacturing method and color filter
KR102296790B1 (en) * 2018-02-06 2021-09-02 삼성에스디아이 주식회사 Photosensitive resin composition, photosensitive resin layer using same and color filter

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190004536A (en) * 2017-07-04 2019-01-14 삼성에스디아이 주식회사 Composition, quantum dot optical sheet, back light unit comprising the same and display apparatus
CN110297391A (en) * 2018-03-21 2019-10-01 东友精细化工有限公司 Light converts resin combination, light conversion layer folds substrate and image display device

Also Published As

Publication number Publication date
KR20210044044A (en) 2021-04-22
KR20230169894A (en) 2023-12-18
TW202116720A (en) 2021-05-01
KR102609622B1 (en) 2023-12-01
WO2021075741A1 (en) 2021-04-22
CN114096640A (en) 2022-02-25
KR102648364B1 (en) 2024-03-15

Similar Documents

Publication Publication Date Title
TWI689781B (en) Composition including quantum dot, manufacturing method of quantum dot and pixel and color filter
TWI824100B (en) Quantum dot, composition and cured layer using thereof, color filter and display device including the cured layer and method of manufacturing the cured layer
TW201743130A (en) Photosensitive resin composition, photosensitive resin layer and color filter using same
KR20190108366A (en) Photosensitive resin composition, photosensitive resin layer using the same and color filter
TWI786364B (en) Quantum dot, curable composition, curing layer, color filter and display device
TWI757888B (en) Quantum dot, curable composition comprising the same, cured layer using the composition, and color filter including the cured layer
KR102648364B1 (en) Quantum dot, curable composition comprising the same, cured layer using the composition and color filter including the cured layer
TWI833108B (en) Curable composition, cured layer using the same, and display device including cured layer
US11912911B2 (en) Quantum dot, curable composition comprising the same, cured layer using the composition and color filter including the cured layer
TWI789616B (en) Quantum dot, curable composition comprising the same, cured layer using the composition, color filter including the cured layer, and display device
KR102566511B1 (en) Photosensitive resin composition including quantum dot, photosensitive resin layer using the same and color filter
TW202337920A (en) Curable composition, cured layer using the composition,color filter including the cured layer and display device including the color filter
TW202315924A (en) Curable composition, cured layer using the composition, color filter including the cured layer, and display device including the color filter
TW202337921A (en) Curable composition, cured layer using the composition, color filter including the cured layer, and display device including the color filter
TW202315898A (en) Curable composition, cured layer using the composition, color filter including the cured layer, and display device including the color filter
TW202348637A (en) Curable composition, cured layer using the composition, color filter including the cured layer, and display device including the color filter
JP2023539515A (en) A curable composition, a cured film produced using the composition, and a color filter containing the cured film
KR20220036676A (en) Curable composition, cured layer using the same and display device including cured layer
KR20220115443A (en) Curable composition, cured layer using the same and display device including cured layer
TW202231837A (en) Curable composition, cured layer using the composition, color filter including the cured layer and display device including the color filter
KR20220115442A (en) Curable composition, cured layer using the same and display device including cured layer